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Summary 
DNA methylation belongs to a complex epigenetic regulatory network of processes and 
has been shown to be essential for normal embryonic development and plays a crucial 
role in gene silencing. Dnmt1 is the major DNA methyltransferase responsible for the 
inheritance of DNA methylation during replication and its catalytic activity is tightly 
regulated by its N-terminal domain, as well as accessory interacting factors. Our primary 
goal was to gain further insight on the role and regulation of crucial subunits within the N-
terminal domain of Dnmt1 and decipher their involvement in the enzyme’s catalytic activity 
in living cells.  Moving towards this end, we investigated the importance of the PCNA 
binding domain (PBD) and the CXXC zinc finger motif in mouse embryonic stem (ES) cells. 
For this purpose, we performed complementation and rescue assays in dnmt1-/- mouse ES 
cells, which allowed the analysis of the catalytic activity of Dnmt1 in vivo. In addition to 
classical methylation detection methods, such as bisulfite sequencing and COBRA, we 
established a quantitative method to analyze DNA methylation profiles by pyrosequencing. 
Using these approaches we showed that both N-terminal subunits of Dnmt1, PBD and 
CXXC zinc finger motif seem to be dispensable for the enzyme’s catalytic activity in living 
cells, although the PBD interaction with PCNA, enhances the activity of Dnmt1 by two-
fold.  
Next we attempted to address a rather controversial function of Dnmt1, which is its 
possible involvement in de novo methylation of unmethylated DNA sequences in vivo, a 
function, which is first and foremost established by Dnmt3a and Dnmt3b. To this aim, we 
developed a new FACS based approach for the generation of stable ES cells lines and 
succeeded in establishing triple knockout (dnmt1-/-, dnmt3a-/- dnmt3b-/-) ES cells that 
stably express a Dnmt1 expression construct. Pyrosequencing was employed as a highly 
sensitive method, in order to monitor even subtle changes on the methylation level 
changes of those cell lines, aiming to clarify the possible de novo methylation activity of 
Dnmt1. Using this approach, we succeeded in clearly demonstrating that Dnmt1 has no 
detectable de novo methylation activity in this system, favoring its unique function in 
maintaining DNA methylation.  
Finally, due to the important known interaction between Dnmt1 and Np95, which has been 
shown to be crucial for DNA methylation maintenance, we were interested in looking into a 
possible interaction between Np95 and the de novo methyltransferases, Dnmt3a and 
Dnmt3b and its functional significance. By co-immunoprecipitation experiments, we found 
that there is an even stronger interaction between Np95 and the de novo 
methyltransferases compared to its interaction with Dnmt1. To resolve a possible function 
and therefore, the physiological role of this interaction, we developed a fluorescent CMV 
promoter-silencing assay in vivo. By the use of this assay we were able to detect an 
involvement of several epigenetic factors in this silencing mechanism. Interestingly, we 
found that apart from Np95, Dnmt3a and Dnmt3b, additionally histone-modifying 
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enzymes, such as G9a, are involved in silencing of the CMV promoter. Moreover, we 
clearly showed that DNA methylation is not required for the initiation of this silencing 
process. These findings point towards a silencing mechanism where histone modifications 
mediate the first step, which is then followed by DNA methylation. Still, to which extend 
this mechanism exists in vivo had to be further investigated. Considering the above, we 
proceeded by studying the involvement of Np95 and the active methyltransferases on 
silencing of endogenous promoter regions in vivo. For this purpose we differentiated wild 
type, dnmt and np95 knockout cell lines into embryoid bodies and monitored methylation 
level changes of pluripotency promoter regions during differentiation. In this system and in 
contrast to our previous findings, we observed that silencing of the pluripotency factors 
oct4 and nanog is initially independent of Np95 and the DNA methyltransferases Dnm1, 
Dnmt3a and Dnmt3b. Taken together, our data favor a silencing process that is initially 
independent of DNA methylation and suggest that DNA methylation is required for long 
term and stable gene silencing.  
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1.  [Introduction]  
C.H. Waddington first introduced the Epigenetic Landscape as a metaphor for biological 
development in 1945. He coined the term epigenetics from epi (Greek for over, above) and 
genetics to describe the study of “casual interactions between genes and their products, 
which bring their phenotypes into being.” (Waddington,1954). In mammals and other 
multicellular organisms, all cells carry the same genetic information encoded in the 
deoxyribonucleic acid (DNA) sequence. Yet different cell lineages show a broad range of 
functional and morphologic diversity, which results from different patterns of 
transcriptionally active and silent genes. Epigenetic research studies the mechanisms that 
generate and maintain different patterns of gene expression without changing the DNA 
sequence. On one hand, epigenetic processes stabilize expression patterns to preserve 
cell type identity, while on the other hand, they must allow cells to respond to 
environmental and developmental cues and therefore must be highly dynamic. The 
molecular basis of epigenetic processes is complex and includes DNA and histone 
modifications. A large number of histone modifying enzymes can alter histone proteins 
through methylation, acetylation, phosphorylation and ubiquitination. 
The best-characterized DNA modification is the covalent addition of a methyl group to the 
5-carbon atom of cytosine (C), preferentially in a context followed by a guanine (G). These 
dinucleotides are called CpG sites and are surprisingly underrepresented in the genome, 
most likely because they are mutation hot spots (Coulondre et al, 1978) leading to CpG 
depletion during evolution. Apart from single CpG sites there are regions dense of CpG 
sites called CpG islands. In the human genome, around 30.000 CpG islands were 
identified. They are often found in promoter regions and first exons of many housekeeping 
genes where they are associated with regulatory functions (Bird, 1986; Antequera, 2003).  
In contrast to sparsely distributed CpG sites, which are highly methylated, CpG islands 
and sites within regulatory elements are often unmethylated (Antequera & Bird, 1993). 
Methylation in regulatory regions is inversely correlated with transcriptional activity of the 
associated gene. The correlation of methylation and gene activity makes the methylation 
analysis of regulatory regions an attractive tool to study gene activity. DNA methylation is 
involved in transcriptional repression by at least two described mechanisms. On one hand, 
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DNA methylation may directly preclude binding of transcription factors by preventing 
proteins that specifically bind methylated CpG sites to bind to their recognition site. On the 
other hand, methylcytosine-binding proteins recruit repressive chromatin modifiers and 
remodeling factors (Bird, 1986). DNA methylation is involved in gene silencing and has 
been shown to be crucial for embryonic development (Okano et al, 1999), genomic 
imprinting, (Li et al, 1993) X-inactivation in mammals (Beard et al, 1995)  and silencing of 
retroviral DNA elements (Dong et al, 2008).  
5-methylcytosine (5-mC) is often considered the 5th base in the genome. Recently, a family 
of proteins (TET) has been described that catalyzes the conversion from methylcytosine to 
hydroxymethylcytosine, which might be considered as the 6th base in the genome (Tahiliani 
et al, 2009). This modification has initially been found in genomic DNA of neurons 
(Kriaucionis & Heintz, 2009)  and mouse embryonic stem cells (Tahiliani et al, 2009). The 
function of this modification is still unclear. Hydroxymethylcytosine might be an 
intermediate product in the pathway of active demethylation and an epigenetic signal.  
1.1 Role of DNA Methylation in Development and Disease  
During development and differentiation distinct sets of genes are either activated or 
silenced by different epigenetic processes. These processes involve DNA methylation, 
histone modification, polycomb repressive complexes, as well as non-coding RNAs and 
lead to functional and morphological specialization of cell types and lineages. Once 
established, these patterns are maintained through cell division cycles and thus contribute 
to the identity of the differentiated state.  
Mammalian development is accompanied by dramatic changes in the epigenetic state, 
especially methylation of tissue specific genes, as well as global DNA methylation levels. 
Genome wide epigenetic reprogramming occurs in two waves of demethylation, first in 
early embryos and second in primordial germ cells (PGC’s) (Reik et al, 2001). During 
preimplantation, the paternal genome is rapidly and most likely actively demethylated while 
the maternal genome becomes passively demethylated through cell divisions until 
blastocyst stage (Reik et al, 2001). These passive and active demethylation processes 
remove most of the parental methylation marks. Subsequently, a wave of de novo 
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methylation establishes new cell type specific methylation profiles after implantation. 
Genomic imprinting is a specialized developmental mechanism where genes are allele 
specifically expressed depending on the parental origin. Only a small number of all genes 
are special imprinted genes and they are often organized in clusters.    
To investigate the role of methylation, mice with reduced methyltransferase activity were 
generated (Li et al, 1992; Li et al, 1993). The analysis of imprinted genes in these mice, 
such as H19, insulin-like growth factor 2 (Igf-2), and Igf-2 receptor (Igf-2r) has clearly 
demonstrated that DNA methylation is involved in the control of differential expression (Li 
et al, 1993). In PCGs methylation of imprints are erased and according to the parental 
origin newly established. However, imprinted genes are protected from this wave of 
erasure and de novo methylation that takes place after fertilization (Morgan et al, 2005). 
Specific patterns of gene expression are important to control cell identity and proliferation. 
Misregulation of DNA methylation can lead to tumorigenesis. Global, as well as gene-
specific changes of DNA methylation have been observed in the analysis of tumor cells. 
While cancer cells are locally hypermethylated they show global hypomethylation, which is 
often accompanied by chromosomal instability and nuclear disorganization (Dodge et al, 
2005). Additionally, hypomethylation can lead to oncogene expression, which directly 
affects growth control of cancer cells.  Gaudet and colleagues explored the involvement of 
DNA hypomethylation in tumorigenesis by generating hypomorphic dnmt1 mice (Gaudet, 
2003). Those mice showed a 90% reduced Dnmt1 expression level, were growth-
restricted and developed aggressive T-cell tumors several months after birth. Local 
hypermethylation often occurs in regulatory regions and CpG islands of tumorsuppressor 
genes and thus leads to their silencing. During tumorigenesis, epigenetic silencing often 
affects key signaling pathways by either disruption or activation of involved genes and is 
proposed to be an initial event (Feinberg & Tycko, 2004; Yamada & Jackson-Grusby, 
2005). The effect of DNA methylation was also extensively studied in the human colon 
cancer cell line HCT116, where hypermethylation of the sfrp genes was found to cause 
activation of the Wnt signaling pathway, and thereby aberrantly increased proliferation and 
expansion of stem-cell populations (Taketo, 2004). Moreover, in colon, lung and breast 
cancer cells the CDKN/p16 regulatory region was de novo methylated and thereby 
inactivated (Gonzalez-Quevedo et al, 2004). 
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Epigenetic mutations are in contrast to genetic alterations reversible, which makes them 
an interesting target for cancer therapy. For instance, DNA methyltransferase inhibitors like 
the nucleoside analogue 5`-aza-deoxycytidine (Decitabine) are already used in clinical 
studies for the treatment of breast and colon cancer (Yoo & Jones, 2006).  
Apart from involvement in tumor formation, epigenetic disregulations have also been 
shown to be involved in several other diseases, such as ICF (Immune deficiency, 
centromeric instability and facial abnormalities), Fragile X and RETT syndrome as well as 
the imprinting disorders Prader-Willi and Angelmann syndrome (Amir et al, 1999; Basehore 
& Friez, 2009; Zeschnigk et al, 1997; Hansen et al, 1999; Cassidy & Schwartz, 1998). The 
ICF syndrome is caused by a missense mutation in the dnmt3b gene affecting the catalytic 
C-terminal domain. Dnmt3b is one of the de novo methyltransferases and this mutation 
results in a loss of function.  ICF patients carry mutations in both Dnmt3b alleles resulting 
in hypomethylation of pericentromeric heterochromatin and genomic instability (Hansen et 
al, 1999; Xu et al, 1999). Interestingly, ICF is the only known epigenetic syndrome that is 
based on a genetic mutation in one of the DNA methyltransferase genes. 
Methyl cytosine binding protein 2 (MeCP2) is a protein that selectively binds methylation 
marks and induces chromatin compacting by recruiting remodeling factors. Mutations in 
the X-chromosome located mecp2 gene results in the neurodevelopmental disorder RETT 
and leads to a defective readout of DNA methylation and chromosome instability (Nan & 
Bird, 2001). Highest expression levels of MeCP2 have been found in brain tissues, which 
might explain the neuronal symptoms. Another X-chromosome linked epigenetic disorder 
is the Fragile-X syndrome. It is caused by an expansion of a trinucleotide repeat in the 
regulatory region of the FMR1 (fragile X mental retardation-1) gene (Basehore & Friez, 
2009). A trinucleotide expansion of over 200 repeats is subsequently methylated, which 
then results in silencing of the FMR1 gene. This gene is required for neural development 
and its silencing leads to mental retardation in patients (Basehore & Friez, 2009; Stöger et 
al, 1997). The imprinting diseases Prader-Willi (PWS) and Angelmann (AS) syndrome are 
special cases of epigenetic disorders (Cassidy & Schwartz, 1998). Many imprinted genes 
are organized in clusters. One of those clusters is located on chromosome 15 and a 
uniparental disomy 15, or a deletion in this region results in either PWS or AS. The clinical 
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symptoms differ drastically and depend on whether and where the deletion occurs in the 
maternally (AS) or paternally (PWS) inherited chromosome. 
1.2 DNA methyltransferases  
DNA methylation is established and maintained by a highly conserved family of DNA 
methyltransferases (Dnmts). So far, five members have been described (Dnmt1, 2, 3a, 3b 
and 3L) yet only three of them have been shown to be active DNA methyltransferases 
(Dnmt1, Dnmt3a and Dnmt3b). 
 
Figure 1-1 Schematic representation of the mammalian DNA methyltransferase family. All Dnmts exhibit a 
similar catalytic domain that features highly conserved catalytic motifs (I-X) The Dnmts differ in their 
regulatory region. Dnmt1 contains the PCNA binding domain (PBD), the pericentric heterochromatin 
targeting sequence (TS), a CXXC type zinc finger motif (ZnF), and two (BAH). The regulatory domains of 
Dnmt3a and 3b comprise a PWWP domain and a ATRX-like PHD domain. Dnmt2 has no regulatory domain 
and consists sonly of a catalytic part. The Dnmt3 like protein Dnmt3L has a small regulatory part including a 
PHD domain but lacks the essential motifs for catalytic activity.  
All active Dnmts consist of a unique variable N-terminal regulatory domain and a C-
terminal catalytic part that is highly conserved, even throughout different species (Goll & 
Bestor, 2005). Active Dnmts catalyze the transfer of a methylgroup from S-adenosyl L-
methionine (SAM) to the 5`-position of a cytosine base. Dnmt1, Dnmt3a and Dnmt3b are 
the best-characterized members of the DNA methyltransferase family comprising different 
functions and target sites. Dnmt3a and 3b establish methylation marks de novo during 
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development whereas Dnmt1 maintains DNA methylation during DNA replication. Even 
though Dnmt2 contains all conserved catalytic motifs, it shows only residual DNA 
methyltransferase activity (Hermann et al, 2003). Instead, Dnmt2 has been shown to 
methylate cytoplasmic tRNA (Goll et al, 2006). The Dnmt3-like protein Dnmt3L is a 
cofactor of the de novo methyltransferases. Interaction stimulates the catalytic activity of 
Dnmt3a and 3b and the interaction is essential for methylation of retrotransposable 
elements and maternal imprints (Bourc'his et al, 2001; Hata et al, 2002; Hu et al, 2008). 
Dnmt3L is the only member that lacks crucial catalytic motifs and is catalytically inactive 
(Aapola et al, 2001). 
1.2.1 Establishment of new methylation patterns - Dnmt3a and Dnm3b 
The establishment of new methylation marks predominately happens in a highly controlled 
way during embryogenesis and development of germ cells, and is catalyzed by members 
of the Dnmt3 family. Dnmt3a, Dnmt3b and their isoforms were first described in 1999 and 
are the only known active de novo methyltransferases (Okano et al, 1999). They are highly 
expressed in embryonic stem cells, down-regulated during differentiation and only little 
expression can be detected in somatic lineages, thus underlining a predominant role of de 
novo methylation during embryogenesis (Okano et al, 1999; Okano et al, 1998). 
Inactivation of both de novo methyltransferase genes results in early embryonic lethality, 
although embryonic stem (ES) cells (ESCs) show no measurable proliferation defect and 
undifferentiated cells grow normally under tissue culture conditions. Interestingly, knockout 
mice lacking either Dnmt3a or Dnmt3b die at different stages during embryonic 
development. Dnmt3a null mice showed a significant growth defect and died roughly 4 
weeks after birth. In contrast, dnmt3b null mice were not viable and several developmental 
defects were observed in these embryos. This significant difference suggests a major role 
of Dnmt3b during early development while Dnmt3a has a predominant role later in 
development (Okano et al, 1999). Methylation of repetitive sequences, such as major and 
minor satellite sequences, and intracisternal A-particle (IAP) elements were analyzed and 
compared in single and double null (dnmt3a -/-, dnmt3b -/-; DKO) ES cells. Interestingly, only 
cells lacking Dnmt3b or both Dnmt3’s show an extensive lack of methylation at minor 
satellite repeats, suggesting that minor satellites are exclusively methylated by Dnmt3b. 
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Like all active eukaryotic DNA methyltransferases, both de novo methyltransferases are 
comprised of a large regulatory N-terminal domain and a highly conserved C-terminal 
catalytic domain. The regulatory part is essential for protein-protein interactions, the 
correct targeting to specific sites and harbors several conserved domains like the PWWP 
and ATRX homology domain. Although Dnmt3a and Dnmt3b are highly similar in their 
protein structure they have distinct functions and different target sites.  
The ATRX-like PHD domain of Dnmt3a and Dnmt3b is similar to a domain of the 
chromatin associated X-linked ATRX protein, suggesting a role in protein-protein or 
protein-DNA interaction (Argentaro et al, 2007). The PHD domain of Dnmt3a interacts with 
histone deacethylase 1 (HDAC1) and is involved in transcriptional repression of tissue 
specific gene (Aoki et al, 1998; Fuks et al, 2001; Bachman et al, 2001).  
While structure and function of ATRX domain is similar in Dnmt3a and Dnmt3b, the PWWP 
domain has distinct functions in both enzymes and is thought to determine the functional 
differences of both enzymes. Dnmt3a and Dnmt3b are enriched at pericentric 
heterochromatin (PH) in ES cells. Mutations in the PWWP domain disrupt the association 
and correct targeting to PH and abolishes the capability of Dnmt3a and Dnmt3b to 
methylate satellite repeats (Chen et al, 2004). However, localization studies with GFP 
fusion proteins in mouse embryonic fibroblasts (NIH cells) suggest that localization of 
Dnmt3a and Dnmt3b is similar but not strictly identical. In those cells, Dnm3a was stronger 
and more obvious enriched at PH than Dnmt3b, which might be due to the preference of 
Dnmt3a to methylate major satellites while Dnmt3b preferentially methylates minor 
satellites (Chen et al, 2004). Mutations in the PWWP domain of Dnmt3b result, among 
others, in a lack of methylation of minor satellites (Xu et al, 1999). This might explain the 
chromosomal instability that accompanies the ICF syndrome. Taken together, Dnmt3a and 
Dnm3b are both required for de novo methylation but have distinct functions and target 
sites.  
1.2.2 Maintenance of DNA methylation patterns - Dnmt1 
Once established, DNA methylation marks have to be maintained after and during each 
replication cycle. Among the active methyltransferases, Dnmt1 was described first and 
later shown to be essential for maintaining DNA methylation during DNA replication in 
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proliferating cells (Bestor & Ingram, 1983; Leonhardt et al, 1992). Null mutation of the 
Dnmt1 gene results in drastically reduced, but stable levels of methylation. These dnmt1-/- 
ES cells carry only about 20% of the normal methylation levels, are impaired in their 
differentiation ability and the homozygous embryos cannot develop further than the 8-
somite stage (Li et al, 1992; Lei et al, 1996). However, dnmt1-/- ES cells grow surprisingly 
normal, while a knockout in differentiated somatic cells leads to a p53 induced apoptosis 
(Robertson et al, 2000).  
Among the methyltransferase family, Dnmt1 has the largest N-terminal regulatory region, 
which comprises several unique domains that define function and sequence specificity of 
the respective protein. In contrast to the de novo methyltransferases, Dnmt1 is regulated 
in a cell cycle dependent manner and protein expression levels peak during S-Phase 
(Robertson et al, 2000). The association of Dnmt1 with the replication machinery mediated 
by interaction of the PCNA binding domain (PBD) of Dnmt1 and the proliferation cell 
nuclear antigen (PCNA) is proposed to be an efficient mechanism to couple replication and 
maintenance of methylation (Chuang et al). Moreover, Dnmt1 has been found at sites of 
DNA damage and it has been described that PCNA recruits Dnmt1 via its PBD domain to 
those sites (Mortusewicz et al, 2005). In this study we further investigated the dynamics 
and role of the interaction of Dnmt1 with the replication machinery (Schermelleh et al, 
2007), as it will be discusses later on (see chapter 3.2) 
In addition to the association with the replication machinery, Dnmt1 localizes at 
heterochromatic regions especially in late S-Phase until early G1. This association with 
constitutive heterochromatin is mediated by the highly conserved and unique TS (targeting 
sequence) domain of Dnmt1 (Leonhardt et al, 1992). This targeting is independent of the 
replication machinery, histone modifications like H3K9 trimethylation and interacting 
proteins such as the histone modifying enzyme SUV39H1 and histone binding protein HP1 
(Easwaran et al., 2004). More importantly, it has been shown that the TS domain directly 
interacts with the nuclear protein Np95 (Uhrf-1) and thereby recruits Dnmt1 to 
hemimethylated DNA sites (Sharif et al, 2007; Bostick et al, 2007;  Achour et al, 2008). 
Recent structural studies indicate that the TS domain may have an autoinhibitory effect on 
the catalytic activity of Dnmt1 (Syeda et al, 2011). The Np95 protein could act in this 
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context as an activator of Dnmt1, which will be discussed later in more detail (see chapter 
3.2).  
Apart from PBD and TS, the regulatory N-terminal part comprises a CXXC Zinc finger, two 
Bromo-Adjacent Homology (BAH) domains and several nuclear localization signals (NLS). 
The zinc finger is composed of eight conserved cysteine residues that can bind two zinc 
ions.  This motif is thought to be essential for allosteric activation, catalytic activity of the 
enzyme, and was also shown to interact with the catalytic domain (Fatemi et al, 2001; 
Margot et al, 2000). DNA binding properties of the CXXC zinc finger of Dnmt1 have been 
discussed controversially. While the mouse Dnmt1 motif was described to bind 
preferentially to hemimethylated sites, the human DNMT1 zinc finger has been shown to 
bind to unmethlytated CpG sites (Pradhan et al, 2008; Fatemi et al, 2001).  Given that 
these studies used not only different species but also different start and endpoints of the 
constructs, binding properties of this motif still remains to be extensively studied. This 
specific motif and its function was subject of this work and our results will be discussed in 
light of recent publications later on.  
The regulatory part of Dnmt1 is linked via a flexible glycin-lysin linker to the highly 
conserved catalytic domain. Even though the catalytic domain contains all motives 
essential for catalytic activity described for bacterial methyltransferases, expression of the 
isolated catalytic domain of Dnmt1 did not show any catalytic activity (Margot et al, 2000). 
In fact, most of the N-terminal region including the TS domain is essential for protein 
activity and deletion of larger parts results in complete abolishment of enzymatic activity in 
vivo. Structure and function of Dnmt1 is extremely sensitive to deletions by disturbing the 
complex folding of the protein, arguing for a highly complex intra- and Intermolecular 
interplay between several domains and other proteins (Fellinger et al, 2009; Zimmermann 
et al, 1997). 
1.2.3 DNA methyltransferase Crosstalk 
A well established model divides the family of methyltransferases based on their functions. 
This model also supports the hypothesis that the methyltransferases have unique, non-
overlapping functions; either in maintenance of DNA methylation during replication (Dnmt1) 
or in establishing new methylation marks (Dnmt3a and Dnmt3b). However, a closer look at 
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available data suggests that crosstalk between the members of the family is fundamentally 
important and Dnmt1, Dnmt3 and Dnmt3b have overlapping roles in maintenance and de 
novo methylation.  
 
Figure 1-2 Maintenance and de novo methylation. Dnmt1 is the major enzyme that is maintains DNA 
methylation during replication. Dnmt3a and Dnmt3b are de novo methyltransferases that establish new 
methylation marks predominately during embryogenesis and differentiation. However, Dnmt3a and Dnmt3b 
have been shown to be involved in maintenance of special sequences and Dnmt1 is discussed to have de 
novo methylation activity, yet to which extent has still to be investigated.  
As mentioned above, Dnmt1 has a strong preference for hemi-methylated DNA in vitro, 
underlining its predominant role in maintaining DNA methylation during replication 
(Hermann et al, 2004b; Pradhan et al, 1999; Fatemi et al, 2001). However, it remains to be 
discussed whether Dnmt1 might also play a role in de novo methylation of certain sites 
within the genome. In contrast to all previous studies and clear classification of Dnmt’s in 
maintenance and de novo methyltransferases, studies indicated an additional role of 
Dnmt1 in de novo DNA methylation processes. By using a recombinant human DNMT1 
protein in an in vitro methylation assay, binding preference for hemi-methylated over 
unmethylated DNA were compared (Pradhan et al, 1999). Although DNMT1 showed a 
strong preference for hemimethylated DNA, this study suggests an additional de novo 
methylation activity on unmethylated DNA substrate. In addition, hypermethylation of 
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imprinted promoter regions have been found in tumor cells overexpressing Dnmt1, which 
also could hint to an involvement of Dnmt1 in de novo methylation (Biniszkiewicz et al, 
2002). However, clear data supporting a de novo activity of Dnmt1 in living cells is still 
missing. 
The division of de novo and maintenance methyltransferases is not strict and can be 
influenced in both directions. Dnmt1 and the de novo methyltransferase Dnmt3a 
cooperate during de novo methylation, which was shown by a fivefold stimulation of 
methylation activity if both enzymes are present in vitro (Fatemi et al, 2002). In addition, 
Dnmt1 and Dnmt3a efficiently methylated nucleosomal DNA in vitro and their N-terminal 
domains are essential for the binding ability to nucleosoms. Nucelosomes, compared to 
naked DNA reduce the accessibility of DNA binding proteins and enzymes to their 
substrate but reflects the native target form in living cells. Isolated catalytic domains of 
Dnmt1 and Dnmt3b, as well as the bacterial SssI methyltransferase are not able to bind 
DNA that is organized in higher order chromatin structures including nucleosomes. Only 
full-length Dnmt enzymes are able to bind nucleosomal DNA, indicating the significance of 
intra- and intermolecular interactions in regulating the methylatransferase activity including 
targeting, unwrapping the chromatin substrate and finishing the process by its enzymatic 
activity (Gowher et al, 2005; Okuwaki & Verreault, 2004)). 
Interestingly, Dnmt3a and Dnmt3b are also involved in maintenance of methylation 
patterns of specific sequences as well as global methylation patterns (Chen et al, 2003). 
Embryonic stem cells that lack both enzymes (dnmt3a-/-, dnmt3b-/- ; DKO) clearly show 
progressive loss of several analyzed sequences, including imprinted genes, repetitive 
elements, and non-imprinted genes (Liang et al, 2002). Moreover, 30% of the CpG sites in 
DKO cells were found to be hemimethylated. Given the fact that Dnmt1 is still present in 
those cells, this result underlines that Dnmt1 alone is not sufficient to fully maintain the 
methylation at those sites. 
In addition to the active methyltransferases, a Dnmt-like protein (Dnmt3L) is enzymatically 
inactive but essential for activity of the de novo methyltransferases (Aapola et al, 2004; 
Hata et al, 2002). Dnmt3L is highly expressed in ES and germ cells. In germ cells, Dnmt3L 
interacts with Dnmt3a leading to a methylation dependent silencing of retrotransposons 
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(Bourc'his et al, 2001). Furthermore, in ES cells maternal methylation-specific imprinting is 
dependent on the involvement of Dnmt3L (Bourc'his et al, 2001; Hata et al, 2002).  
Knockout ES cells that lack all three active methyltransferases (TKO) have no residual 
methylation, but grow surprisingly normal (Tsumura et al, 2006). Due to the complete 
abolishment of methylation as well as the lack of active methyltransferases, TKO cells are 
an attractive tool to study interaction, interplay and distinct functions of Dnmt1, Dnmt3a 
and Dnmt3b, which was a main subject of this work and will be discussed in detail later on 
(see chapter 3.3).  
1.3 Epigenetic Crosstalk 
The epigenetic code is composed of several factors including DNA methylation, chromatin 
modifications, non-coding RNAs and polycomb repressive complexes and influence 
cooperatively chromatin structures. In addition, a complex network is involved to 
determine and preserve a certain epigenetic state. Interactions of methyltransferases with 
chromatin modifying enzymes as well as methylcytosine binding proteins and other 
regulating proteins are essential key factors in this network. Together, DNA methylation 
and histone modifications regulate gene expression and chromatin structure in a 
cooperative way.  
Several groups have shown that Dnmt1 interacts with Np95, also known as Uhrf1 and that 
this interaction is essential for maintaining DNA methylation (Bostick et al, 2007; Sharif et 
al, 2007). Mouse ES cells with a genetic ablation of Np95 have a surprisingly similar loss of 
global as well as local, gene specific methylation comparable to dnmt1 null ES cells and 
both knockout mice show a similar developmental arrest (Sharif et al, 2007). These 
similarities underline the dependence of faithful DNA methylation maintenance on the 
interaction and presence of both enzymes. Np95 is a multi-domain protein that is able to 
bind hemi-methylated CpG sites via its SET and RING-finger associated (SRA) domain. It 
also mediates loading of Dnmt1 to heterochromatin replication sites. Correct localization 
and targeting of Np95 is dependent on methylated sites and the presence of Dnmt1. 
Immunofluorescence studies compared localization of both proteins and showed that they 
co-localize throughout S-Phase. Localization of Np95 to replication foci was completely 
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abolished in unmethylated TKO ES cells, while a higher enrichment of Np95 to replication 
foci was observed in dnmt1 null ES cells, which have a higher amount of hemimethylated 
sites (Sharif et al, 2007). Taken together, these findings underline the crucial role of Np95 
in maintenance of DNA methylation and a key role in targeting Dnmt1 to hemimethylated 
sites during S-Phase. Moreover, Np95 plays a additional role in linking DNA methylation 
with histone modification and binds specifically to histone 3 lysine 9 trimethylated tails 
(H3K9me3) via a tandem tudor domain (Rottach et al., 2009a). Recently, a new member of 
the Np95 family, Np97 (Uhrf 2), has been found that harbors similar domains like Np95 
(Bronner et al., 2007). However, little is know about the functional relevance of Np97 apart 
from its involvement in degradation of polyglutamine aggregates (Iwata et al., 2009).  
Histone 3 and 4 (H3K4) tails are highly modified and modifications at those sites contribute 
and determine chromatin structure and compaction. In particular, histone 3 lysine 9 (H3K9) 
methylation has been shown to correlate with regions of silenced genes within eu- and 
heterochromatic regions, while H3K4 methylation is often linked to active genes in 
euchromatin regions (Cowell et al, 2002; Litt et al, 2001). It was shown that the histone-
modifying enzyme G9a is specific for mono- and di- methylation, while the Suv39 class is 
responsible for trimethylation of H3K9 (Rea et al, 2000; Tachibana et al, 2008). 
Consequently, genetic loss of G9a decreases H3K9 methylation. Interestingly, Dnmt1 and 
G9a directly interact with each other and they have a surprisingly similar cellular 
distribution during replication and show similar embryonic lethality (Dong et al, 2008). In 
addition, knockdown of Dnmt1 results in an impaired G9a loading onto chromatin. Those 
findings indicate a coordinate link of histone methylation and the maintenance of DNA 
methylation. 
G9a not only interacts with Dnmt1 and but also with Np95 and the lymphoid specific 
helicase (Lsh) that is involved in chromatin remodeling and associated with pericentric 
heterochromatin (Jarvis et al, 1996; Myant et al, 2011). Moreover, Lsh has been found to 
interact with Dnmt’s and histone deacetylases (HDAC1 and HDAC2) suggesting a crucial 
role in linking histone remodeling complexes and DNA methylation for a cooperative 
transcriptional repression (Myant & Stancheva, 2008; Zhu et al, 2006). Knockout of LSH 
was shown to be lethal and crucial for embryonic development. Global DNA methylation, 
as well as methylation of repetitive and gene specific sequences is drastically reduced in 
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lsh-/- ES cells (Myant & Stancheva, 2008). These findings suggest an important role of Lsh 
in transcriptional repression by DNA methylation as well as interaction with histone 
deacetylases and thereby contributing to heterochromatic formation.  
Apart from histone deacethylases, histone demethylases are also linked to stable DNA 
methylation. A lysine-specific demethylase 1 (LSD1) has a dual role and specifically 
demethylates H3K4 and H3K9, but more astonishing also demethylates Dnmt1 and 
thereby stabilizes the protein. Lsd1 knock out ES cells have reduced levels of Dnmt1 and 
subsequently also reduced global DNA methylation levels (Wang et al, 2009). These results 
propose a link of DNA and histone methylation by a LSD1 that on one hand removes 
histone methylation marks, while it stabilizes Dnmt1 on the other hand and thereby 
assures faithful DNA methylation maintenance.  
Methylcytosine binding proteins (MBDs) are also key players in the complicated epigenetic 
network that links DNA methylation and histone modifications. The mammalian family of 
MBD’s consists of five members (MeCP2 and MBD1-4) whereas MeCP2, MBD1, MBD2 
and MBD4 specifically bind methylcytosine. In particular, a heterodimer of MBD2 and 
MBD3 recognizes and binds to hemimethylated CpG sites and directly interacts with 
Dnmt1 at late replication foci (Tatematsu et al, 2000). MeCP2 was the first described 
family member, binds to methylcytosine and subsequently recruits HDACs for further gene 
silencing (Nan et al, 1996).  
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Figure 1-3 Epigenetic crosstalk between DNA methylation and histone modifications. (A) Dnmt1 binds to 
PCNA via the PBD domain to the replication fork. Np95 (Uhrf1) binds to hemimethylated DNA, recruits 
Dnmt1 and thereby allows DNA methylation maintenance. Histone modifying enzymes such as Suv39, G9a 
and HDAC1/2 interact with Dnmt1 and Np95 and enforces further gene silencing by removing acetyl groups 
from histone tails (HADAC1/2) and adding methyl groups to H3K9 (G9a, Suv39). (B) De novo 
methyltransferases Dnmt3a and Dnmt3b interact with the Dnmt3-like protein Dnmt3L, which serves as an 
activating and regulating factor. LSD1 removes methylation from H3K9 where Dnmt3L can bind. (C) Long 
term gene silencing is mediated by HP1, which recruits Suv39 to generate more binding sites for HP1. 
(Rottach et.al. 2009) 
In summary, Dnmt1 and Np95 are loaded onto the replication machinery and interaction of 
Dnmt’s and Np95 with chromatin modeling factors such as G9a, Suv39h, Lsh and LSD1 
enforces further gene silencing (Myant & Stancheva, 2008; Viré et al, 2006). Methylcytosin 
reading proteins such as the MBD family bind methylated CpG sites and contribute to the 
compaction of the chromatin.  
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1.4 Mouse embryonic stem cells  
Pluripotency describes the capability of cells to differentiate into all three germ layers: 
ectoderm, endoderm and mesoderm. Pluripotent cells can only be found in early embryos 
and exist in a very short time frame during development. Mouse embryonic stem (ES) cells 
are obtained by isolating cells from the inner cell mass (ICM) of blastocysts and they 
maintain their pluripotent state and retain an undifferentiated state under special tissue 
culture conditions throughout many divisions (self-renewal). ES cells can differentiate in 
vitro and in vivo into all three germ layers, which makes them a valuable tool to study 
differentiation and early developmental processes. Moreover, ES cells can genetically be 
manipulated and knockouts of several important genes of the epigenetic network are 
viable although somatic cells lacking those proteins undergo apoptosis.  
Among several other transcription factors Oct4, Sox2 and Nanog are essential to maintain 
the pluripotent state and cell identify of the ICM as well as ES cell lineages (Avilion et al, 
2003; Babaie et al, 2007; Chambers et al, 2003). They are central players in a 
transcriptional network that on one hand activates genes necessary for survival while on 
the other hand they help repressing other genes that are involved in cellular differentiation 
processes. Upon differentiation, Oct4, Sox2 and Nanog are silenced and down regulated 
while cell type specific genes become activated (Boyer et al, 2005). Routinely, ES cells are 
grown on a layer of feeder cells or in the presence of the cytokine Leukemia Inhibitory 
Factor (LIF) to maintain their pluripotent state by inhibiting differentiation processes. LIF 
stimulates self-renewal of ESC’s through activation of the STAT-signaling pathway and 
upon removal of LIF spontaneous differentiation is initiated (Hall et al, 2009; Niwa et al, 
2009).  
To investigate the role of epigenetic factors during differentiation, ES cells can be 
differentiated in vitro. Several methods are used and established to differentiate ES cells.  
Differentiation can either be induced spontaneously by removal of LIF or by using various 
molecular factors that force differentiation into certain cellular lineages. A commonly used 
method is based on the three dimensional aggregation of ES cells into embryoid bodies 
(EBs) in absence of LIF (Keller, 1995). To generate EBs several methods can be used, 
either by culturing ES cells on bacterial plates that do not allow cell adhesion or by using 
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the “hanging drop” method. Under these conditions ES cells are able to aggregate and 
form a colony of differentiated cells, which resembles early embryonic development. The 
hanging drop method has been shown to be more efficient in forming EBs and provides a 
more homogenous differentiation process. 
 
Figure 1-4: Differentiation of ES cells into embryoid bodies (EB). Isolating cells from the ICM of blastocysts 
generates ES cells. They can be kept in culture over several passages without losing their pluripotent stage 
and self-renewal ability. Embryoid body formation is based on the three dimensional aggregation of ES cells 
under LIF removal and resembles early embryonic development. ES cells can differentiate into cell types from 
all three germ layers: mesoderm, ectoderm and endoderm.  
Upon stimulation of ESC’s with chemical defined reagents it is possible to direct the 
differentiation process into specific cell lineages. Among many other factors retinoic acid 
(RA) is widely used. It regulates growth control and plays a critical role in neuronal 
differentiation. RA treatment of ESCs induces growth arrest and differentiation into different 
neuronal cells such as radial glia cells (Bibel et al, 2004). 
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The capacity of ES cells to differentiate and their pluripotency can also be tested in vivo by 
injecting ES cells into immune-deficient mice (Doetschman et al, 1985). The injected cells 
proliferate and differentiate into teratomas. Cells of all three germ layers can be found in 
those tumor cells including also complex organ-like structures (Martin, 1981). Routinely, 
this is a common mode to test new ES cell lines for their pluripotency and differentiation 
ability.  
As mentioned before, ES cells lacking epigenetic key players such as DNA 
methyltransferases or histone modifying enzymes are able to tolerate genome-wide 
hypomethylation without being impaired in their ability to keep their undifferentiated 
characteristics and proliferation. However, they are often impaired and deficient in their 
differentiation capability. In this study the role of epigenetic factor during differentiation was 
addressed by methylation analysis and comparison of different ES lines that lack 
epigenetic factors (see chapter 2.7). 
1.5 Mapping DNA Methylation 
DNA methylation is altered in different tissues, various diseases and methylation levels 
change drastically during differentiation. Therefore, analysis of DNA methylation is a 
powerful early diagnosis tool in cancer diagnostics. The sensitivity of the selected method 
is crucial; especially when early methylation changes in cancer cells are investigated. 
Moreover, analysis and comparison of methylation in different cell types as well as in 
knockout cell lines can help understanding the complex regulation in the epigenetic 
network.  
1.5.1 Global Methylation 
Several methods are established to determine global methylation, including 
Immunostaining, methylation-specific restriction, and high performance separation 
techniques such as high-performance capillary electrophoresis (HPCE) and high-
performance liquid electrophoresis (HPLC) (Kuo et al, 1980; Fraga et al, 2000). 
Immunostaining with a 5-mC antibody is commonly used in tissue samples, as well as in 
cell culture. However, Immunostaining lacks high sensitivity and is not able to quantitatively 
measure the overall methylcytosine content. To obtain more accurate quantitative data, 
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methylation-specific restriction is used where genomic DNA is treated and digested with a 
methylation-specific enzyme. 
The most accurate methods to determine global methylation are HPLC and a HPEC 
based method, which has been shown to be more sensitive. For a HPLC analysis, 
genomic DNA is treated with ribonuclease enzymes to obtain single nucleosides, which 
are subsequently quantified. These methods provide highly accurate quantitative and 
specific data of the overall amount of methylcytosine. However, a large amount of genomic 
DNA for each sample is required. Recently, genome wide methylation analysis protocols 
that involve next generation high-throughput deep sequencing become available. The 
biggest challenge here is to overcome the huge amount of bioinformatics data sets that 
are generated, which also prevents these methods to be used in routine analysis. 
However, deep sequencing methods are very useful in clinical samples that involve 
analysis of global methylation levels as well as genome wide CpG promoter analysis in 
comparison to the transcriptome.  
1.5.2 Gene-Specific Methylation 
While global methylation measures the overall 5-methylcytosine content and genome wide 
analysis is often accompanied with a high amount of data sets, methylation analysis of 
specific promoter regions is widely used. To study sequence specific methylation levels 
and patterns, many methods are based on bisulfite treatment of the DNA followed by PCR 
amplification (Clark et al, 1994; Frommer et al, 1992). During bisulfite conversion cytosine 
is selectively deaminated to uracil, while 5-methylcytosine remain unchanged. In the 
subsequent PCR reaction methylated cytosine are amplified as cytosine and unmethylated 
cytosine results in a thymine, subsequently methylation levels can be determined by 
different methods. An effective method is the combined bisulfite restriction analysis 
(COBRA) where a specific sequence is amplified in a PCR reaction after bisulfite treatment. 
The PCR product is digested with enzymes that distinguish methylated from unmethylated 
sites. The digested fragments are separated on an agarose gel, thus resulting in a semi-
quantitative analysis (Xiong & Laird, 1997). However, COBRA is limited to the restrictions 
sites created in the analyzed sequences and only few CpG sites within the amplified 
sequence can be analyzed with this assay.   
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Classical bisulfite sequencing is often referred to as the gold standard in analyzing 
sequence specific DNA methylation levels, due to the fact that it provides detailed 
information of individual molecules at single CpG sites resolution. For this method, the 
bisulfite PCR is cloned into a bacterial expression vector and single clones are sequenced. 
This approach allows a detailed analysis of all CpG sites within each analyzed molecule. 
Despite the fact that this method allows to determine the status of each CpG site within a 
single molecule, generating quantitative data requires sequencing of a large number of 
clones. A method based on real-time sequencing technology overcomes these limitations 
(Ronaghi, 2001). 
 
Figure 1-5 Principle of pyrosequencing. A quantitative sequencing by synthesis method in which 
incorporated nucleotides are monitored bioluminometrically. Each nucleotide that is incorporated by a 
polymerase releases a pyrophosphate (PPi), which is used by sulfyrylase to generate ATP. Subsequently, 
ATP is used by luciferase to generate a light signal that is proportional to the amount of incorporated 
nucleotides. Apyrase degrades not incorporated nucleotides.  
Pyrosequencing is a sequencing-by-synthesis method in which the incorporation of 
nucleotides is monitored bioluminometrically. The intensity of response is directly 
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proportional to the amount of incorporated nucleotides. After bisulfite conversion of the 
genomic DNA, a region is amplified using a biotinylated primer and the PCR pool is 
subsequently pyrosequenced. By measuring the amount of cytosine (unmethylated 
cytosine) over the amount of thymine (methylated cytosine) at each CpG site a quantitative 
analysis is obtained (Tost et al, 2003; Tost & Gut, 2007). This study focused on the 
analysis of selected single copy gene promoters that are normally methylated in ES cells 
such as the skeletal α-actin promoter (Warnecke & Clark, 1999). This gene is expressed 
and unmethylated only in skeletal muscle cells and therefore serves as a good target to 
study re-methylation events in hypomethylated knock out ES cells. Repetitive elements, 
such as major and minor satellite sequences and IAP sequences were also studied to 
obtain a general overview of the methylation status within the studied genome.  
1.6 Aim of this work 
The aim of this study was to get further inside into the regulatory mechanism of epigenetic 
maintenance throughout cell cycle and differentiation, focusing on the maintenance DNA 
methyltransferase 1 and its interacting partner Np95.  
The first part of this study focused on the regulatory function and role of the PBD domain 
and the CXXC zinc finger motif of Dnmt1 in catalytic activity (see chapters 0 and 2.1). 
Dnmt1 interacts with the replication machinery by a PBD mediated interaction with the 
replication processivity factor PCNA and the CXXC zinc finger motif has been shown to be 
involved allosteric activation of Dnmt1. To address these questions, we performed rescue 
assays in hypomethylated dnmt1-/- ESC’s with a GFP-Dnmt1 construct that is either 
deficient in its binding ability to PCNA or a CXXC zinc finger deletion construct. We 
analyzed the mutant’s ability to restore DNA Methylation in promoter regions and repetitive 
elements.  
In the following the hypothesis was addressed whether Dnmt1 has an additional role in de 
novo methylation besides it’s predominate role in maintaining DNA methylation during 
replication (see chapter 2.3 and 2.4) Overlapping roles for Dnmt1 and for the de novo 
methyltransferases Dnmt3a and Dnmt3b has been controversially discussed. To address 
this question, we used mouse dnmt1-/-dnmt3a-/-dnmt3b-/- (TKO) ESC’s that are devoid of 
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any methylation. These cell lines are deficient in all three active DNA methyltransferases: 
Dnmt1, Dnmt3a and Dnmt3b which results in a complete lack of methylation. This makes 
them a powerful tool to study activity and regulation of methyltransferases in vivo. Due to 
the slow kinetics of the methyltransferase reaction, it was imperative to generate stable cell 
lines expressing the respective DNA methyltransferase. In this study a new FACS based 
approach in generating stable GFP fusion protein expressing cell lines was established. 
We analyzed promoter regions and repetitive elements for de novo methylation using a 
pyrosequencing-based assay to obtain quantitative data.  
During the generation of stable cell lines, we observed that the commonly used 
cytomegalovirus (CMV) promoter for ectopic expression constructs was silenced in the 
respective ESCs. To obtain further inside into the mechanism of CMV promoter silencing 
in mouse ESCs we established a promoter-silencing assay using fluorescent reporters (see 
chapter 2.6). We analyzed several ESCs deficient for key players in the epigenetic network 
to address the question whether DNA methylation or histone modification changes are 
required in this process.  Interestingly, we showed that in the absence of the Dnmt1 
interacting partner Np95, mouse ES cells are not able to silence the CMV promoter, 
although all three DNA methyltransferases are present in those cells. Consequently, we 
determined the role of Np95 and the DNA methyltransferases in epigenetic silencing of 
endogenous promoters by differentiating mouse ESCs into embryoid bodies (see chapter 
2.7 and 2.8). By analysis of the methylation profile of pluripotency gene promoter regions 
we addressed the role of DNA methyltransferases as well as Np95 in silencing of 
pluripotency genes during differentiation.  
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2. [Results]  
 
 
 
 
 
 
Dynamics of Dnmt1 interaction with the replication 
machinery and its role in postreplicative maintenance of 
DNA methylation 
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2.1 Dynamics of Dnmt1 interaction with the replication machinery and its role in 
postreplicative maintenance of DNA methylation 
Nucleic Acids Research, 2007, 1–12
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ABSTRACT
Postreplicative maintenance of genomicmethylation
patterns was proposed to depend largely on the
binding of DNA methyltransferase 1 (Dnmt1) to
PCNA, a core component of the replication machin-
ery. We investigated how the slow and discontinu-
ous DNA methylation could be mechanistically
linked with fast and processive DNA replication.
Using photobleaching and quantitative live cell
imaging we show that Dnmt1 binding to PCNA is
highly dynamic. Activity measurements of a PCNA-
binding-deficient mutant with an enzyme-trapping
assay in living cells showed that this interaction
accounts for a 2-fold increase in methylation effi-
ciency. Expression of this mutant inmouse dnmt1/
embryonic stem (ES) cells restored CpG island
methylation. Thus association of Dnmt1 with the
replication machinery enhances methylation effi-
ciency, but is not strictly required for maintaining
global methylation. The transient nature of this
interaction accommodates the different kinetics of
DNA replication and methylation while contributing
to faithful propagation of epigenetic information.
INTRODUCTION
Genomic DNA in mammalian cells is commonly methyl-
ated at position 5 of cytosine residues in CpG sequences.
This epigenetic modification plays an important role in the
regulation of gene expression and chromatin structure and
is essential for normal development, cell differentiation,
X chromosome inactivation and genomic imprinting (1,2).
Cell-type-specific methylation patterns are established de
novo in early developmental stages by the action of
Dnmt3a and 3b and are then maintained through
subsequent cell generations primarily by the action of
Dnmt1 (3,4). In somatic cells, Dnmt1 is the predominant
DNA methyltransferase in terms of abundance, contribu-
tion to global methyltransferase activity and to genomic
methylation levels (2,5). Reduction of Dnmt1 levels leads
to hypomethylation, genomic instability and cancer (6).
Aberrant genomic methylation is often associated with
human disease and tumorigenesis (7).
Due to its strong preference for hemimethylated
substrate DNA in vitro (8–10) and its accumulation at
replication sites during S-phase (11,12) Dnmt1 is thought
to act on hemimethylated CpG sites generated during
DNA replication. The association of Dnmt1 with
replication factories was proposed as an efficient
mechanism for coupling maintenance of genomic methyl-
ation patterns to DNA replication (11). Later, direct
interaction with the replication processivity factor PCNA
was shown and a small PCNA-binding domain (PBD)
was mapped to the N-terminal region of Dnmt1 (12,13).
This domain was also shown to be necessary for
recruitment of Dnmt1 to DNA damage sites, suggesting
that it is responsible for coupling DNA repair and
restoration of methylation patterns (14). Thus, direct
interaction with PCNA would ensure that methylation
patterns are faithfully preserved in different situations
involving DNA synthesis. However, DNA replication is
highly processive taking about 0.035 s per nucleotide
(15), while in vitro steady-state kinetic analysis of purified
recombinant Dnmt1 revealed rather low turn-over rates
of about 70–450 s per methyl group transfer (16).
Although DNA methylation by Dnmt1 may be faster
in vivo, it is not likely to come close to the 3–4 orders of
magnitude faster DNA replication. In fact, cytosine
methylation is a highly complex reaction involving
recognition of hemimethylated CpG sites, binding of
S-adenosylmethionine, flipping of the cytidine base out
of the double helix, formation of a covalent bond
between the enzyme and the cytidine, transfer of the
methyl group and release of the covalent bond by
b-elimination (17–19). These considerations leave open
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the question of how DNA replication and methylation
are kinetically and mechanistically coordinated.
In addition to Dnmt1 several other factors directly and
indirectly involved in DNA replication, such as DNA
Ligase I, Fen1, CAF-1 and Cyclin A have been shown to
redistribute to replication foci during S-phase (20–24).
Many of these factors have been found to interact directly
with PCNA, which forms a homotrimeric ring around the
DNA helix and serves as a platform for tethering them to
the replication machinery (25). Even taking into account
the trivalent nature of the PCNA ring, the sheer number
of its potential binding partners during replication makes
it clear that they cannot all possibly bind at the same time
in a constitutive manner.
The functional relevance of the interaction between
Dnmt1 and PCNA and its contribution to the main-
tenance of epigenetic information after DNA replication,
however, remains unclear. We have addressed this
question by comparing the kinetics and activity of GFP-
tagged wild-type Dnmt1 and PCNA-binding-deficient
mutants in live cell assays and Dnmt1 deficient embryonic
stem (ES) cells. Our data show that the interaction of
Dnmt1 with PCNA is highly transient, increases the
efficiency of postreplicative methylation by 2-fold, but is
not required for restoring CpG methylation in Dnmt1
deficient ES cells.
MATERIALS AND METHODS
Expression constructs
The expression constructs RFP-PCNA, GFP-Ligase,
GFP-Dnmt1wt, GFP-Dnmt11-171, GFP-Dnmt1C1229W as
well as the PBD-GFP construct were described earlier
(13,21,26,27). The GFP-Dnmt1Q162E and GFP-
Dnmt1F169S expression constructs were derived from the
GFP-Dnmt1wt construct by overlap extension PCR
mutagenesis (28,29) using the outer forward primer
50-CAG ATC TCG AGC TCA AGC TTC-30, the inner
reverse primer 50-GTG TCA AAG CTC TGA TAG ACC
AGC-30, the inner forward primers 50-GAACCACCAG
GGAGACCACCATC-30 for Q162E and 50-CACGGCTC
ACTCCACGAAGG-30 for F169S and the outer reverse
primer 50-CTGGAATGACCGAGACGCAGTCG-30.
The final PCR fragments containing the mutations were
digested with BglII and HindIII and exchanged with the
corresponding fragment in the GFP-DNMT1wt construct.
Mutations were confirmed by DNA sequencing and
molecular size of fusion proteins was tested by expression
in HEK 293T cells and western blot analysis. For stable
transfections we inserted the cassette containing the wt
Dnmt1 cDNA fused to GFP from the GFP-Dnmt1wt
construct into the pCAG-IRESblast vector (30).
Cell culture, transfection and FACS-sorting
Human embryonic kidney (HEK) 293T cells and mouse
C2C12 myoblasts were cultured in DMEM supplemented
with 10% and 20% fetal calf serum, respectively, and
50 mg/ml gentamycine. HEK 293T cells were transfected
with polyethylenimine (Sigma) (31). For live cell observa-
tions C2C12 myoblasts were grown to 30-40% confluence
on Lab-Tek chamber slides (Nunc) or m-slides (Ibidi)
and transfected with TransFectin transfection reagent
(Bio-Rad) according to the manufacturer’s instructions.
Cells were then incubated overnight before performing
live cell analysis. Nuclear localization of GFP-Dnmt1wt
was identical to endogenous Dnmt1 as determined by
immunostaining with an affinity purified polyclonal
antiserum against the N-terminal domain of mouse
Dnmt1. GFP-Dnmt1 localization was not affected by
additional co-expression of RFP-PCNA (controls not
shown). Dnmt1 immunostaining showed that typical
expression levels of transfected GFP-Dnmt1 constructs
in cells selected for live cell imaging were comparable to
those of endogenous Dnmt1 protein (Supplementary
Figure 1). For stable expression of GFP-Dnmt1wt,
C2C12 cells were grown in a p100 tissue culture dish
and transfected as described earlier. Cells were then
cultured with 10 mg/ml blasticidin for at least 20 days
before homogeneity and levels of expression were deter-
mined by fluorescence microscopy and western blotting
(Supplementary Figure 2). Mouse wild type and dnmt1/
J1 ES cells (s allele) (5) were cultured without feeder cells
in gelatinized flasks as described (27). J1 cells were
transfected with Transfectin (BioRad) 3–4 h after seeding
and GFP-positive cells were sorted with a FACS Vantage
SE cell sorter (Becton–Dickinson).
Co-immunoprecipitation
HEK 293T cells were transiently transfected with
expression plasmids as described above. After 48 h about
70–90% of the cells expressed the GFP constructs as
determined by fluorescence microscopy. Extracts from
1 107 cells were prepared in 200 ml of lysis buffer
(20mM Tris/HCl pH 7.5, 150mM NaCl, 0.5mM EDTA,
2mM PMSF, 0.5% NP40). After centrifugation super-
natants were diluted to 500 ml with lysis buffer without
NP40. Extracts were incubated with 1 mg of a GFP-
binding protein coupled to sepharose (manuscript in
preparation) for 1 h at 48C with constant mixing.
Immunocomplexes were pulled down by centrifugation.
The supernatant was removed and 50 ml were collected
(referred to as non-bound). The beads were washed twice
with 1ml of dilution buffer containing 300mM NaCl and
resuspended in SDS-PAGE sample buffer. Proteins were
eluted by boiling at 958C and subjected to SDS-PAGE
followed by immunoblotting. Antigens were detected with
a mouse monoclonal anti-GFP antibody (Roche) and a
rat monoclonal anti-PCNA antibody (32).
In vitromethyltransferase assay
Extracts from HEK 293T cells expressing the indicated
GFP constructs were prepared and immunoprecipitations
were performed as described above. After washing with
dilution buffer containing 300mM NaCl the beads were
washed twice with assay buffer (100mM KCl, 10mM
Tris pH 7.6, 1mM EDTA, 1mM DTT) and resuspended
in 500 ml of assay buffer. After adding 30 ml of methyl-
ation mix {[3H]-SAM (S-adenosyl-methionine); 0.1mCi
(Amersham Biosciences), 1.67 pmol/ml hemimethylated ds
35 bp DNA (50 pmol/ml), 160 ng/ml BSA} incubation was
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carried out for 2.5 h at 378C. The reactions were spotted
onto DE81 cellulose paper filters (Whatman) and the
filters were washed 3 times with 0.2M (NH4)HCO3, once
with ddH2O and once with 100% ethanol. After drying,
radioactivity was measured by liquid scintillation. Samples
without enzyme and with 2mg of purified human
recombinant DNMT1 were used as negative and positive
controls, respectively.
Combined bisulfite restriction analysis (COBRA)
Genomic DNA was isolated by the phenol–chloroform
method (33) and bisulfite treatment was as described (34)
except that deamination was carried out for 4 h at 558C.
Primer sets and PCR conditions for CpG islands of
skeletal -actin, H19 (region A) and dnmt1o promoters,
Xist exon 1 and intracisternal type A particle long terminal
repeats (IAP LTRs) were as described (35–39). PCR
products were digested with the following enzymes:
skeletal -actin and dnmt1o promoters and IAP LTRs
with HpyCH4IV (New England BioLabs); H19 with
Bsh136I and Xist with TaqI (both from Fermentas).
Digests were separated by agarose electrophoresis except
for IAP LTR fragments, which were separated in 10%
acrylamide gels. Digestion fragments were quantified from
digital images using ImageJ software (http://rsb.info.nih.
gov/ij/). The results were corrected for PCR bias, which
was calculated as described (40). Briefly, COBRA assays
were performed on genomic DNA from untransfected
Dnmt1/ J1 cells methylated in vitro with recombinant
SssI methyltransferase (New England BioLabs) and mixed
in different proportions with unmethylated DNA from the
same cells (Supplementary Figure 6). Bias curves and
corrections were calculated using WinCurveFit (Kevin
Raner Software). For each amplified sequence digestion
with restriction enzymes whose recognition sequence
includes cytosine residues in a non-CpG context was
used to control for complete bisulfite conversion except
for the skeletal -actin promoter, where bisulfite sequen-
cing revealed about 99% conversion efficiency in all
samples (Supplementary Figure 5).
Live cell microscopy, FRAP analysis and trapping assay
Live cell imaging and FRAP experiments were performed
on a TCS SP2 AOBS confocal laser scanning microscope
(Leica) using a 63 /1.4NA Plan-Apochromat oil immer-
sion objective. The microscope was equipped with a
heated environmental chamber set to 378C. Fluorophores
were excited with the 488 nm line of an argon laser and a
561 nm solid state diode laser. Confocal image series were
typically recorded with a frame size of 256 256 pixels, a
pixel size of 100 nm, and with 150ms time intervals. The
laser power was typically set to 2–4% transmission with
the pinhole opened to 3 Airy units. For FRAP analysis,
half of the nucleus was photobleached for 300ms with all
laser lines of the argon laser set to maximum power at
100% transmission. Typically 20 prebleach and 400
postbleach frames were recorded for each series.
Quantitative evaluation was performed using ImageJ.
The mean fluorescence intensities of the bleached
and unbleached region for each time point were back-
ground subtracted and normalized to the mean of the last
10 prebleach values (single normalized). These values were
divided by the respective total nuclear fluorescence in
order to correct for total loss of nuclear fluorescence as
well as for the gain of nuclear fluorescence due to import
from the cytoplasm over the time course (double normal-
ized). Since the fluorescence in the bleached region differed
from cell to cell and typically did not reach background
level the values were also normalized to zero. Here, only
the distal two-thirds of the unbleached part in the first
postbleach frame were considered as reference to take into
account fast diffusing molecules invading into the
bleached half (triple normalized). For each construct
and cell cycle stage 6–10 nuclei were averaged and the
mean curve as well as the standard error of the mean
(SEM) was calculated. Half times of recovery were
calculated from the mean curves.
The trapping assay to measure postreplicative methyla-
tion efficiency in living cells was previously described (27).
5-Aza-20-deoxycytidine (Sigma) was added at a final
concentrations of 30 mM and cells were incubated for the
indicated periods before performing FRAP experiments.
Microscope settings were as described above except that a
smaller ROI (3mm 3 mm) was selected and the time
interval was set to 208ms. FRAP data were double
normalized as described above.
For presentation, we used linear contrast enhancement
on entire images. For color figures we chose magenta as
false color for red fluorescence to accommodate for
colorblindness.
RESULTS
Point mutations within the PBD abolish the interaction of
Dnmt1 with PCNA
We recently demonstrated a loss of association with
replication foci in early and mid S-phase of a GFP-Dnmt1
fusion construct with a deletion of the first 171 amino
acids which includes most of the PBD (GFP-Dnmt11-171)
(13). To address the function of the PBD in early and mid
S-phase more specifically and to exclude potential
misfolding of the protein due to the large deletion we
have generated GFP-Dnmt1 constructs bearing single
point mutations of highly conserved residues within the
PIP (PCNA-interacting peptide)-Box (41) of the PBD
(GFP-Dnmt1Q162E and GFP-Dnmt1F169S) (Figure 1).
Either of these mutant constructs were expressed in
C2C12 mouse myoblasts together with RFP-PCNA,
which served as S-phase marker (42). Both Dnmt1
constructs showed a diffuse nuclear distribution in early
and mid S-phase cells (Figure 2B and Supplementary
Figure 3), in contrast to the wild-type Dnmt1 construct
(GFP-Dnmt1wt) which was concentrated at replication
foci during early and mid S-phase (Figure 2A). In late
S-phase and G2, however, the wild type as well as all the
PBD mutant constructs, including GFP-Dnmt11–171,
were similarly concentrated at chromocenters (Figure 2A
and B and Supplementary Figure 1), confirming the
additional binding to heterochromatin in late S-phase
mediated by the TS domain (13). Co-immunoprecipitation
experiments confirmed that the Q162E point mutation
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abolishes the interaction between Dnmt1 and PCNA
(Figure 2C). Similar results were obtained with GFP-
Dnmt1F169S and GFP-Dnmt11–171 (Supplementary
Figure 3). Thus, both Q162E and F169S point mutations
prevent accumulation of Dnmt1 at replication foci during
early to mid S-phase, while localization at constitutive
heterochromatin in late S-phase and G2 is not affected.
These results clearly confirm the role of the PBD in
mediating the interaction between Dnmt1 and PCNA
in vivo.
The PBD-mediated interaction of Dnmt1 at replication sites
is highly transient
To investigate the dynamics of the PBD-mediated inter-
action at replication sites we measured fluorescence
recovery after photobleaching (FRAP) of GFP-Dnmt1wt
throughout S-phase. GFP-Dnmt1wt and RFP-PCNA were
co-expressed in C2C12 cells and a small square region of
interest (ROI) was bleached (Figure 3). Consistent with
earlier observations (26,43) RFP-PCNA showed hardly
any recovery within the observation period of 100 s,
whereas in the same period GFP-Dnmt1 recovered fully,
with very similar kinetics in early and mid S-phase, but
notably slower in late S-phase. This result shows that the
binding of Dnmt1 at replication sites is more dynamic
during early and mid S-phase than in late S-phase, when
Dnmt 1 is likely slowed down by the additional interaction
with chromatin mediated by the TS domain (13).
To address the kinetic properties of the PBD-mediated
binding to replication sites more specifically, we per-
formed quantitative FRAP analysis of GFP-Dnmt1wt and
GFP-Dnmt1Q162E in G1 and early/mid S-phase. As
replication sites are not homogeneously distributed in
the nucleus, we chose to bleach half nuclei (half-FRAP) to
ensure that the bleached region contains a representative
number of potential binding sites (Figure 4A). In early/
mid S-phase nuclei GFP-Dnmt1wt recovered with a
halftime (t1/2) of 4.7 0.2 s and reached complete equili-
bration (t1) in about 56 s. These values place Dnmt1
among the more dynamic factors involved in chromatin
transactions previously determined with half-FRAP
analyses (44). In comparison to GFP-Dnmt1wt, GFP-
Dnmt1Q162E showed a slightly increased mobility
(t1/2=4.4 0.2 s; t1 45 s), which is likely due to
the lack of binding to PCNA rings at replication sites.
In the absence of active replication sites in G1, GFP-
Dnmt1wt and Dnmt1Q162E showed nearly identical
kinetics, which were remarkably similar to the kinetics
of Dnmt1Q162E in early/mid S-phase. These data indicate
that PCNA binding has only a minor contribution to
Dnmt1 kinetics in S phase.
The recovery rates measured for the full-length con-
structs were considerably slower than the rate of GFP
alone (t1/2=0.8 0.1 s; t1 10 s), which was used to
control for unspecific binding events. As t1/2 is roughly
proportional to the cubic root of the molecular mass
(45,46), the 8-fold size difference of GFP alone to the
full-length construct (27 and 210 kDa, respectively) would
only account for about a 2-fold slower recovery. Instead,
GFP-Dnmt1 full-length constructs recover more slowly,
pointing to one (or more) additional and yet uncharacter-
ized cell cycle independent interaction(s).
In order to dissect the PBD-mediated interaction from
superimposing effects caused by other potential interac-
tions we assayed the FRAP kinetics of a GFP fusion with
the isolated PBD of Dnmt1, i.e. amino acids 159–178
(PBD-GFP). We found that in S–phase the recovery
was only about 2 times slower than GFP alone
(t1/2=1.5 0.1 s; t1 16 s), thus confirming the highly
transient nature of the PBD interaction with PCNA. In
non-S-phase cells, PBD-GFP showed an increase in
mobility (t1/2=1.1 0.1 s; t1 11 s) similar to that
observed with the full-length wild-type construct.
For direct comparison we further analyzed another
PCNA-interacting enzyme, DNA Ligase I fused to GFP
(GFP-Ligase), and found a similar mobility shift in S
phase (t1/2=2.4 0.3 s; t1 27 s) compared to non-S-
phase cells (t1/2=2.1 0.3 s; t1 17 s). Thus, with all
three PCNA-interacting GFP fusion proteins (GFP-
Dnmt1wt, PBD-GFP and GFP-Ligase), but not with the
PCNA-binding mutant, the transient association with the
replication machinery (PCNA) caused a slower recovery
as compared to G1/non-S-phase (Figure 4B, inset).
Together the limited but significant contribution of the
PBD-mediated interaction to the kinetic properties of
GFP-Dnmt1 and the high mobility of PBD-GFP in
Figure 1. Structure of Dnmt1 and alignment of PCNA-binding
domains (PBD). (A) Schematic representation of the mouse Dnmt1
consisting of an N-terminal regulatory and a C-terminal catalytic
domain. The PBD, the TS domain, the Zn-binding domain (Zn), the
two bromo-adjacent homology domains (BAH) and the catalytic center
(PC motif) are highlighted. (B) Alignment of Dnmt1 PBDs from
different species. Highly conserved residues are gray shaded. Accession
numbers: Mus musculus P13864; Homo sapiens P26358; Rattus
norvegicus Q9Z330; Bos taurus Q6Y856; Sus scrofa Q4TTV6; Ovis
aries Q865V5; Gallus gallus Q92072; Monodelphis domestica Q8MJ28;
Xenopus laevis Q6GQH0; Paracentrotus lividus Q27746; Xiphophorus
maculatus Q9I8X6; Brachydanio rerio Q8QGB8. (C) Alignment of
PBDs in different proteins from Mus musculus. Gray shaded amino
acids are highly conserved within the PIP-Box. Accession numbers:
Dnmt1 P13864; Fen1 P39749; p21 P39689; DNA Ligase1 P37913;
Polymerase d/subunit p66 Q9EQ28; XPG P39749; UNG:P97931
MSH6 P54276.
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S–phase clearly indicate that binding of Dnmt1 to PCNA
at replication foci is highly transient.
Interaction with PCNA enhances methylation efficiency
in vivo only moderately
Next we investigated the contribution of the highly
transient interaction with PCNA to the postreplicative
methylation activity of Dnmt1. Earlier it was shown that
N-terminal deletions of mouse Dnmt1 comprising the
PBD did not alter catalytic activity in vitro (47,48). To test
the catalytic activity of the GFP-Dnmt1 constructs used in
this study they were expressed in HEK 293T cells,
immunopurified and directly assayed for methyltransfer-
ase activity in vitro. While the catalytically inactive GFP-
Dnmt1C1229W mutant (27) displayed only background
activity, GFP-Dnmt1Q162E and GFP-Dnmt11-171 exhib-
ited enzymatic activity comparable to GFP-Dnmt1wt
(Figure 5D), indicating that neither the Q162E point
mutation nor deletion of the first 171 amino acids affect
the enzymatic activity of Dnmt1.
Figure 2. Mutation of the PBD abolishes Dnmt1 interaction with PCNA and prevents accumulation at replication sites in early and mid S-phase.
(A, B) Confocal mid sections of living mouse C2C12 myoblasts expressing either GFP-Dnmt1wt (A) or GFP-Dnmt1Q162E (B). Cells were co-
transfected with RFP-PCNA to identify replication foci and to distinguish S-phase stages. Scale bars: 5mm. GFP-Dnmt1wt accumulates at replication
sites throughout S phase where it co-localizes with RFP-PCNA. In G2 cells a fraction of Dnmt1 remains associated with the late replicating
pericentric heterochromatin. In contrast, GFP-Dnmt1Q162E shows a fully dispersed nuclear distribution in early and mid S-phase stages, whereas in
late S-phase and G2 association with centromeric heterochromatin is still observed. (C) Endogenous PCNA efficiently co-immunoprecipitates
with GFP-Dnmt1wt but not with GFP-Dnmt1Q162E. Cell extracts were prepared from HEK 293T cells expressing either GFP-Dnmt1wt or GFP-
Dnmt1Q162E. Precipitated proteins were detected by immunostaining with antibodies against GFP and PCNA, respectively.
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To establish whether the binding to PCNA is required
for postreplicative methylation in vivo, we tested the
activity of GFP-Dnmt1wt and GFP-Dnmt1Q162E in living
cells using a recently developed trapping assay (27). This
assay takes advantage of the catalytic mechanism of
DNA (cytosine-5) methyltransferases which involves
transient formation of a covalent complex with the C6
position of the cytosine residue. When the cytosine
analogue 5-aza-20-deoxycytidine (5-aza-dC) is incorpo-
rated into the DNA during replication the covalent
complex of Dnmt1 and 5-aza-dC cannot be resolved and
Dnmt1 is trapped at the site of action. Time-dependent
immobilization, i.e. trapping of GFP-tagged Dnmt1 at
replication foci can be visualized and measured by FRAP
and reflects enzymatic activity of the fusion protein.
C2C12 cells co-transfected with RFP-PCNA and either
GFP-Dnmt1wt or GFP-Dnmt1Q162E as well as C2C12 cells
stably expressing GFP-Dnmt1wt were incubated in the
presence of 30 mM 5-aza-dC. In early S-phase the focal
enrichment of GFP-Dnmt1wt at replication sites increased
over time reflecting the accumulation of immobilized
enzyme and after 40min GFP-Dnmt1wt was completely
immobilized (Figure 5A). Similar kinetics were observed
in mid S-phase (data not shown). As shown above GFP-
Dnmt1Q162E displayed a diffuse nuclear distribution in
early S-phase cells (Figure 5B). However, with prolonged
incubation in the presence of 5-aza-dC an increasing focal
accumulation at replication sites was observed.
Quantitative FRAP analysis revealed that the immobiliza-
tion rate of GFP-Dnmt1Q162E, which is a direct measure of
its enzymatic activity, was only about 2-fold slower than
GFP-Dnmt1wt, resulting in complete trapping after
90min. These results indicate that the PCNA-binding-
deficient mutant binds to DNA and is catalytically
engaged at hemimethylated sites generated during
replication.
Immobilization of GFP-Dnmt1wt at replication sites does not
prevent progression of the replication machinery
We then probed the stability of the interaction between
Dnmt1 and the replication machinery by trapping Dnmt1
with 5-aza-dC and long-term live imaging. In the case of
stable interaction, covalent immobilization of Dnmt1
would be expected to stall the progression of the
replication machinery. C2C12 cells co-transfected with
the GFP-Dnmt1wt and RFP-PCNA constructs were
incubated in the presence of 10 mM 5-aza-dC and
individual S-phase cells were imaged at consecutive time
points for an extended period of time (Figure 6).
Progressive separation of GFP-Dnmt1wt and RFP-
PCNA foci could be clearly observed over a time period
of 2 h, indicating that trapping of Dnmt1 did not prevent
the progression of replication factories. This result is
consistent with the FRAP kinetics of GFP-Dnmt1wt
demonstrating the transient nature of the interaction
between Dnmt1 and PCNA.
GFP-Dnmt1Q162E rescues CpGmethylation in Dnmt1/
ES cells
To investigate the contribution to maintenance of
methylation patterns by the PBD-mediated interaction
with PCNA in vivo we transiently expressed either GFP-
Dnmt1wt or GFP-Dnmt1Q162E in Dnmt1 deficient mouse
ES cells, which are severely hypomethylated in all genomic
compartments (5,49). GFP-positive cells were isolated by
FACS sorting 24h and 48 h after transfection and
methylation of single-copy sequences and intracisternal
type A particle (IAP) interspersed repetitive elements was
analyzed by COBRA. An increase in methylation at all
tested sites was observed in cells expressing either the wild
type or the mutant Dnmt1 constructs already 24 h after
transfection (Figure 7 and Supplementary Figure 4A).
Figure 3. Transient binding of Dnmt1 at replication sites in different S-phase stages. (A) GFP-Dnmt1wt (green) and RFP-PCNA (magenta)
co-expressed in mouse C2C12 cells co-localize at replication sites in early, mid and late S-phase. Fluorescence bleaching of a small region of interest
reveals fast recovery of GFP-Dnmt1wt, whereas RFP-PCNA shows almost no recovery within the observation period. (B) Quantitative evaluation of
the FRAP experiments shown in (A) reveal a significantly faster recovery of GFP-Dnmt1wt in early and mid S-phase compared to late S-phase. Scale
bars: 5 mm.
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Figure 4. Effect of the PBD on protein mobility in S-phase cells. (A) Half nucleus FRAP series of C2C12 cells expressing GFP-Dnmt1wt and GFP-
Dnmt1Q162E, PBD-GFP and GFP alone as indicated in the second column. Cell-cycle stages were identified by the subnuclear pattern of co-expressed
RFP-PCNA (first column). Selected pre- and postbleach frames are shown in false color. Lower signal-to-noise ratio of FRAP series images is due to
the higher imaging frame rate. Rectangles indicate the bleached ROI. The column marked with t1/2 displays frames corresponding to the half time
of fluorescence recovery. The column marked with t1 displays the frames corresponding to approximately the time points when fluorescence
recovery reached the plateau. Bar: 5 mm. (B) Quantitative evaluation of FRAP experiments. Wild-type Dnmt1 shows a small but significant decrease
in mobility in early/mid S-phase (dark blue curve) as compared to G1 phase (light-blue curve). A similar mobility shift between early/mid S and non-
S-phase cells is also seen for PBD-GFP (dark green and green curve, respectively) and for GFP-Ligase (dark gray and gray curve, respectively). No
such shift is observed for the PCNA-binding-deficient Dnmt1 mutant (red and orange curve, respectively). GFP alone (light-green curve) is shown as
reference. For clarity only every fourth time point is displayed; data are represented as meanSEM. Kinetic shifts are indicated by shadings in the
enlarged inset.
Nucleic Acids Research, 2007 7
Further substantial increase of methylation 48 h after
transfection was observed only for the skeletal -actin
promoter where the methylation level approached that
observed in wild-type cells. The result for the skeletal
-actin promoter were confirmed and extended by bisulfite
sequencing (Supplementary Figure 5). It was previously
reported that re-expression of wild-type Dnmt1 in
dnmt1/ ES cells does not lead to restoration of
methylation at imprinted genes since passage through
the germ line is needed for re-establishment of methylation
patterns in these sequences (49). We analyzed the
promoter of the imprinted H19 gene to control for the
Figure 5. PCNA-binding-deficient mutant Dnmt1 is catalytically active and shows moderately reduced postreplicative methylation activity in vivo.
(A–C) Trapping assay for the analysis of postreplicative methylation activity in vivo. (A, B) Confocal mid sections (upper panel) and corresponding
FRAP series (lower panel) of a C2C12 mouse myoblast cell co-transfected with RFP-PCNA and either GFP-Dnmt1wt (A) or GFP-Dnmt1Q162E
(B) before and at selected time points after incubation with 5-aza-dC. Before drug treatment the observed cells were in early S-phase as indicated by
the RFP-PCNA pattern (left). Boxes indicate bleached ROI’s, which are shown magnified in the lower panels at indicated time points of the FRAP
series. Quantitative FRAP analysis is shown on the right. Scale bars: 5mm. (C) Time-dependent increase of immobile fractions of GFP-Dnmt1wt and
GFP-Dnmt1Q162E. Individual cells assayed at consecutive time points are indicated by closed (GFP-Dnmt1wt) and open (GFP-Dnmt1Q162E) symbols.
Character symbols represent different cells each assayed at a single time point. + symbol indicates data points obtained with C2C12 cells stably
expressing GFP-Dnmt1wt (C2C12-GMT1) without co-expression of RFP-PCNA. (D) In vitro methyltransferase assay for GFP-Dnmt1wt, GFP-
Dnmt11-171, GFP-Dnmt1Q162E and the catalytically inactive mutant GFP-Dnmt1C1229W. GFP fusions were expressed in HEK 293T cells,
immunopurified and the amount of [3H]CH3 transferred to a hemimethylated oligonucleotide substrate was measured. To normalize for the amount
of precipitated protein aliquots were analyzed by SDS-PAGE and Coomassie staining (lower panel).
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specificity of our assay and found that indeed expression
of neither GFP-Dnmt1wt nor GFP-Dnmt1Q162E resulted
in increased methylation of this sequence (Figure 7). To
further evaluate methylation of repetitive sequences we
stained transiently transfected dnmt1/ cells with an
antibody against 5-methylcytidine that detects highly
methylated satellite repeats present at mouse chromocen-
ters (pericentromeric heterochromatin). Restoration of
high DNA methylation levels at chromocenters was
observed in both cells expressing GFP-Dnmt1wt and
GFP-Dnmt1Q162E (Supplementary Figure 4B).
The experimental procedures employed did not allow
detection of significant differences in remethylation
kinetics between the two constructs. Nevertheless, these
results show that the PCNA-binding-deficient mutant is,
like wild-type Dnmt1, able to rescue methylation of both
single copy and repetitive sequences in vivo.
DISCUSSION
Faithful replication of genetic and epigenetic information
is crucial to ensure the integrity and identity of proliferat-
ing cells. Earlier work has demonstrated that the main-
tenance methyltransferase Dnmt1 binds to the replication
processivity factor PCNA and is thus recruited to
replication sites (12). The interaction between Dnmt1
and the replication machinery was proposed as a
mechanism for coupling maintenance of genomic methyl-
ation to DNA replication (11). By traveling along with the
replication machinery Dnmt1 would be able to restore
symmetrical methylation as soon as hemimethylated CpG
sites are generated. The estimated kinetics of DNA
replication in vivo and DNA methylation by Dnmt1
Figure 7. PCNA-binding-deficient mutant Dnmt1 restores methylation of single-copy sequences in dnmt1/ ES cells. Mouse dnmt1/ ES cells were
transiently transfected with either the GFP-Dnmt1wt or GFP-Dnmt1Q162E constructs and FACS-sorted 24h and 48 h after transfection. Methylation
of single-copy sequences was assayed by COBRA. Shown are methylation percentages at assayed CpG sites with respect to genomic DNA from
dnmt1/ ES cells methylated in vitro with the recombinant methyltransferase SssI (100% methylation; see also Supplementary Figure 6).
Mean values and standard errors of duplicate amplifications from each of two independent experiments are indicated.
Figure 6. Immobilization of Dnmt1 does not prevent progression of
DNA replication. S-phase C2C12 myoblasts expressing GFP-Dnmt1wt
(green) and RFP-PCNA (magenta) were imaged without drug
treatment (upper row) and at the indicated time points after addition
of 10 mM 5-aza-dC to the medium (lower row). In the control cell the
two constructs largely co-localize during transition from mid to late
S-phase, whereas in the presence of 5-aza-dC progressive separation of
green and red foci indicate immobilization of GFP-Dnmt1wt at
postreplicative hemimethylated sites and progression of replication
foci containing RFP-PCNA. Projections of confocal mid sections are
shown. Scale bar: 5 mm.
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in vitro, however, differ by 3–4 orders of magnitude
arguing against a stable coupling. Although DNA
methylation may be faster in vivo it is not likely to come
much closer to the DNA replication rate. In other words,
it is reasonable to assume that methylating a cytosine
takes far longer than to incorporate it. Also, DNA
replication is essentially a continuous process, while
methylated CpG sites are encountered discontinuously in
vertebrate genomes. Stable binding of Dnmt1 to the
replication machinery would stall replication at each
hemimethylated CpG site. Here we show that the
interaction of Dnmt1 with the replication machinery
in vivo is highly dynamic and that immobilization of
Dnmt1 at postreplicative hemimethylated sites does not
prevent the progression of DNA replication. The transient
nature of the interaction between Dnmt1 and the
replication machinery allows rapid release and transfer
of Dnmt1 to hemimethylated substrate sites, reconciling
the paradox of the relative rates of DNA replication and
methylation. According to basic principles of enzyme
kinetics the local enrichment of Dnmt1 at replication foci
would increase the postreplicative methylation rate. At the
same time, transient binding of Dnmt1 enables also other
replication factors to interact with PCNA. Similar binding
dynamics have been shown for the interaction of PCNA
with DNA Ligase I and Fen1 (26) and may thus represent
a common feature of PBD-containing factors.
Interestingly, the interaction between Dnmt1 and
PCNA is believed to be a major mechanism for the
methylation maintenance activity of Dnmt1, but its
functional relevance had never been tested experimentally.
Here we show two lines of evidence that this interaction is
not crucial for the maintenance of methylation patterns in
mammalian cells. First, postreplicative methylation rate of
wild-type Dnmt1 measured in vivo is only 2-fold faster
than that of a PCNA-binding-deficient mutant. Second,
methylation of both single copy and repetitive sequences
in Dnmt1 deficient ES cells was restored by this PCNA-
binding-deficient Dnmt1 mutant with efficiency compar-
able to wild-type Dnmt1. The maintenance of DNA
methylation without direct coupling to the replication
machinery could in part be explained by the preference of
Dnmt1 for hemimethylated sites (8–10). Also, genetic
manipulation in the mouse indicate that Dnmt1 is at least
5-fold more abundant than necessary for maintaining
normal methylation levels (6,50). Thus, the combined
effect of the affinity for hemimethylated sites, relative
abundance and simple diffusion could explain the
relatively fast immobilization of PCNA-binding-deficient
mutants in the presence of 5-aza-dC. In addition, the
ability of Dnmt1 to methylate nucleosomal DNA in vitro
(51–53), suggests that maintenance of DNA methylation is
not necessarily restricted to the short time window before
nucleosome assembly.
Recent structural data on Ligase I:PCNA and FEN-
1:PCNA complexes indicate that for these enzymes PCNA
does not simply serves as a loading platform for the
replication machinery, but also causes allosteric activation
(56,57). The data presented here cannot rule out a similar
mechanism for Dnmt1, but clearly show that interaction
with PCNA is not a prerequisite for enzyme activity
in vivo. The transient nature of this interaction also argues
against PCNA as a classic processivity factor for
postreplicative DNA methylation. The major role of the
PCNA interaction most likely is to increase the local
Dnmt1 concentration and thereby enhance methylation
efficiency at replication sites.
Notably, it is still unclear whether the role and
regulation of Dnmt1 is similar in different cell types and
species. While Dnmt1 is clearly essential for maintenance
of DNA methylation in mouse cells (5,54), it seemed
dispensable in human tumor HCT116 cells (32). However,
two reports recently showed that DNMT1 is essential for
maintenance of DNA methylation also in these human
tumor cells (32,55). It turned out that genomic methyla-
tion was maintained by a residual, truncated DNMT1
form lacking the PBD, arguing that PCNA binding is not
strictly required in these cells (32).
Also, the requirement of Dnmt1 for cell viability remains
unsettled. In mouse fibroblasts inactivation of the dnmt1
gene caused a continuous loss of genomic methylation
leading to apoptotic cell death after several cell division
cycles (54). Similar results were obtained after depletion of
DNMT1 activity by RNA interference in human cells (32).
Surprisingly, conditional deletion of the DNMT1 locus in
the same cells caused immediate apoptotic cell death long
before substantial passive loss of genomic methylation
could occur (58) arguing for additional roles of DNMT1.
In this regard, the association of Dnmt1 with hetero-
chromatin in G2 phase and occasionally in mitosis in
mouse cells (13) would fit well with the mitotic catastrophe
observed upon deletion of the DNMT1 gene in HCT116
cells. In addition, the PBD-mediated association of Dnmt1
with repair sites (14) may indicate a direct role in the
maintenance of genome integrity (59). Clearly, more
experiments are required to resolve the species and cell-
type-specific role and regulation of Dnmt1.
In summary, we demonstrate that the association of
Dnmt1 with the replication machinery is not strictly
required for maintaining global methylation but still
enhances in vivo methylation efficiency by 2-fold.
Whereas the benefit of Dnmt1 to be directly recruited to
replication foci seems subtle in short-term cell culture
experiments, it may be more relevant in long-lived
organisms and in situations where the nuclear concentra-
tion of Dnmt1 is limiting. Indeed, Dnmt1 levels vary
considerably in different tissues and developmental stages
(60,61). Based on sequence features of the dnmt1 gene a
modular structure was proposed to originate from an
ancestral DNA methyltransferase that evolved by stepwise
acquisition of new domains (47). Thus, the improved
efficiency of postreplicative methylation achieved by the
PBD-mediated transient binding to PCNA likely repre-
sents an additional safety mechanism, which was acquired
in the course of evolution and contributes to the faithful
maintenance of epigenetic information over the entire
lifespan of complex organisms.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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Supplementary Figure 1. Comparison of endogenous and GFP-tagged Dnmt1 levels in 
transiently transfected C2C12 myoblasts. Cells were fixed with 3.7% formaldehyde 24 h after 
transfection with the GFP-Dnmt1wt expression construct. Endogenous and GFP-tagged Dnmt1 
were detected with polyclonal rabbit antibodies against the N-terminal domain of Dnmt1 and 
Alexa555 coupled secondary antibodies. DNA was counterstained with 4’,6-diamidino-2-
phenylindole (DAPI). Widefield epifluorescence images were acquired with an Axiophot 2 
microscope (Zeiss) equipped with a 63x/1.4 NA oil objective and a 12-bit CCD camera. (A) 
The upper row shows exemplary images with a late S phase cell moderately expressing GFP-
Dnmt1 typically chosen for live cell microscopy (arrowhead). Dnmt1 immunostaining shows 
slightly higher fluorescence compared to untransfected cells (arrows) due to the ectopically 
expressed GFP-Dnmt1 in addition to endogenous Dnmt1. Overexpressing cells with much 
brighter nuclear fluorescence (lower row, asterisks) were not considered for live cell analyses. 
Scale bars: 10 µm. (B) Quantification of total Dnmt1 levels in transfected and untransfected 
cells. Average nuclear antibody signal (endogenous Dnmt1 and GFP-Dnmt1) from transfected 
and untransfected cells was determined for each image. Signal ratios of moderately and 
overexpressing transfected cells to untransfected cells were calculated for each image and 
then averaged. Error bars indicate SD. 
 
 
 
 
 
Supplementary Figure 2. Comparison of endogenous and GFP-tagged Dnmt1 levels in 
stably transfected C2C12 myoblasts (C2C12-GMT1) after 20 days of selection with 10 µg/ml 
blasticidin. (A) Cells were fixed with 3.7% formaldehyde and DNA was counterstained with 
4’,6-diamidino-2-phenylindole (DAPI). Widefield epifluorescence images were acquired with 
an Axiophot 2 microscope (Zeiss) equipped with a 63x/1.4 NA oil objective and a 16-bit CCD 
camera. About 75% of the cells show stable expression of GFP-Dnmt1. Scale bar: 10 μm.   
(B) Western blot analysis to compare the levels of GFP-Dnmt1wt and endogenous Dnmt1 in 
stably transfected C2C12 cells. The detection was performed with an antibody against the 
N-terminal domain of Dnmt1 (Grohmann et al., 2005, BMC Dev Biol 5, 18) and a monoclonal 
anti-GFP antibody (Roche). Untransfected C2C12 cells were used as a control. After 
correction for the fraction of expressing cells, the expression level of GFP-Dnmt1wt amounts 
to about 90% of the endogenous Dnmt1.  
 
 
 
Supplementary Figure 3. Mutations of the PBD abolish Dnmt1 interaction with PCNA and 
prevent accumulation at replication sites in early and mid S phase. (A, B) Confocal mid 
sections of living mouse C2C12 myoblasts expressing either GFP-Dnmt1F169S (A) or GFP- 
Dnmt1Δ1-171 (B). Both constructs show a dispersed nuclear distribution in early and mid S 
phase stages, whereas in late S phase association with pericentric heterochromatin is 
observed. Cells were co-transfected with RFP-PCNA to identify replication foci and to 
distinguish S phase stages. Scale bars: 5 µm. (C) Endogenous PCNA efficiently co-
immunoprecipitates with GFP-Dnmt1wt but not with GFP-Dnmt1F169S and GFP- Dnmt1Δ1-171. 
GFP fusion constructs were expressed in HEK 293T cells. Precipitated proteins were detected 
by immunostaining with antibodies against GFP and PCNA, respectively. 
 
 
 
Supplementary Figure 4. PCNA binding-deficient Dnmt1 mutants restore methylation of 
repetitive DNA sequences in Dnmt1 null ES cells. (A) Mouse dnmt1-/- J1 ES cells were 
transiently transfected with either the GFP-Dnmt1wt or GFP-Dnmt1Q162E constructs and 
FACS-sorted 24 and 48 h after transfection as in Figure 7. Methylation of IAP LTRs was assayed 
by COBRA. Shown are cumulative methylation percentages at 2 HpyCH4IV sites (ACGT) with 
respect to genomic DNA from dnmt1-/- ES cells methylated in vitro with the recombinant 
methyltransferase SssI (100% methylation). Mean values and standard errors of duplicate 
amplifications from each of two independent experiments are indicated. (B) 48 h after 
transfection with either GFP-Dnmt1wt or GFP-Dnmt1Q162E Dnmt1 null ES cells were stained with 
an antibody against 5-methylcytidine (5mC) and their DNA counterstained with TO-PRO-3 as 
described (Schermelleh et al., 2005, Nat Methods 2, 751). Staining of wild type ES cells is shown 
as a control in the first row. Individual channels are indicated at the top and in the merge channel 
GFP, 5mC and TO-PRO-3 stainings are shown in green, red and blue, respectively. Cells 
expressing either GFP-Dnmt1wt or GFP-Dnmt1Q162E showed remethylation of repetitive DNA at 
chromocenters. Similar results were obtained with the GFP-Dnmt1F169S and GFP-Dnmt1Δ1-171 
mutant constructs (data not shown). Scale bar: 5 µm. 
 
 
 
Supplementary Figure 5. Bisulfite sequencing of the skeletal α-actin promoter in wt, Dnmt1 
null and Dnmt1 null J1 ES cells transiently transfected with either the GFP-Dnmt1wt or 
GFP-Dnmt1Q162E constructs as in Figure 7. Transfected cells were FACS-sorted and genomic 
DNA isolated 24 and 48 h after transfection as indicated. Genomic DNA from dnmt1-/- ES cells 
methylated in vitro with recombinant SssI methyltransferase was used as a control. PCR products 
were cloned with the StrataClone PCR Cloning Kit (Stratagene) and individual clones sequenced 
by automated sequencing at MWG Biotech. Black lines represent sequences from individual 
clones. Open and closed circles represent unmethylated and methylated cytosines, respectively. 
Global percentages of converted cytosines and methylation at CpG sites within the analyzed 
sequence are indicated on the right.  
 
 
 
Supplementary Figure 6. Determination of PCR bias in COBRA assays. Genomic DNA 
from untransfected Dnmt1-/- J1 cells was methylated in vitro with recombinant SssI 
methyltransferase (New England BioLabs) and mixed with unmethylated DNA from the 
same cells in the proportions reported at the top of each lane. COBRA assays for the 
indicated sequences were performed on each sample as described in Materials and 
Methods. At the top of each panel the digests of bisulfite PCR fragments from these 
genomic DNA mixtures are shown. Uncut fragments, corresponding to unmethylated 
molecules, and restriction fragments (cut; only one out of two for skeletal α-actin, 
Dnmt1o and H19A promoters and two out of three for Xist exon 1), corresponding to 
methylated molecules, are shown. Measured methylation percentages were plotted 
against expected ones. Closed and open circles represent measured values and values 
expected in the absence of bias. Best fit curves and bias coefficients (b) were generated 
and calculated, respectively, using WinCurveFit (Kevin Raner Software) and according 
to the equation: 
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Introduction
In mammals DNA methylation is restricted to cytosine residues
and mainly involves CpG dinucleotides. CpG methylation is
widespread across mammalian genomes, including gene bodies
regardless of their transcriptional activity [1–4]. However, highly
CpG-rich regions (CpG islands) are refractory to methylation and
mostly coincide with promoters of constitutively active genes. The
methylation state of other regulatory sequences with moderate to
low CpG density, including promoters and enhancers, shows
developmental and/or tissue-specific variations and positively
correlates with a transcriptionally silent state [1,3–8]. Dense
methylation of repetitive sequences is also thought to maintain
these elements in a silent state and thus contribute to genome
stability [9–11]. In mammals cytosine methylation is catalyzed by
a family of DNA methyltransferases (Dnmts) [12]. Dnmt3a and
Dnmt3b establish methylation patterns during embryonic devel-
opment of somatic as well as germ cell lineages and, consistently,
show developmental stage and tissue specific expression patterns.
In contrast, Dnmt1 is ubiquitous and generally the most abundant
DNA methyltransferase in mammalian tissues, where it associates
with the replication machinery and restores symmetrical methyl-
ation at hemimethylated CpG sites generated by the semi-
conservative DNA replication process [13]. Thus, Dnmt1
maintains methylation patterns with high fidelity and is essential
for embryonic development and genome integrity [9,14,15].
Dnmt1 is a large enzyme with a complex domain structure that
likely evolved by fusion of at least three genes [16]. It comprises a
regulatory N-terminal region and a C-terminal catalytic domain
connected by a linker of seven glycine-lysine repeats (Figure 1A)[17].
The N-terminal part contains a PCNA binding domain (PBD), a
heterochromatin targeting sequence (TS), a CXXC-type zinc finger
domain and two Bromo-Adjacent Homology domains (BAH1 and
BAH2). The C-terminal domains of mammalian Dnmts contain all ten
catalytic motifs identified in bacterial DNA (cytosine-5) methyltrans-
ferases [12]. Thus, prokaryotic and mammalian cytosine methyltrans-
ferases are thought to adopt the same catalytic mechanism. However,
the C-terminal domain of Dnmt1 is the only DNA methyltransferase
domain in Dnmts that is not catalytically active when expressed
separately. Indeed, interaction with the N-terminal part is required for
allosteric activation of the enzyme [18]. Remarkably, the first 580
amino acids (aa) of human DNMT1 are dispensable for both
enzymatic activity and substrate recognition, whereas deletion of the
first 672 aa results in an inactive enzyme [19]. Interestingly, this
truncation eliminates part of the CXXC domain, suggesting an
involvement of this domain in allosteric activation. However, addition
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16627
CXXC Domains of Dnmt1 and Tet1
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e16627
of an N-terminal fragment containing the isolated CXXC domain to
the catalytic domain was not sufficient for catalytic activation [20].
CXXC-type zinc finger domains are found in several other
proteins with functions related to DNA or chromatin modification,
including the histone H3 lysine 4 (H3K4) methyltransferases mixed-
lineage leukaemia (MLL) proteins 1 and 4, the CpG-binding protein
(CGBP, also known as Cfp1 or CXXC1), the methyl-CpG binding
domain protein 1 (MBD1), the H3 lysine 36 (H3K36) demethylases
KDM2A and B (also known as JHD1A/FBXL11 and JHD1B/
FBXL10) and the MLL1 fusion partner TET1 (Figure 1A) [21–28].
The CXXC domains of some of these proteins were shown to
mediate specific binding to double stranded DNA templates
containing unmethylated CpG sites [21,22,29,30]. A region of
Dnmt1 which mainly includes the CXXC domain (aa 628–753) was
also shown to bind Zn ions and DNA [20,31,32]. However, available
data on the selectivity of this DNA binding activity are conflicting.
Whereas a fragment including aa 613–748 of mouse Dnmt1 was
shown to bind DNA with a slight preference for hemimethylated
CpG sites [20], aa 645–737 of human DNMT1 were shown to
selectively bind unmethylated DNA [32]. As these studies used
different constructs and species, the selectivity of DNA binding by
the CXXC domain of Dnmt1 with regard to CpG methylation state
and the role of the CXXC domain in allosteric activation and
substrate discrimination remain to be firmly established.
Notably, not all CXXC domains show DNA binding activity, as
exemplified by the fact that only one out of three CXXC domains
in MBD1 binds DNA [29]. Interestingly, TET1 was recently
shown to be a 2 oxoglutarate- and Fe(II)-dependent dioxygenase
responsible for converting genomic 5-methylcytosine (mC) to 5-
hydroxymethylcytosine (hmC) [33,34]. However, it is not known
whether the CXXC domain of TET1 is involved in recognition of
methylated DNA substrates.
Here we report a functional study and characterization of the
DNA binding activity for the CXXC domains of mouse Dnmt1
and Tet1 proteins. We generated isolated CXXC domain and
deletion constructs based on structural homology models to
minimize structural alterations. We show that the CXXC domain
of Dnmt1 preferentially binds DNA substrates containing
unmethylated CpG sites, but does not contribute significantly to
the DNA binding properties of the full length enzyme and is
dispensable for its catalytic activity in vitro and in vivo. In addition,
we found that the CXXC domain of Tet1 does not bind DNA in
vitro and is also dispensable for catalytic activity of Tet1 in vivo.
Results
Sequence homology and structural modeling identify
distinct CXXC domain subtypes
Dnmt1 contains a zinc finger domain of the CXXC type, which
is present in several mammalian proteins including MLL1
(Figure 1A–C) and is highly conserved among Dnmt1 sequences
from various animal species (Figure S1 in File S1). The primary
structure of CXXC domains spans two clusters of 6 and 2 cysteine
residues separated by a stretch of variable sequence and length.
Sequence alignment and homology tree construction identified
three distinct groups of CXXC domains (Figure 1B and C). The
sequence between the two cysteine clusters in the CXXC domains
of Dnmt1, CGBP/Cfp1, Fbxl19, Mll1, Mll2 and Kdm2 proteins
and CXXC domain 3 of Mbd1 is highly conserved and contains a
KFGG motif. The two other homology groups, including the
CXXC domains 1 and 2 of Mbd1 on one side and those of Tet1,
Cxxc4/Idax, Cxxc5/RINF and Cxxc10 on the other side, lack the
KFGG motif and diverge from the first group and from each other
in the sequence between the cysteine clusters. We generated
structural homology models for the CXXC domains of mouse
Dnmt1 and Tet1 using the NMR structure of the MLL1 CXXC
domain as a template (Figure 1D and E)[35]. The CXXC domains
of these proteins adopt an extended crescent-like structure that
incorporates two Zn2+ ions each coordinated by four cysteine
residues. The peptide of the MLL1 CXXC domain predicted to
insert into the major groove of the DNA double helix (cyan in
Fig. 1E) is located on one face of the structure and is contiguous to
the KFGG motif [35]. The predicted structure of the Tet1 CXXC
domain lacks the short 310 helix (g1 in Figure 1E) formed by
residues PKF and partially overlapping the KFGG motif, but is
similar to the MLL1 CXXC domain in the region of the DNA-
contacting peptide. However, each of the two predicted b-strands
in Tet1 carries three positive charges, whereas there is only one or
no charged residue in the C-terminal strands of the CXXC
domains in MLL1 and Dnmt1. Depending on the orientation of
the positively charged side chains, it cannot be excluded that the
charge density prevents strand pairing in the Tet1 CXXC domain.
The Dnmt1 CXXC domain binds unmethylated DNA
To investigate the binding properties of the Dnmt1 CXXC
domain, we generated a GFP fusion construct including aa 652–699
(GFP-CXXCDnmt1). According to our homology model the ends of
this fragment form an antiparallel b-sheet that structurally delimits
the domain as in MLL1. We first compared the localization and
mobility of GFP-CXXCDnmt1 and GFP in mouse C2C12
myoblasts. While GFP was diffusely distributed in both nucleus
and cytoplasm, GFP-CXXCDnmt1 was exclusively nuclear with a
punctuated pattern throughout the nucleoplasm and was enriched
in nucleoli, a pattern independent of cell cycle stage (Figure 2A and
Figure S2 in File S1). Enrichment in the nucleus and nucleoli is
frequently observed with constructs containing stretches with high
density of basic residues. After photobleaching half of the nuclear
volume we observed a slower fluorescence recovery rate for GFP-
CXXCDnmt1 than for GFP (Figure 2B). To rule out a contribution of
nucleolar interactions to the slower kinetics of GFP-CXXCDnmt1,
Figure 1. Sequence and predicted structural homology of CXXC domains. (A) Schematic representation of the domain structure in Dnmt1 and
Tet1. The catalytic domain and the N-terminal region of Dnmt1 are connected by seven lysine-glycine repeats [(KG)7]. PBD: PCNA binding domain; TS:
targeting sequence; CXXC: CXXC-type zinc finger domain; BAH1 and 2: bromo-adjacent homology domain; NLS: nuclear localization signal; Cys-rich:
cysteine rich region. (B) Alignment of mammalian CXXC domains. Numbers on the right side indicate the position of the last amino acid in the
corresponding protein. The Mbd1a isoform contains three CXXC motifs (Mbd1_1-3). Absolutely conserved residues, including the eight cysteines
involved in zinc ion coordination are highlighted in red and the conserved KFGG motif is in red bold face. Positions with residues in red face share 70%
similarity as calculated with the Risler algorithm [66]. At the top residues of MLL1 involved in b sheets b1 and b2 (black arrows), a helices a1 and a2 and
strict a turns (TTT) are indicated. All sequences are from M. musculus. Accession numbers (for GenBank unless otherwise stated): Dnmt1, NP_034196;
Mll1, NP_001074518; Mll4, O08550 (SwissProt); CGBP, NP_083144; Kdm2a, NP_001001984; Kdm2b, NP_001003953; Fbxl19, NP_766336; Mbd1,
NP_038622; CXXC4/Idax, NP_001004367; CXXC5, NP_598448; CXXC10 (see Materials and Methods). (C) A homology tree was generated from the
alignment in (B). The three subgroups of CXXC domains identified are in different colors. Average distances between the sequences are indicated. (D–E)
Homology models of the mouse Dnmt1 (D; red) and Tet1 (E; blue) CXXC domains superimposed to the CXXC domain of MLL1 (green; [35]). MLL1
residues that were described to contact DNA according to chemical shift measurements [35] are cyan in (E), while cysteines involved in coordination of
the two zinc ions are yellow. Arrows point to the KFGG motif in MLL1 and Dnmt1. The locations of a helices and b sheets are indicated as in (B).
doi:10.1371/journal.pone.0016627.g001
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we separately bleached nucleoplasmic and nucleolar regions and
found that GFP-CXXCDnmt1 has even faster kinetics within the
nucleolus (Figure S3 in File S1). These results are consistent with a
binding activity of GFP-CXXCDnmt1 in the nucleus and very
transient, unspecific binding in the nucleolus. To investigate
whether the CXXC domain of Dnmt1 binds DNA and its possible
selectivity with respect to CpG methylation we used a recently
developed fluorescent DNA binding assay [36,37]. GFP-
CXXCDnmt1 was transiently expressed in HEK293T cells, im-
munopurified with the GFP-trap (Figure S4 in File S1) and
incubated with fluorescent DNA substrates containing either no
CpG site or one central un-, hemi- or fully methylated CpG site in
direct competition. As shown in Figure 2C, GFP-CXXCDnmt1
displayed a significant preference for the substrate containing one
unmethylated CpG site, which increased substantially with a five-
fold higher concentration of the DNA substrates (Figure S5 in File
S1). These results are consistent with the reported binding pre-
ference of the CXXC domains in human DNMT1 and other factors
belonging to the same CXXC homology group [21,22,29,32].
Notably, the CXXC domains 1 and 2 of Mbd1 lack the KFGG
motif and do not bind DNA, while mutation of this motif prevented
DNA binding by the CXXC domain of MLL1 [29,38]. Therefore,
we generated a GFP-CXXCDnmt1 construct where the KFGG motif
was mutated to AAGG (GFP-CXXCDnmt1KF/AA, Figure S4 in File
S1) to test the requirement of the KFGG motif for binding by the
CXXC domain of Dnmt1. The mutant domain showed signifi-
cantly decreased binding to all DNA substrates and complete loss of
preferential binding to the unmethylated substrate in vitro
(Figure 2B). In addition, GFP-CXXCDnmt1KF/AA showed faster
recovery after photobleaching (FRAP) in vivo compared to the
corresponding wild type construct (Figure 2C). These results further
support the importance of the KFGG motif for DNA binding by
CXXC domains.
The CXXC domain of Tet1 shows no specific DNA binding
activity and is dispensable for enzymatic activity in vivo
It was recently shown that Tet1 oxidizes genomic mC to hmC.
However, the mechanism by which Tet1 is targeted to genomic
mC is not known. Our model for the structure of the Tet1 CXXC
domain diverged from the structure of the MLL1 CXXC domain
with respect to the KFGG motif but not to the DNA-contacting
peptide, suggesting that the Tet1 CXXC domain may still bind
DNA. To test this we generated a GFP-tagged Tet1 CXXC
Figure 2. Properties of isolated Dnmt1 and Tet1 CXXC domains. (A–B) Subcellular localization (A) and binding kinetics (B) of GFP-CXXCDnmt1,
GFP-CXXCDnmt1KF/AA, GFP-CXXCTet1 and GFP in mouse C2C12 myoblasts. Localization and binding kinetics were independent from the cell cycle stage
(Figures S2 and S5 in File S1). Arrowheads in (A) point to nucleoli. Scale bar: 5 mm. Binding kinetics were analyzed by FRAP. (C) DNA binding specificity
of the Dnmt1 and Tet1 CXXC domains. GFP, GFP-CXXCDnmt1, GFP-CXXCDnmt1KF/AA and GFP-CXXCTet1 were pulled down from extracts of transiently
transfected HEK293T cells and incubated with fluorescent DNA substrates containing no CpG site or one central un-, hemi- or fully methylated CpG
site in direct competition (noCGB, UMB, HMB, FMB, respectively). Shown are the mean DNA/protein ratios and corresponding standard errors from 5
(GFP), 4 (GFP-CXXCDnmt1 and GFP-CXXCDnmt1KF/AA) and 2 (GFP-CXXCTet1) independent experiments. * P = 0.01; ** P = 0.007; ***P = 0.001.
doi:10.1371/journal.pone.0016627.g002
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construct (GFP-CXXCTet1) following the same criteria as for GFP-
CXXCDnmt1 and investigated its cellular localization, in vivo
binding kinetics and in vitro DNA binding activity. GFP-CXXCTet1
was prevalently nuclear with a homogeneous distribution includ-
ing nucleoli that was independent of cell cycle stage (Figure 2A and
Figure S6 in File S1). After photobleaching GFP-CXXCTet1
showed very fast recovery kinetics similar to GFP (Figure 2B) and
its DNA binding activity in vitro was also similar to the background
levels of the GFP control (Figure 2C). We conclude that the
isolated CXXC domain of Tet1 has no specific DNA binding
activity. Together with the observation that the CXXC domains 1
and 2 of Mbd1 also lack the KFGG motif and do not bind DNA
[29] and that mutation of this motif reduced DNA binding by the
CXXC domains of both Dnmt1 (Figure 2C) and MLL1 [38], this
result indicates that the KFGG motif is a major determinant for
DNA binding by CXXC domains.
To assess whether the CXXC domain is required for catalytic
activity of Tet1 we generated a GFP-Tet1 fusion construct and a
corresponding mutant lacking the CXXC domain (GFP-
Tet1DCXXC). In C2C12 myoblasts GFP-Tet1 and GFP-
Tet1DCXXC showed punctuated nuclear patterns that did not
depend on the cell cycle stage (Figure 3A and data not shown).
The same constructs were transfected in HEK293T cells and
global levels of genomic hmC were measured using a recently
described hmC glucosylation assay [39]. Overexpression of GFP-
Tet1 and GFP-Tet1DCXXC determined a similar 5-fold increase of
genomic hmC levels relative to control samples overexpressing
GFP (Figure 3B), indicating that the CXXC domain is not
required for enzymatic activity of Tet1 in vivo.
Deletion of the CXXC domain does not affect the activity
of Dnmt1 in vitro
To explore the role of the CXXC domain in Dnmt1 function
we generated GFP-Dnmt1 fusion constructs where the CXXC
domain, as defined by our homology model, was deleted. We
reasoned that precise deletion of the entire structure delimited by
the antiparallel b-sheet (Figure 1D) would have the highest
chances to preserve native folding of the rest of the protein. We
introduced this deletion in GFP fusion constructs encoding either
the full length Dnmt1 or the isolated N-terminal region (GFP-
Dnmt1DCXXC and GFP-NTRDCXXC, respectively; Figure 4A and
Figure S4 in File S1). We then compared DNA binding properties,
catalytic activity and interaction between N-terminal region and
C-terminal catalytic domain of DCXXC and corresponding wild
type constructs. Competitive DNA binding assays with the same
set of substrates as used for the experiments with GFP-
CXXCDnmt1 and GFP-CXXCTet1 reported above (Figure 2C)
showed that both GFP-Dnmt1 and GFP-Dnmt1DCXXC bind DNA
independently of the presence and methylation state of a CpG site
(Figure 4B). As the isolated CXXC domain preferentially bound
the substrate containing an unmethylated CpG site, the result with
GFP-Dnmt1 and GFP-Dnmt1DCXXC indicates that the CXXC
domain contributes negligibly to the DNA binding specificity of
the full-length enzyme.
Several groups reported that interaction between the N-
terminal region and the C-terminal catalytic domain of Dnmt1
leads to allosteric activation of Dnmt1 [16,18–20,40]. To test
whether the CXXC domain is involved in this intramolecular
interaction, we co-expressed either GFP-tagged N-terminal region
(GFP-NTR) or GFP-NTRDCXXC constructs with a Cherry- and
His-tagged C-terminal domain (Ch-CTD-His) in HEK293T cells
and performed co-immunoprecipitation experiments. Ch-CTD-
His co-precipitated both GFP-NTR and GFP-NTRDCXXC,
indicating that the CXXC domain is dispensable for the
interaction between the N-terminal region and the C-terminal
domain of Dnmt1 (Figure 4C).
To investigate whether the CXXC domain is needed for
enzymatic activity or substrate recognition, we tested formation of
the covalent complex with cytosine and transfer of the methyl
group for GFP-Dnmt1 and GFP-Dnmt1DCXXC. We first employed
an assay to monitor covalent complex formation that exploits the
formation of an irreversible covalent bond between the enzyme
and the mechanism-based inhibitor 5-aza-2-deoxycytosine (5-aza-
dC). This results in permanent trapping of the enzyme by DNA
substrates containing 5-aza-dC, as opposed to the reversible
complex formed with substrates containing the natural substrate 2-
deoxycytosine (dC) [36]. GFP-Dnmt1 and GFP-Dnmt1DCXXC
were incubated with fluorescent DNA substrates containing either
dC (binding) or 5-aza-dC (trapping) at a single CpG site in direct
competition. DNA-protein complexes were then isolated by GFP
pulldown and molar DNA/protein ratios were calculated from
fluorescence measurements (Figure 4D). Covalent complex
Figure 3. Cellular localization and in vivo catalytic activity of GFP-Tet1 and GFP-Tet1DCXXC. (A) Live images of C2C12 myoblasts expressing
GFP-Tet1. Scale bar: 5 mm. (B) Genomic hmC content in HEK293T cells overexpressing GFP, GFP-Tet1 and GFP-Tet1DCXXC. Shown are mean values and
standard deviation of hmC percentage over total cytosine for three measurements from one transfection.
doi:10.1371/journal.pone.0016627.g003
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formation was then estimated by comparing trapping and binding
activities. GFP-Dnmt1 and GFP-Dnmt1DCXXC showed compara-
ble covalent complex formation rates (trapping/binding ratios),
which were about 15- and 12-fold higher for hemi- than un-
methylated substrates, respectively (Figure 4E). Together with the
data from binding experiments (Fig. 4B), this result indicates that
the preference of Dnmt1 for hemimethylated substrates is
determined at the covalent complex formation step rather than
upon DNA binding. Furthermore, the CXXC domain clearly does
not play a major role in determining either the efficiency or the
methylation state-specificity of covalent complex formation.
Next, we tested whether deletion of the CXXC domain affects
the ability of Dnmt1 to transfer [3H]methyl groups from the donor
S-adenosylmethionine (SAM) to a poly(dI?dC)-poly(dI?dC) sub-
strate, a standard DNA methyltransferase activity assay. This
showed that in vitro GFP-Dnmt1 and GFP-Dnmt1DCXXC are equally
active methyltransferases (Figure S7 in File S1). This result is in
contrast with a previous report showing that deletion of aa 647–690
in human DNMT1 encompassing the CXXC domain resulted in a
drastic loss of catalytic activity [32]. However, according to our
homology model the deletion by Pradhan et al. would eliminate the
predicted N-terminal b-strand (b1 in Figure 1) preventing the
formation of the antiparallel b-sheet and potentially distort the
folding of the rest of the protein. This is in contrast with our GFP-
Dnmt1DCXXC mutant that was designed to retain the b-sheet
structure. To test whether this may account for the observed
discrepancy, we generated GFP fusion constructs of wild type
human DNMT1 and the same deletion as reported by Pradhan et al.
and tested covalent complex formation with 5-aza-dC containing
DNA substrates as described above. While the human wild type
construct showed the same preference for hemimethylated over
unmethylated trapping substrates as the mouse constructs, this
preference was clearly reduced for the human CXXC deletion
mutant (Figure S8 in File S1). This result is consistent with the loss of
enzymatic activity shown by Pradhan et al. for this mutant and
together with the retention of trapping and catalytic activity by the
different deletion in GFP-Dnmt1DCXXC suggests that disruption of
the antiparallel b-sheet delimiting the CXXC domain results in
further distortion and loss of activity of the enzyme.
In conclusion, we showed that, in vitro, deletion of the CXXC
domain does not affect the interaction between N-terminal region
and C-terminal domain, DNA binding, the preference for
hemimethylated substrates upon covalent complex formation
and the methyltransferase activity of Dnmt1. Together, these
data strongly argue against an involvement of the CXXC domain
in allosteric activation of Dnmt1.
Figure 4. DNA binding specificity, intramolecular interaction and trapping of wild-type Dnmt1 and CXXC deletion constructs in
vitro. (A) Schematic representation of Dnmt1 expression constructs. (B) DNA binding specificity of GFP-Dnmt1 and GFP-Dnmt1DCXXC were assayed as
described in Figure 2C. (C) Co-immunoprecipitation of the C-terminal domain of Dnmt1 (Ch-CTD-His) and the N-terminal region with and without
deletion of the CXXC domain (GFP-NTR and GFP-NTRDCXXC, respectively). GFP fusions were detected using an anti-GFP antibody, while the C-terminal
domain construct was detected using an anti-His antibody. GFP was used as negative control. I = input, B = bound. (D) Comparison of binding and
trapping activities for GFP-Dnmt1 and GFP-Dnmt1DCXXC to monitor irreversible covalent complex formation with hemimethylated substrates. (E)
Relative covalent complex formation rate of GFP-Dnmt1 and GFP-Dnmt1DCXXC on substrates containing one un- (UMT) or hemi-methylated CpG site
(HMT) in direct competition. The trapping ratio for GFP-Dnmt1 on unmethylated substrate was set to 1. In (D) and (E) the means and corresponding
standard deviations of triplicate samples from three independent experiments are shown. GFP was used as negative control.
doi:10.1371/journal.pone.0016627.g004
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Deletion of the CXXC domain does not affect Dnmt1
activity in vivo
We then undertook a functional characterization of the GFP-
Dnmt1DCXXC construct in vivo. We first compared localization and
binding kinetics of GFP-Dnmt1 or GFP-Dnmt1DCXXC in mouse
C2C12 myoblasts co-transfected with RFP-PCNA, which served
as S-phase marker [41]. GFP-Dnmt1DCXXC showed the same cell-
cycle dependent nuclear localization pattern as previously shown
for GFP-Dnmt1 and endogenous Dnmt1 (Figure 5A)[42,43].
Interaction with PCNA via the PBD directs Dnmt1 to replication
foci throughout S-phase. In addition, in late S-phase and G2
Dnmt1 is enriched at chromocenters, clusters of pericentric
heterochromatin (PH) that are observed as discrete domains
densely stained by DNA dyes in mouse interphase cells.
Association of Dnmt1 with PH at these stages is mediated by
the TS domain [42]. Thus, the CXXC domain clearly does not
contribute to the subnuclear localization of Dnmt1 at this level of
resolution.
We also compared the mobility of GFP-Dnmt1 and GFP-
Dnmt1DCXXC in living C2C12 myoblasts by FRAP analysis
(Figure 5B). These experiments revealed that the kinetics of
Dnmt1 is not significantly affected by deletion of the CXXC
domain in early-mid as well as late S-phase.
To test covalent complex formation in living cells, we used a
previously established trapping assay [44]. Mouse C2C12
myoblasts were co-transfected with RFP-PCNA and either GFP-
Dnmt1 or GFP-Dnmt1DCXXC and treated with 5-aza-dC.
Immobilization of the Dnmt1 constructs at the site of action was
then measured by FRAP analysis (Figure 5C). GFP-Dnmt1 and
GFP-Dnmt1DCXXC showed very similar trapping kinetics, the
immobile enzyme fraction reaching nearly 100% after 20 and 40
minutes in early-mid and late S-phase, respectively. This result
clearly shows that the CXXC domain is dispensable for covalent
complex formation also in vivo.
Finally, we compared the ability of GFP-Dnmt1 and GFP-
Dnmt1DCXXC to restore DNA methylation patterns in mouse
dnmt12/2 ESCs. Cells transiently expressing either GFP-Dnmt1 or
GFP-Dnmt1DCXXC were FACS sorted 48 h after transfection.
Isolated genomic DNA was then bisulfite treated and fragments
corresponding to major satellite repeats, intracisternal type A
particle (IAP) interspersed repeats, skeletal a-actin and H19a
promoters were amplified and subjected to pyrosequencing
(Figure 6). As shown previously [43], under these conditions
GFP-Dnmt1 partially restored methylation of major satellite and
IAP repeats and the skeletal a-actin promoter, but not of the
imprinted H19a promoter, as establishment of the methylation
imprint requires passage through the germ line [45]. Methylation
patterns of all these sequences in cells expressing GFP-
Dnmt1DCXXC were very similar to those in GFP-Dnmt1
expressing cells, including the lack of (re-) methylation at the
H19a promoter. These results suggest that the CXXC domain is
not required for maintenance of DNA methylation patterns by
Dnmt1 and does not restrain the DNA methyltransferase activity
of Dnmt1 on unmethylated CpG sites. Thus, the CXXC domain
does not play a major role in subcellular localization, it does not
contribute to the global binding kinetics of Dnmt1 and, consistent
with the in vitro data reported above, is dispensable for maintaining
DNA methylation patterns in living cells.
Figure 5. Cell cycle dependant cellular localization, protein mobility and trapping of wild-type Dnmt1 and CXXC deletion
constructs in mouse C2C12 myoblasts. (A) Cell cycle dependent localization of GFP-Dnmt1 and GFP-Dnmt1DCXXC constructs. Scale bar: 5 mm. (B)
Analysis of binding kinetics of GFP-Dnmt1 and GFP-Dnmt1DCXXC in early and late S-phase cells by FRAP. The recovery curve for GFP is shown for
comparison. (C) In vivo trapping by FRAP analysis in cells treated with 5-aza-dC. The trapped enzyme fraction is plotted over time for early and late S-
phase cells. For each construct three to six cells in early-mid and late S phase were analysed per time point. Shown are mean values 6 SEM. In (A–C)
RFP-PCNA was cotransfected to identify cell cycle stages in living cells.
doi:10.1371/journal.pone.0016627.g005
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Discussion
We generated homology models based on the reported structure
of the MLL1 CXXC domain to design isolated CXXC domain
constructs and CXXC domain deletion mutants for Dnmt1 and
Tet1 with minimal probability of structural alteration. According
to these models CXXC domains are delimited by an antiparallel
b-sheet, a discrete structural element. Our data show that the
CXXC domain of mouse Dnmt1 preferentially binds DNA
substrates containing unmethylated CpG sites as previously shown
for CXXC domains of human DNMT1 and other mammalian
proteins. We note that sequences C-terminal to the corresponding
peptide in CGBP/Cfp1 were reported to be required for DNA
binding in vitro [22] and that only a significantly larger peptide
spanning the CXXC-3 domain of Mbd1a was tested for DNA
binding. However, sequences C-terminal to CXXC domains are
not conserved (Figure 1B) and our data show that they are not
required for DNA binding by the CXXC domain of Dnmt1.
Nevertheless, all the CXXC domains reported to selectively bind
unmethylated CpG sites cluster in a distinct homology group and
contain the KFGG motif. The latter was shown to be crucial for
DNA binding by the CXXC domain of MLL1 [38] and here we
extend this observation to the CXXC domain of Dnmt1.
Sequence alignment reveals two distinct CXXC domain homology
groups that lack the KFGG motif (Figure 1A). Consistent with a
role of this motif in DNA binding, members of these groups such
as CXXC-1/2 of Mbd1 [29] and the CXXC domain of Tet1 (this
study) show no DNA binding activity. While no specific function is
known for CXXC-1/2 of Mbd1, the CXXC domain of Tet1 is
closely related to those in CXXC4/Idax and CXXC5/RINF that
were shown to mediate protein-protein interactions [46–48]. This
suggests that the CXXC domain of Tet1, rather than mediating
DNA binding, may function as a protein-protein interaction
domain. However, our data do not rule out the possibility that the
DNA binding properties of the CXXC domain within the context
of full length Tet1 may be different from those of the isolated
domain. Nevertheless, we show that the CXXC domain is not
required for enzymatic activity of Tet1 in vivo.
Although we observed a clear DNA binding activity by the
isolated CXXC domain of Dnmt1, we found that, within the
context of the full length enzyme, this domain is dispensable for
overall DNA binding properties, preference for hemimethylated
substrates upon covalent complex formation, methyltransferase
activity and allosteric activation as well as for the ability to restore
methylation of representative sequences in dnmt1 null ESCs.
Consistent with our data, a recent report showed a preference of
the CXXC domain of human DNMT1 for substrates containing
unmethylated CpG sites [32]. However, the same report showed
that deletion of the CXXC domain from the human enzyme
results in a significant decrease in methyltransferase activity on
hemimethylated substrates in vitro and 25% lower methylation at
rDNA repeats upon overexpression in HEK293 cells, suggesting a
dominant negative effect of the deletion construct. These
discrepancies may be due to the fact that the fragment deleted
by Pradhan et al. includes the N-terminal strand of the predicted
antiparallel b-sheet, potentially leading to disruption of native
folding, to species-specific differences and/or to the analysis of
non-physiological expression levels in HEK293 cells. In our
trapping assay the same human deletion mutant showed reduced
covalent complex formation, consistent with loss of enzymatic
activity. The report from Pradhan et al. also showed that mutation
of cysteine 667 to glycine within the CXXC domain of human
Figure 6. The CXXC deletion construct of Dnmt1 restores methylation in dnmt1 null cells. Mouse dnmt12/2 ESCs transiently expressing
GFP-Dnmt1 or GFP-Dnmt1DCXXC were isolated by FACS-sorting 48 h after transfection and CpG methylation levels within the indicated sequences
were analyzed by bisulfite treatment, PCR amplification and direct pyrosequencing. Methylation levels of untransfected wild type and dnmt12/2 ESCs
are shown for comparison.
doi:10.1371/journal.pone.0016627.g006
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DNMT1 disrupts DNA binding and enzymatic activity. However,
as this point mutation involves one of the zinc coordinating
residues it is not unlikely to alter peptide folding with negative
consequences potentially extending beyond the CXXC domain
and including reduced enzymatic activity. In this respect the
dominant negative effect observed upon overexpression of this
mutant may be explained by the prevalent occurrence of Dnmt1
as a dimer [49]. These observations, together with preserved
ability for covalent complex formation and catalytic activity of our
CXXC domain deletion, support the validity of our homology
model-driven approach for functional characterization of the
CXXC domain. In addition, our genetic complementation
approach constitutes a rather physiologic functional assay.
However, due to the transient approach and the analysis of
genomic methylation at only a few representative sequences, subtle
or highly sequence specific effects of deletion of the CXXC
domain cannot be excluded.
It was recently shown that binding of Cfp1/CGBP and
KDM2A to CpG islands through their CXXC domains leads to
local enrichment and depletion of H3K4 and H3K36 methylation,
respectively [26,30]. Analogously, Dnmt1 may bind CpG islands
through its CXXC domain. However, this interaction would not
lead to a straightforward functional interpretation as CpG islands
with high CpG density are generally refractive to DNA
methylation and a function of Dnmt1 as a de novo DNA
methyltransferase is not well established. It could be envisaged
that binding to unmethylated CpG sites/islands by the CXXC
domain may have a negative effect on the enzymatic activity of
Dnmt1 and restrain its function as a de novo DNA methyltrans-
ferase. However, we show that in dnmt1 null ESCs methylation of
the imprinted H19a promoter is not restored upon expression of
either wild type or DCXXC Dnmt1 constructs, arguing against a
negative regulatory function of the CXXC domain.
Notably, binding of unmethylated CpG sites by KFGG motif-
containing CXXC domains does not exclude a role in protein-
protein interaction as the CXXC domain of MLL1 was reported
to interact with both DNA and Polycomb Repressive Complex 1
components HPC2/CBX4 and BMI-1 [21,50]. Therefore, it is
possible that the CXXC domain of Dnmt1 has regulatory
functions in specific cell types or developmental stages that may
involve DNA binding and/or interaction with other proteins. The
generation of dedicated animal models may be instrumental for
testing these possibilities.
Materials and Methods
Bioinformatic methods
Alignments were performed using the ClustalW2 software [51].
The CXXC domain homology tree (Figure 1C) was generated
from the alignment in Figure 1B with Jalview 2.4 by unweighted
pair group method with arithmetic mean (UPGMA). The
neighbor-joining method gave the same result. Average distances
between the sequences were calculated using the BLOSSUM62
matrix. The human CXXC10 coding sequence [52] was
determined by assembling ESTs AI438961, BX114363,
BX492895, BU633058.1, AW207644.1 and the genomic sequence
AC073046.7. The putative translational start site is located
16308 bp upstream of the annotated transcriptional start site of
TET3. A partial coding sequence of murine Cxxc10 containing
the CXXC domain was identified by aligning the human
CXXC10 protein sequence to the ORFs present in
NT_039353.7 upstream of the tet3 gene from position 35663306
to 35808487). A very high match was found 13266 nt upstream of
tet3 at positions 35676374-35676572 of NT_039353.7. To build
homology models for the CXXC domains of Dnmt1 (aa 645–696)
and Tet1 (aa 561–614), we submitted the respective sequences to
the HHpred server [53]. The best template was the CXXC
domain of MLL1 (PDB-ID: 2J2S). The 49 residues of the CXXC
domain in Dnmt1 can be aligned to this domain with 45%
sequence identity and only a single amino acid gap after residue
661 (Figure 1B). 3D models were calculated with the homology
modeling software MODELLER [54] (version 9.5) using this
alignment. Distance restraints were given to MODELLER to
enforce a distance of 2.360.1 Å between the eight sulphurs in the
Zn-coordinating cysteines and the Zn2+ ions. TM-align [55] was
used to superpose the model structure with the template domain.
Images were generated using the PyMol Molecular Graphics
System (Version 1.3, Schrödinger, LLC). The quality of the
models and the underlying alignments were checked with DOPE
[56] and Verify3D [57] and results for both models were found to
be comparable to the MLL1 template structure (2J2S).
Expression constructs
Fusion constructs were generated using enhanced green
fluorescent protein, monomeric red fluorescent protein or
monomeric cherry and are here referred to as GFP, RFP and
Cherry fusions, respectively. Mammalian expression constructs for
GFP, mouse GFP-Dnmt1, GFP-NTR and human RFP-PCNA
were described previously [42,44,49,58]. The deletion construct
GFP-Dnmt1DCXXC was obtained by replacing the sequence
coding for aa 655–696 with three alanine codons in the GFP-
Dnmt1 construct as described [59]. The GFP-DNMT1DCXXC
construct was generated by subcloning the sequence coding for
human DNMT1DCXXC from the homonymous construct by
Pradhan et al. [32] in the pEGFP-C2 vector (Clonetech). To
generate GFP-Tet1 three partially overlapping fragments span-
ning the Tet1 coding sequence were amplified using E14 ESCs
cDNA as template. The fragments were then joined by overlap
extension PCR and inserted into the pCAG-GFP-IB vector [43].
To generate GFP-Tet1DCXXC aa 569-621 of murine Tet1 were
deleted from GFP-Tet1 using a type IIs restriction endonuclease
approach as described [60]. To generate GFP-CXXCDnmt1 and
GFP-CXXCTet1 sequences coding for the respective CXXC
domains (aa 643-700 for Dnmt1 and 561-614 for Tet1) were
amplified by PCR using the GFP-Dnmt1 expression construct and
cDNA from E14 ESCs as templates, respectively. PCR fragments
were then inserted into the pCAG-GFP-IB vector. GFP-
NTRDCXXC was obtained by replacing the BglII-XhoI fragment
of GFP-NTR with the same fragment of GFP-Dnmt1DCXXC. Ch-
CTD-His was generated by replacing the GFP coding sequence in
a GFP-CTD construct [49] with the Cherry coding sequence. All
constructs were confirmed by sequencing.
Cell culture, transfection and cell sorting
HEK293T cells [61] and mouse C2C12 myoblasts [62] were
cultured in DMEM supplemented with 50 mg/ml gentamicin and
10% and 20% fetal calf serum, respectively. For expression of
fusion proteins HEK293T cells were transfected with polyethy-
lenimine (Sigma). For live cell imaging, C2C12 cells were grown
to 40% confluence on Lab-Tek chambers (Nunc) or m-slides
(Ibidi) and transfected with TransFectin transfection reagent
(BioRad) according to the manufacturer’s instructions. Mouse
ESCs were cultured as described [63] and transfected with
FuGENE HD (Roche) according to the manufacturer’s instruc-
tions. ESCs were sorted with a FACS Aria II instrument (Becton
Dickinson). The dnmt12/2 J1 ESCs used in this study are
homozygous for the c allele [14].
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In vitro DNA binding and trapping assays
In vitro DNA binding and trapping assays were performed as
described previously [36,37] with the following modifications.
DNA substrates labeled with four different ATTO fluorophores
(Tables S1 and S2 in File S1) were used at a final concentration of
125 nM each in the pull-down assay with immobilized GFP
fusions. After removal of unbound substrate, the amounts of
protein and DNA were determined by fluorescence intensity
measurements with a Tecan Infinite M1000 plate reader using
calibration curves from purified GFP or DNA coupled ATTO
fluorophores, respectively. The following excitation/emission 6
detection bandwidth settings were used: 490/511610 nm for
GFP, 550/580615 nm for ATTO550, 600/630615 nm for
ATTO590, 650/670610 nm for ATTO647N and 700/
720610 nm for ATTO700. Cross detection of GFP and different
ATTO dyes was negligible with these settings. Binding and
trapping ratios were calculated dividing the concentration of
bound DNA substrate by the concentration of GFP fusion on
the beads.
In vivo mC hydroxylation assay
Genomic DNA was isolated from HEK293T cells 24 h after
transfection with the GFP-Tet1 and GFP-Tet1DCXXC constructs
and global hmC levels were measured using the in vitro
glucosylation assay as previously described [63], except that
100 nM b-glucosyltransferase and only UDP-[3H]glucose donor
(0.43 mM) were used.
Co-immunoprecipitation
Co-immunoprecipitation was performed as described previously
[49,64]. Shortly, HEK293T cells were transiently co-transfected
with expression plasmids for GFP fusions and the Ch-CTD-His
construct, harvested and lysed. GFP fusions were pulled down
using the GFP-Trap [65] (Chromotek) and subjected to western
blotting using anti-GFP (Roche or Chromotek) and anti-His
(Invitrogen) monoclonal antibodies.
Live cell microscopy, FRAP analysis and live cell trapping
assay
Live cell imaging and FRAP experiments were performed as
described previously [43]. For each construct 6-15 nuclei were
averaged and the mean values as well as the standard errors were
calculated. For presentation, we used linear contrast enhancement
on entire images. The DNA methyltransferase trapping assay was
described previously [44]. Briefly, transfected cells were incubated
with 30 mM 5-aza-dC (Sigma) for the indicated periods of time
before photobleaching experiments. FRAP analysis was performed
with a confocal laser scanning microscope (TCS SP5, Leica)
equipped with a 636/1.4 NA Plan-Apochromat oil immersion
objective. Microscope settings were as described except that a
smaller region of interest (3 mm63 mm) was selected for photo-
bleaching. Mean fluorescence intensities of the bleached region
were corrected for background and for total loss of nuclear
fluorescence over the time course, and normalized by the mean of
the last 10 prebleach values.
DNA Methylation Analysis
Genomic DNA was isolated with the QIAmp DNA Mini Kit
(Qiagen) and 1.5 mg were bisulfite converted using the EZ DNA
Methylation-Gold Kit (Zymo research) according to the manu-
facturer’s instructions. Primer sets and PCR conditions for IAP-
LTR, skeletal a-actin and H19 promoters were as described [43].
Primer sequences for major satellites were AAAATGAGAAA-
CATCCACTTG (forward primer) and CCATGATTTT-
CAGTTTTCTT (reverse primer). For amplification we used
Qiagen Hot Start Polymerase in 1x Qiagen Hot Start Polymerase
buffer supplemented with 0.2 mM dNTPs, 0.2 mM forward
primer, 0.2 mM reverse primer, 1.3 mM betaine (Sigma) and
60 mM tetramethylammonium-chloride (TMAC, Sigma). Pro-
moter regions and IAP-LTR were amplified with two subsequent
(nested) PCR reactions and major satellite repeats were amplified
with a single amplification reaction. Pyrosequencing reactions
were carried out by Varionostic GmbH (Ulm, Germany).
Pyrosequencing primers are listed in Table S3 in File S1.
Supporting Information
File S1 Tables S1–S3, Figures S1–S8 and Supplemental
methods.
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46. Andersson T, Södersten E, Duckworth JK, Cascante A, Fritz N, et al. (2009)
CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural
Stem Cells. J Biol Chem 284: 3672–3681.
47. Hino S-i, Kishida S, Michiue T, Fukui A, Sakamoto I, et al. (2001) Inhibition of
the Wnt Signaling Pathway by Idax, a Novel Dvl-Binding Protein. Mol Cell Biol
21: 330–342.
48. London TBC, Lee H-J, Shao Y, Zheng J (2004) Interaction between the internal
motif KTXXXI of Idax and mDvl PDZ domain. Biochem Biophys Res
Commun 322: 326–332.
49. Fellinger K, Rothbauer U, Felle M, Langst G, Leonhardt H (2009) Dimerization
of DNA methyltransferase 1 is mediated by its regulatory domain. J Cell
Biochem 106: 521–528.
50. Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ (2003) MLL repression domain
interacts with histone deacetylases, the polycomb group proteins HPC2 and
BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad
Sci U S A 100: 8342–8347.
51. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucl Acids
Res 22: 4673–4680.
52. Katoh M (2004) Identification and characterization of human CXXC10 gene in
silico. Int J Oncol 25: 1193–1199.
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Table S1. Sequences of DNA oligonucleotides used for preparation of double stranded DNA 
substrates. M: 5-methylcytosine. 
Name Sequence 
CG-up 5’- CTCAACAACTAACTACCATCCGGACCAGAAGAGTCATCATGG -3’ 
MG-up  5’- CTCAACAACTAACTACCATCMGGACCAGAAGAGTCATCATGG -3’ 
noCG-up 5’- CTCAACAACTAACTACCATCTGGACCAGAAGAGTCATCATGG -3’ 
Fill-In-550 5’- ATTO550-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-590 5’- ATTO590-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-647N 5’- ATTO647N-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-700 5’- ATTO700-CCATGATGACTCTTCTGGTC -3’ 
 
Table S2. DNA substrates used for the in vitro DNA binding and trapping assays. 
Name CpG site Label Oligo I Oligo II dCTP reaction  Purpose 
noCGB 700 no CpG site 700 noCG-up Fill-In-700 dCTP Binding 
UMB 550 
unmethylated 
550 
CG-up 
Fill-In-550 
dCTP Binding 
UMB 590 590 Fill-In-590 
UMB 647N 647N Fill-In-647N 
UMB 700 700 Fill-In-700 
UMT 550 550 Fill-In-550 5-aza-dCTP Trapping
HMB 590 
hemimethylated 
590 
MG-up 
Fill-In-590 
dCTP Binding 
HMB 647N 647N Fill-In-647N 
HMT 550 550 Fill-In-550 
5-aza-dCTP Trapping
HMT 647N 647N Fill-In-647N 
FMB 647N fully methylated 647N MG-up Fill-In-647N 5methyl dCTP Binding 
 
Table S3. Primers used for pyrosequencing. Each primer is biotinylated at the 5’ end. 
Name Sequence 
skeletal α-actin-1 5’- AGTTGGGGATATTTTTTATA -3’ 
skeletal α-actin-1b  5’- TTTTGGTTAGTGTAGGAGAT -3’ 
skeletal α-actin-2 5’- TGGGAAGGGTAGTAATATTT -3’ 
H19-1 5’- ATAGTTATTGTTTATAGTTT -3’ 
H19-2 5’- AGGAATATGTTATATTTAT -3’ 
IAP LTR-1 5’- CCCTAATTAACTACAACCCA -3’ 
IAP LTR-2 5’- TGTAGTTAATTAGGGAGTGA -3’ 
Major Satellite-1 5’- AAAATGAGAAATATTTATTTG -3’ 
Major Satellite-2 5’- GAGAAATATATACTTTAGGA -3’ 
Frauer et al.  Supplemental Information File 
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Figure S1. Dnmt1 domain structure and alignment of Dnmt1 CXXC domains from different 
species. Numbers on the right side indicate the position of the last amino acid in each 
sequence. PBD: PCNA binding domain; TS: targeting sequence; CXXC: CXXC-type zinc 
finger domain; BAH1 and 2: bromo-adjacent homology domain; (KG)7: seven lysine-glycine 
repeats. Absolutely conserved residues are highlighted in red. Positions with residues in red 
face share 70% similarity as calculated with the Risler algorithm {Mohseni-Zadeh, 2004 
#133}. The alignment was generated with ClustalW2 and displayed with ESPript 2.2. 
GenBank accession numbers are: Mus musculus: NP_034196; Homo sapiens: 
NP_001124295; Bos taurus: NP_872592; Monodelphis domestica: NP_001028141; Gallus 
gallus: NP_996835; Xenopus laevis: NP_001084021; Danio rerio: NP_571264; 
Paracentrotus lividus: Q27746 (Swiss Prot); Apis mellifera: NP_001164522 (Dnmt1a); 
Bombyx mori: NP_001036980. 
Frauer et al.  Supplemental Information File 
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Figure S2. The cellular localization of GFP-CXXCDnmt1 is independent of cell cycle stage. 
Live images of C2C12 mouse myoblasts cotransfected with expression constructs for 
GFP-CXXCDnmt1 and RFP PCNA. The latter served for identification of the cell cycle stage. 
Scale bar: 5 µm. 
Frauer et al.  Supplemental Information File 
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Figure S3. Differential mobility of GFP-CXXCDnmt1 in nucleoli and nucleoplasm of mouse 
C2C12 myoblasts measured by FRAP analysis. Identical regions of interest over the 
nucleoplasm or nucleoli (as exemplified in the inset) were bleached and recovery curves were 
recorded over 30 seconds. GFP-CXXCDnmt1 kinetics is faster in nucleoli than in the nucleus, 
which indicates more transient (possibly unspecific) binding in the former than in the latter. 
Scale bar: 5 µm. 
Frauer et al.  Supplemental Information File 
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Figure S4. GFP fusion pulldowns from transiently transfected HEK293T cells using the 
GFP-trap. Shown is a SDS polyacrylamide gel stained with coomassie blue. I = input (1%); B 
= bound (10%). 
Frauer et al.  Supplemental Information File 
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Figure S5. The CXXC domain of Dnmt1 preferentially binds unmethylated CpG sites. GFP 
and GFP-CXXCDnmt1 purified from transiently transfected HEK293T cells with the GFP trap 
were challenged with fluorescent DNA substrates containing no CpG site or one central un-, 
hemi- or fully methylated CpG site in direct competition (noCGB, UMB, HMB and FMB, 
respectively) as in Figure 2C, except that a five-fold higher concentration (625 nM) of each 
substrate was used. 
Frauer et al.  Supplemental Information File 
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Figure S6. The cellular localization of GFP-CXXCTet1 is independent of cell cycle stage. Live 
images of C2C12 mouse myoblasts cotransfected with expression constructs for 
GFP-CXXCTet1 and RFP PCNA. The latter served for identification of the cell cycle stage. 
Scale bar: 5 µm. 
Frauer et al.  Supplemental Information File 
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Figure S7. Radioactive methyltransferase activity assay for GFP Dnmt1 and 
GFP-Dnmt1∆CXXC. The transfer of [3H]-methyl groups to poly(dI•dC)-poly(dI•dC) substrate 
was measured for increasing volumes of GFP fusion proteins immunopurified from 
transiently transfected HEK293T cells. Counts per minute (cpm) were normalized to the 
relative protein concentration as determined by SDS-PAGE analysis. GFP was used as 
negative control. Numbers above the bars indicate the volume (µl) of protein solution added. 
Frauer et al.  Supplemental Information File 
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Figure S8. Competitive DNA binding and trapping assays for human GFP-DNMT1 and 
GFP-DNMT1∆CXXC. GFP, GFP-DNMT1 and GFP-DNMT1∆CXXC were purified from 
transfected HEK293T cells using the GFP-trap and incubated with fluorescent DNA 
substrates containing one central unmethylated (UM) or hemimethylated (HM) CpG site in 
direct competition. Both substrates contained either dC (binding) or 5 aza dC (trapping) on the 
strand opposite to the differentially methylated one. The comparison of binding and trapping 
ratios reflects irreversible covalent complex formation. Note the reduction in trapping of 
GFP-DNMT1∆CXXC relative to GFP-DNMT1 by the hemimethylated substrate. Shown are 
mean values and standard deviation of DNA/protein ratios from two independent 
experiments. 
Frauer et al.  Supplemental Information File 
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SUPPLEMENTARY METHODS 
 
In vitro methyltransferase activity assay 
Eight milligrams of His-tagged GFP-binding protein (GBP; Chromotek) were coupled to 1ml 
Ni-NTA agarose beads (Qiagen) by incubating for 2 h at 4°C in PBS and unbound protein 
was washed out twice with PBS. Extracts of HEK293T cells expressing GFP or a GFP fusions 
were prepared in 200 µl lysis buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM 
imidazole, 0.5 % Tween-20, 2 mM MgCl2, 1 mg/ml DNaseI, 2 mM PMSF, 1X mammalian 
protease inhibitor mix). After centrifugation, supernatants were diluted to 500 µl with 
immunoprecipitation buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole, 
0.05 % Tween-20) and precleared by incubation with 25 µl of equilibrated Ni-NTA agarose 
beads for 30 min at 4°C followed by centrifugation. Precleared extracts were then incubated 
with 40 µg of His-tagged GFP-trap coupled to Ni-NTA beads for 2 h at 4°C with constant 
mixing. GFP or GFP fusions were pulled down by centrifugation at 540 g. After washing 
twice with wash buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.05 
% Tween-20), complexes were eluted with 60 µl of elution buffer (10 mM Tris pH 7.5, 100 
mM KCl, 1 mM EDTA, 1 mM DTT, 250 mM imidazole) for 10 min at 25°C with constant 
mixing. 10 µl aliquots of all eluates were subjected to western blot analysis using mouse or rat 
monoclonal antibodies to GFP (Roche and Chromotek, respectively) and quantified by 
densitometry. Indicated volumes of eluate were incubated with 1 µg of poly(dI·dC)- 
poly(dI·dC) substrate (Sigma), 0.5 µg/µl of BSA and 1 µCi of S-adenosyl-[3H-
methyl]-methionine in 50 µl of trapping buffer (10 mM Tris pH 7.5, 100 mM KCl, 1 mM 
EDTA, 1 mM DTT) for 60 min at 37°C. 15 µl of each sample were spotted onto blotting 
paper and the DNA was precipitated with ice cold 5 % TCA. After washing twice with 5% 
TCA and once with cold 70 % ethanol, paper filters were air dried and analyzed by 
scintillation in 4 ml scintillation cocktail (Rotiszint® eco plus, Roth) for 5 min. 
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De novo activity of DNA methyltransferase 1 in triple 
knock-out mouse ES cells (manuscript in preparation) 
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2.3 De novo activity of DNA methyltransferase 1 in triple knock-out mouse ES cells  
Dnmt1 was the first DNA methyltransferase to be described in mammalian cells and is the 
major enzyme involved in maintenance of DNA methylation patterns of post-replicative 
DNA sequences (Bestor & Ingram, 1983; Hermann et al, 2004a; Leonhardt et al, 1992). 
Dnmt1 has a strong preference for hemi-methylated sites in vitro, although in vitro studies 
revealed residual activity on unmethylated DNA sequences (Frauer & Leonhardt, 2009; 
Hermann et al, 2004a; Pradhan et al, 1999). Moreover, in cancer cells, overexpression of 
Dnmt1 was associated with hypermethylation at specific promoter regions which argues 
for a de novo methylation activity of Dnmt1 (Biniszkiewicz et al, 2002). The question that 
remains unanswered is whether Dnmt1 has de novo methylation activity on unmethylated 
DNA sequences in living cells. To this aim, we analyzed the ability of Dnmt1 to restore 
methylation patterns in methylation devoid triple knockout ES cell line (TKO) (Tsumura et 
al, 2006).  
Mater ia l  and Methods 
Expression constructs and cell lines: The GFP-Dnmt1 expression construct was described 
previously (Frauer et al, 2011). The GFP-Dnmt3a and GFP-Dnmt3b constructs were kindly 
provided by (Okano et al, 1998), triple knock out cell lines were generated and kindly 
provided by (Tsumura et al, 2006). 
Cell culture and transfection: Mouse ES cells were cultured without feeder cells in 
gelatinized flasks and in DMEM supplemented with 16% fetal calf serum, 1000 U/ml LIF, 
ß-mercaptoethanol and L-Glutamin as described previously (Frauer et al., 2011). Cells 
were transfected with a GFP-Dnmt expression construct immediately after splitting with 
FuGENE HD (Roche, Mannheim) according to the manufactures protocol.  
Rescue assay and stable cell line generation: GFP-positive cells were sorted 48 hours after 
transfection with a FACS Vantage SE cell sorter or a FACS Aria II (Becton –Dickinson), 
respectively. Sorted cells were either directly lysed to isolate genomic DNA (48 hours 
rescue assay) or plated under low density for stable cell line generation. The remaining 
GFP-positive cells were subsequently sorted until a stable pool of GFP-expressing cells 
was obtained. After a stable pool of cells was generated, single cells were sorted into a 
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gelatinized 96 well plate to generate single clones. Clones were cultured, expanded and 
proteins were extracted to analyze the expression of the GFP fusion protein. Expression 
levels were compared to the endogenous protein levels in wild type ES cells and clones 
expressing similar levels were chosen.  
Genomic DNA Isolation and Bisulfite Treatment: Genomic DNA was isolated using QIAmp 
DNA Mini kit (Qiagen) kit and 500 ng-1.5 µg DNA was bisulfite treated using either EpiTect 
(Qiagen) or EZ DNA Methylation-Gold Kit (Zymo Research) following the manufactures 
conditions.  
Methylation Analysis based on Pyrosequencing: Bisulfite treated DNA was amplified in a 
PCR reaction with specific Primer sets and PCR conditions for CpG Islands of skeletal α-
actin, H19a, dnmt1o promoter, Xist exon 1, intracisternal type A particle long terminal 
repeat (IAP) and major satellite repeats (see table Table 1 and Table 2).  
Table 1: Bisulfite primer sequences for single copy gene promoters.  
promoter forward pr imer sequence reverse pr imer sequence length CpG 
skeletal- α  
act in 
 
    
GGGGTAGATAGTTGGGGATATTTTT CCTACTACTCTAACTCTACCCTAAAT
A-bio 
309bp 13 
dnmt1o 
 
GTTGTTTTTTGGTTTTTGTGGGTA CAACCTTAACAACACAACTAAAATA   
GTTGTTTTTTGGTTTTTGTGGGTA CAACTATACACTATCAAATAACCT-bio 272bp 4 
H19a GATTAGATAGTATTGAGTTTGTTTGGAGT CCTAAAATACTAAACTTAAATAACCCA
CAA 
  
GAG AAA ATA GTT ATT GTT TAT AGT 
TTT 
ACCATTTATAAATTCCAATACCAAAAA
TAA-bio 
317bp 10 
xist GTTAATTAATGTAGAAGAATTTTTAGTGTT
TA 
TTATTTAAGGAGTTTTGGGGGAATATT
T 
  
GTTAATTAATGTAGAAGAATTTTTAGTGTT
TA 
TTTAATAAGATGTTAGAATTGTAATTTT
TGTG -bio 
458bp 19  
 
Major satellite repeats were amplified in a single PCR reaction and two PCR reactions 
were pooled using a Millipore purification kit, while all other sequences were amplified in a 
nested PCR reaction. The amplified PCR product was subjected to pyrosequencing 
carried out by varionostic GmbH, Ulm.  
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Table 2: Bisulfite primer sequences for repetitive sequences 
sequence forward pr imer sequence reverse pr imer sequence length CpG 
MajSat 
 
AAATGAGAAAtATttAtTTG CCATaATTTTCAaTTTTCTT -bio 234bp 8 
IAP 
 
GTTGTTTTTTGGTTTTTGTGGGTA CAACCTTAACAACACAACTAAAATA   
GTTGTTTTTTGGTTTTTGTGGGTA CAACTATACACTATCAAATAACCT-bio 259bp 4 
 
Methylat ion analys is in TKO cel ls t ransient ly rescued with GFP-Dnmt1 
We investigated the activity of Dnmt1 on unmethylated DNA in TKO ESC’s by re-
expression of Dnmt1 in transient as well as stable rescue experiments. For this aim, we 
used triple knockout (TKO) ESC’s that lack all the three major methyltransferases Dnmt1, 
Dnmt3a and Dnmt3b and therefore are devoid of methylation. We performed a transient 
rescue assay where TKO cells were transfected with GFP-Dnmt1, GFP-Dnmt3a and GFP-
Dnmt3b and analyzed selected sequences to determine the ability to methylate 
unmethylated DNA sequences in vivo. In a transient rescue assay TKO cells were 
transfected with the respective plasmids and FACS sorted after 48 hours. Genomic DNA 
was isolated, bisulfite treated and subjected to pyrosequencing for a quantitative 
methylation analysis. TKO cells rescued with GFP-Dnmt1 remained unmethylated in all of 
the analyzed sequences after 48 hours. In comparison we performed the same approach 
with GFP-Dnmt3a and GFP-Dnmt3b, respectively, which showed that both de novo 
methyltransferases are active and able to re-methylate unmethylated DNA sequences in 
TKO cells.  
Establ ishment of stable TKO cel l  l ines and methylat ion analys is by 
pyrosequencing 
To overcome limitations of a transient rescue assay as well as to analyze long-term effects 
of Dnmt1 expression in TKO cells, we additionally established TKO cell lines, which stably 
express GFP-Dnmt1. For a comparison of different methyltransferase activities we also 
generated stable pools of GFP-Dnmt3a and GFP-Dnmt3b TKO cell lines, respectively. For 
this aim we established a new FACS based approach to generate stable TKO cell lines 
Results 
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since TKO cells are resistant to the most commonly used selective markers (Tsumura et al, 
2006). After several rounds of FACS sorting for GFP positive cells and their subsequent 
propagation all cell lines were stable. We generated pools of TKO cells stably expressing 
GFP-Dnmt1, GFP-Dnmt3a and GFP-Dnmt3b. Furthermore the pool of TKO cells stably 
expressing GFP-Dnmt1 was further subcloned and single clones were selected for further 
methylation analysis. Genomic DNA was isolated, bisulfite treated and subjected to 
pyrosequencing as described for the transient rescue experiment. Moreover, we analyzed 
three different pools of GFP-Dnmt1 stable cell lines over several passages to address 
dynamics and kinetics of a potential de novo methylation activity of Dnmt1 and to detect a 
possible accumulation of methylation over time. Genomic DNA samples were obtained 
three and six weeks after transfection and subjected to pyrosequencing.  
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Figure 2-1: Quantitative methylation analysis of single copy gene promoters in TKO cells rescued with GP-
Dnmt1, GFP-Dnmt3a and GFP-Dnmt3b. Quantitative methylation levels of (A) 13 CpG sites were averaged 
for skeletal α-actin promoter and (B) 4 CpG sites for dnmt1o promoter for each analyzed sample. 
Methylation of wild type and dnm1-/- are displayed for comparison. TKO cells were rescued with GFP-Dnmt1 
and three different pools of stable cell lines (I-III) were analyzed 3 weeks (a) and 6 weeks (b) after stable 
transfection. Four different stable clones (#1,#10,#12,#19) were selected whose dnmt1 expression levels are 
similar compared to the endogenously expressed Dnmt1 in wild type cells (data not shown). CpG 
Methylation was not detected at any time point in any of the analyzed TKO GFP-Dnmt1 cell lines (A,B). TKO 
cells rescued with GFP-Dnmt3a and GFP-Dnmt3b showed detectable methylation in the skeletal α-actin 
promoter (A) and in the dnmt1o promoter (B) indicating de novo methylation activity.  
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 Figure 2-2: Quantitative methylation analysis of imprinted promoter H19a and xist promoter in TKO cells 
rescued with GP-Dnmt1, GFP-Dnmt3a and GFP-Dnmt3b. Quantitative methylation levels of (A) 6 CpG sites 
were averaged for xist promoter and (B) 5 CpG sites for h19a promoter for each analyzed sample. 
Methylation of wild type and dnm1-/- are displayed as comparison. TKO cells were rescued with GFP-Dnmt1 
and three different pools of stable cell lines (I-III) were analyzed 3 weeks (a) and 6 weeks (b) after stable 
transfection. Four different stable clones (#1,#10,#12,#19) were selected whose dnmt1 expression levels are 
similar compared to the endogenously expressed Dnmt1 in wild type cells (data not shown). CpG 
Methylation was not detected at any time point in any of the analyzed TKO GFP-Dnmt1 cell lines (A,B). TKO 
cells rescued with GFP-Dnmt3a and GFP-Dnmt3b showed detectable methylation in the xist promoter (A) 
indicating de novo methylation activity, while no methylation was detectable in the h19a promoter (B). 
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Figure 2-3 Quantitative methylation analysis of repetitive sequences major satellites and IAP elements TKO 
cells rescued with GP-Dnmt1, GFP-Dnmt3a and GFP-Dnmt3b. Quantitative methylation levels of (A) 8 CpG 
sites were averaged for major satellites and (B) 11 CpG sites for IAP elements for each analyzed sample. 
Methylation of wild type and dnm1-/- are displayed as comparison. TKO cells were rescued with GFP-Dnmt1 
and three different pools of stable cell lines (I-III) were analyzed 3 weeks (a) and 6 weeks (b) after stable 
transfection. Four different stable clones (#1,#10,#12,#19) were selected whose dnmt1 expression levels are 
similar compared to the endogenously expressed Dnmt1 in wild type cells (data not shown). CpG 
Methylation was not detected at any time point in any of the analyzed TKO GFP-Dnmt1 cell lines (A,B). TKO 
cells rescued with GFP-Dnmt3a and GFP-Dnmt3b showed detectable methylation in major satellites (A) and 
in the IAP elements (B) indicating de novo methylation activity. 
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Methylat ion analys is in TKO cel ls stably expressing GFP-Dnmt1, GFP-Dnmt3a 
and GFP-Dnmt3b 
The analysis of GFP-Dnmt3a and GFP-Dnmt3b stable cell lines show low but measureable 
de novo methylation in all analyzed sequences, except for the case of H19a, which 
requires passage through the germ line to become methylated (Tucker et al, 1996).  We 
were able to detect a 10-15-fold increase in methylation levels of GFP-Dnmt3a and GFP-
Dnmt3b stable cell lines compared to untreated TKO cells. However, these methylation 
levels do not by far reach those found in dnmt1-/- ES cells where both de novo 
methyltransferases are expressed. Therefore, our data points towards the important role of 
a synergetic function between Dnmt3a and Dnmt3b in de novo methylation activity.  
Surprisingly, in none of the analyzed GFP-Dnmt1 clones and stable pools was DNA 
methylation detectable above background, even after several passages of cultivation (see 
Figure 2-1,  Figure 2-2, Figure 2-3). These findings clearly show that Dnmt1 alone is not 
able to de novo methylate unmethylated DNA sequences in vivo and argues against 
several studies claiming that Dnmt1 has de novo methylation activity apart from its clear 
involvement in maintenance. To clarify whether proximal pre-existing CpG sites are able to 
initiate de novo methylation of Dnmt1 further experiments have to be performed in living 
cells. To this aim introduction of methylation at specific sites followed by a rescue assay 
with Dnmt1 would be necessary. Moreover, to investigate whether interaction between the 
three active methyltransferases might activate de novo activity of Dnmt1, double-rescue 
experiments of the active methyltransferases in combination with their respective 
catalytically inactive “mutants” are necessary to be performed.  
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DNA-methylation of CpG dyads and markov modeling of 
DNA-methylation control in mammals  
(manuscript in preparation)
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2.4 DNA-methylation of CpG dyads and markov modeling of DNA-methylation control in 
mammals  
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Abstract  
Repetitive elements such as LINE1, B1, IAP-LTR-retrotransposons and major Satellites, 
comprise a large portion of the mammalian genome and are major targets of DNA-
methylation mediated silencing (1) (2). Using 454 bisulfite sequencing combined with 
hairpin linker technology we mapped the CpG dyad methylation on both strands of the 
four major classes of repetitive elements at high resolution. A comparative analysis of 
sequence reads generated from somatic cells, wt and mutant ESCs with deficiencies for 
Dnmt1, Dnmt3a, Dnmt3b, Dnmt3L, NP95 and double deficiency for Dnmt3a/3b and 
Suv39h1/2 allowed us to assign cell type differences and enzyme dependent methylation 
changes. The data set was used to develop a comparative Hidden Markov Model (HMM) 
to estimate the relative enzyme rates for de novo and maintenance methylation. The HMM 
shows that i) Dnmts contribute with varying degrees to CpG dyad methylation and ii) 
Dnmts have distinct preferences for the methylation of individual types of repetitive 
elements. Besides a predominant methylation maintenance role of Dnmt1 (and NP95) the 
model also predicts a substantial de novo methylation activity for Dnmt1 at IAPs and major 
satellites. Conversely, Dnmt3a and Dnmt3b have a strong preference for hemimethylated 
CpG dyads contributing to maintain full methylation following replication at certain 
elements. Finally, we identified CpA methylation at specific locations in major satellite 
sequences of ESCs catalysed by distinct position dependent activities of Dnmt3a or 
Dnmt3b, respectively. Dnmt3L enhances this CpA methylation activity along with CpG 
methylation for both enzymes.    
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Introduction 
DNA methylation at the C-5 positions of cytosine (5mC) is a key epigenetic modification in 
mammals essential for normal development of mammals (3). Cytosine methylation is 
predominantly found in CpG dinucleotide context and about 70 to 80% of all CpGs are 
methylated (4). These methylated CpGs are usually located in CpG poor regions and often 
in repetitive sequences (4, 5). About 40% of the genome consists of repetitive elements. 
Four main groups of repetitive elements can be discriminated: long interspersed nuclear 
elements (LINEs), short interspersed nuclear elements (SINEs), long-terminal repeat (LTR) 
retrotransposons and (peri-) centromeric satellites. For these elements, the maintaining of 
DNA methylation during development and aging is important for transcriptional silencing 
and genome stability (1, 6).  
The establishment and maintenance of methylation patterns at palindromic CpG 
sequences (CpG dyads) is performed by three catalytically active DNA methyltransferases 
(Dnmts). In vitro experiments suggest that Dnmt1 prefers hemimethylated CpG (hemi-
mCpG) dyads and maintains the methylation pattern on the newly synthesised strand after 
replication (maintenance methylation). In vitro Dnmt1 shows a low activity on unmethylated 
CpG dyads. Dnmt3a and Dnmt3b methylate DNA de novo, independent of the methylation 
status of the complementary CpG position (7). In vitro analyses furthermore suggest that 
methylation by Dnmt3b and the maintenance function of Dnmt1 mostly occur in a 
processive manner, whereas Dnmt3a and the “de novo function” of Dnmt1 are distributive 
(8-10). However, other groups observe a processive methylation activity for DNMT3a (11). 
Although there is a lot of in vitro data available on Dnmts and their possible functions, little 
is known about their concerted action in vivo at dispersed repetitive elements. Data of 
ESCs with individual and combined Dnmt knockouts indicated preferences of Dnmts for 
specific repetitive elements (2).  In addition Dnmt activities are modulated by Nuclear 
protein of 95 kDa (Np95; also known as Uhrf1) and Dnmt3L. Dnmt3L, a cofactor for the de 
novo methyltransferases, is reported to stimulate Dnmt3a/3b activity, to be needed for de 
novo establishment for imprint methylation and furthermore to enhance the processive 
methylation activity of human Dnmt3a (11-13). Np95 is recruiting Dnmt1 to 
hemimethylated DNA (14, 15) and is interacting with Dnmt3a/3b for gene silencing (16).  
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Different mathematical models were developed to simulate the kinetics of DNA 
methylation (17-20). Initial DNA methylation analysis using hairpin bisulfite sanger 
sequencing allowed to gain a first insight on symmetrical methylation of DNA strands and 
such data were used for initial static mathematical modelling (21, 22).  
In this paper, we present a first comprehensive high resolution methylation analysis 
for both DNA strands using hairpin linker technology. This allowed us to determine the 
methylation symmetry along individual chromosomal fragments of four distinct classes of 
repetitive elements in wt ESCs and ESCs depleted for Dnmt1, Dnmt3a, Dnmt3b, 
Dnmt3a/b, Dnmt3L, Np95 and Suv39h. The complex data set was used to further develop 
hidden Markov models (HMM) which describe the relative contribution of Dnmts for 
maintenance and de novo methylation (17, 18, 22). This provides a number of novel 
insights in the complexity and dynamic of DNA methylation control.  
 
 
Results 
Outl ine and qual ity monitoring of the hairpin bisulf i te sequencing strategy 
We designed specific hairpin linker protocols to amplify representative fragments of the 
four major classes of repetitive elements from bisulfite treated mouse DNA. The sequence 
elements selected were i) major Satellites, ii) IAPLTR1, a class of LTR-retrotransposons, iii) 
the 5’ untranslated region of L1MdTf, a long interspersed element (LINE) and iv) a 
conserved portion of B1 elements, representing a class of short interspersed elements 
(SINEs) (see also Supplementary Table S1 for detailed references). In this paper, we 
conveniently refer to the repeat elements as mSat, IAP, L1 and B1, respectively. Following 
amplification the PCR products were sequenced on a 454 GS-FLX sequencer with an 
average read length of 200-400bp covering 3 to 7 CpG dyads of the respective 
amplicons.  
The addition of an unmethylated hairpin linker containing several unmodified 
cytosines allowed us to directly monitor the bisulfite conversion rates per sequenced 
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molecule. In the linker sequences the conversion rates ranged from 99,1- 99,4% for mSat, 
IAP and L1 sequences, respectively. Sequences of B1 elements showed a slightly lower 
conversion rate of 97.8%, probably due to the more degenerate sequence composition 
and occasional back-folding (Supplementary Fig. S1a, Supplementary Table S2).  
In contrast to conventional single strand bisulphite sequencing, hairpin bisulfite 
sequencing allows to unambiguously distinguish between unmethylated and mutated CpG 
sites. We identify mutated CpGs in all repetitive element to various extend (see white 
positions in Fig.1). A particular abundance of mutated CpGs was found in B1 elements 
with 50% of CpGs being mutated to TpG (see also Supplementary Fig. S1b). Previous 
single strand bisulfite sequencing accounted such TpGs as unmethylated positions 
estimating the total methylation of B1 elements to be only 10%. (23). When correcting for 
mutated sites we find B1 elements to be up to 80% methylated in wt cells.  
 
Analysis of the methylat ion symmetry at CpG dyads in various repetit ive 
elements  
First, we compared the DNA methylation patterns of repetitive elements between mouse 
wt ESC lines, mouse embryonic liver and cultured mouse embryonic fibroblasts (MEFs) 
(Fig.1). The comparison included separate analysis of the three ES cell lines J1 (24), E14 
(15) and WT26 (25) which are the “parental” lines for the Dnmt knockouts (J1) (3, 26, 27), 
the Np95 knockout (E14) (15) and the Suv39h knockout (WT26) analysed (25).  
MSat, IAPs and B1 are highly methylated in all wt ESC and somatic cells. Their 
overall methylation ranges from 60-95% at CpG dyads. The same holds for L1 elements in 
somatic cells (> 74%). In ESCs, however, L1 methylation levels only reach a max. of 30-
52%. Moreover ESCs appear to have a significant general variation in their overall 
methylation levels. The ESC line J1 is significantly higher methylated at all repetitive 
elements compared to E14 and WT26. Also between MEFs and embryonic liver we 
detected a substantial difference in the overall methylation status (Fig. 2a). 
Following a precise alignment to reference sequences using BiQAnalyzerHT (28) we 
calculated the amount of hemimethylated CpG dyads (hemi-mCpGs) for all sequences. 
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Laird et al. and Burden et al. reported values between 4.8% (sperm) and 20.8% 
(leukocytes) of hemi-mCpGs for human LINE1 elements (21, 29). Shao et al. observed 7% 
hemi-mCpG in human Satellite 2 sequences in different tissues (30). In mouse we also 
observe 8 to 25% of all CpGs in a hemimethylated status (Fig. 2b). MEFs show the lowest 
and least variable rate of hemi-mCpG sites across all analysed elements (8 to 10.5%) while 
in embryonic liver the highest amount of hemi-mCpGs is detected across all repetitive 
elements (20 to 25%). Strikingly, unlike the almost equal occurrence of hemi-mCpGs at 
various repetitive elements in differentiated cells, the degree of hemimethylation is much 
more variable in repetitive elements of wt ESCs. While hemimethylation levels of IAPs are 
rather low (9 to 12%) more than 20% of CpGs in L1 are hemimethylated in ESCs (Fig.2b). 
Moreover the extend of hemi-mCpGs at mSat greatly varied between the three wt ESC 
lines.  
  
Loss of single Dnmts has dist inct effects on the methylat ion status of 
repetit ive elements 
Next, we analysed the contributions of Dnmts and cofactors for the maintenance of 
methylation by comparing hairpin bisulfite sequence data of ESCs mutated for Dnmt1, 
Dnmt3a, Dnmt3b, Dnmt3a and 3b (DKO), Dnmt3L and Np95 (UHRF1), respectively. An 
overview of the methylation patterns is given in Fig. 3.  
Deletion of Dnmt1 caused a high reduction of DNA methylation in all analysed 
elements when compared to the corresponding wt ESC. MSat methylation was reduced 
by 66%, IAP by 72%, L1 by 76% and B1 by 74%, respectively. This tendency was also 
observed in previous low resolution data obtained for a subset of repetitive sequence 
elements (2, 26). The effects of Np95 KO were very similar to the Dnmt1 KO (see also 
Bostick et al. (14)). 
In contrast to a general increased hypomethylation at all elements in Dnmt1/Np95 
KOs, the loss of Dnmt3 activities led to element and enzyme specific differences. While 
methylation at IAP and mSat did not change in Dnmt3a or Dnmt3b single KO`s, the double 
KO, analysed at passage 8, lead to a clear decrease of CpG methylation at mSat (24%) 
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and IAPs (17%). Methylation at L1 and B1 did not change in the Dnmt3b single KO but 
was strongly decreased in the Dnmt3a single KO by 64% for L1 and 37% for B1. Hence 
while either the loss of Dnmt3a or Dnmt3b can be compensated by the other enzyme for 
IAPs and mSat the situation is more complex at B1 and L1, respectively. Finally also 
Dnmt3L contributes to the maintenance of methylation. In the Dnmt3L KO methylation 
decreases at all elements but much less pronounced as in the Dnmt3a/3b DKO arguing 
for a stimulatory effect of Dnmt3L on both de novo Dnmts. Note that Dnmt3L KO cells 
were at passage 15 and underwent already almost twice the amount of replications than 
the Dnmt3a/b DKO.  
 
Loss of Dnmt1 and Np95 KO leads to an increase of hemi-mCpG sites  
For all elements we observe a strong increase in the relative amount of hemi-mCpGs (in 
regard to total methylation) in Dnmt1 KO and Np95 KO (Fig. 4a), along with a huge loss of 
overall methylation. This observation highlights the important role of Dnmt1 in maintaining 
symmetrical CpG methylation. However, in both Dnmt1 and Np95 null backgrounds we 
still find a considerable amount of sequences with fully methylated CpG dyads which in 
addition are not sporadically distributed (Fig. 3, Fig. 4b).  
Chromosomal sequences with hemi-mCpG sites on only the upper or lower strand, 
respectively, were much more frequently compared to sequences with (dispersed) hemi-
mCpG sites on both upper and lower strands. Such mosaical hemimethylation was found 
in <2% of mSat, <4,4% of IAP, <7% of L1  and <3,4% of B1 reads (see Fig. 4b). In Dnmt1 
KO cells, mosaical hemi-mCpGs were enriched in IAP, B1 and mSat but not in L1 
sequences. In Np95KO ESCs this mosaical hemimethylation increases further in all four 
repetitive elements indicating that the contribution of Np95 and Dnmt1 to maintain 
methylation pattern are partially distinct. Along this line, the Dnmt1 KO shows a 3,8 (for 
IAPs) and 4,8 (for mSat) fold increase of fully methylated sequences as compared to NP95 
KO (Fig. 4b). In contrast to the Dnmt1 KO and Np95 KO, respectively, the relative 
abundance and distribution of hemimethylated sites does not differ between Dnmt3a and 
Dnmt3b single KOs and DKO.  
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CpA methylat ion is present at major Satel l i tes in ESCs 
Along with the CpG methylation, we identified sites of non-CpG methylation in mSat 
sequences of all WT ESC lines (J1, E14 and WT26). In none of the other elements we 
found evidence for non-CpG methylation. In mSat sequences cytosines at positions 4, 6, 
11 (top strand) and 22 and 28 (botton strand) showed significant methylation levels above 
the conversion background (1.1%) as defined by linker sequence conversion (see above). 
All five unconverted (methylated) positions are found in the CpA sequence context (Fig. 
5a+5b). The highest CpA levels were present at position 6 where up to 10% of all 
sequences of the ESC line J1 contained an unconverted cytosine at this position. It is 
interesting to note in most of the sequence reads only a single CpA methylated position 
was detected (e.g. in 80% of J1 reads with CpAs) (Supplementary Figure S4).  In 
differentiated cells (embryonic liver and MEFs), no methylated CpA positions were 
detected above background. This is in line with previous findings by Lister et al. in human 
ESCs (31) (Fig. 5c).  
 
Dnmt3 family is responsible for non-CpG methylat ion in major satel l i tes 
To address the question, which Dnmts are responsible for CpA methylation we compared 
the relative occurrence of methylated CpAs between wt and the different KO ESC lines 
(Fig. 5d). In Dnmt1 KO the methylation at all five CpA positions remained unchanged 
despite of a greatly reduced CpG methylation level. Notably, sequences of Dnmt1KO 
ESCs with high overall CpG methylation showed increased CpA methylation other than the 
residual sequences with relatively low CpG methylation. Moreover in Dnmt1KO 
sequences, where we observe CpA methylation, the proportion of hemi-mCpGs is 
enriched on the upper strand, i.e. in the strand where we also observe increased CpA 
methylation in wt ESCs (Fig. 6).  
Together these findings clearly point towards an exclusive Dnmt3a and 3b mediated CpA 
methylation. Surprisingly, the relative contribution of Dnmt3a and Dnmt3b, respectively to 
CpA methylation differed at the five position. Whereas CpA methylation at position 6 and 
11 is greatly reduced in a Dnmt3a KO, the loss of Dnmt3b diminishes CpA methylation at 
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position 4, 22 and 28. In Dnmt3a/3b DKO CpA methylation above background is 
completely absent. The loss of Dnmt3L greatly reduces the methylation at most positions 
except position 28.  
 
Suv39h KO decreases CpG methylat ion level at mSat but not L1, B1 or IAP 
and has no inf luence on non CpG methylat ion  
The Suv39h1/2 mediated modification of histone H3 at position 9 was reported to 
influence the targeting of DNA methylation. We therefore included ESCs and MEFs with 
KO for Suv39h1 and Suv39h2 (Suv39dn) in our analysis. Suv39dn ESCs were reported to 
lack H3K9 trimethylation and Dnmt3b localisation at pericentric heterochromatin. Lehnertz 
et al. reported reduced DNA methylation (by southern blot) at mSat in Suv39h KO but not 
at minor Satellites or a C-type retrovirus (25). Our hairpin bisulfite analysis confirmed this 
finding on a sequencing basis. DNA-methylation at major satellites is reduced by 20% in 
Suv39dn ESCs but does not at B1, IAP and Line1 elements. Surprisingly the effect on 
mSat methylation is almost absent in dnMEFs which retain 95% of wt methylation (Fig. 7a). 
Finally despite of the proposed interaction of Suv39h with Dnmt3b at mSat we do not 
observe any influence of the Suv39h absence on CpA methylation particularly not at the 
Dnmt3b specific positions 4, 22 and 28 (Fig. 7b). 
 
Hidden Markov model predicts methylat ion eff iciencies of Dnmts 
The precise determination of fully methylated, hemimethylated and unmethylated CpG 
dyads allowed us to calculate the methylation characteristics for the different Dnmts in a 
modified version of the basic HMM proposed by Sontag et al. (Sontag et al. 2006). The 
comparative data set of some 20.000 sequences (around 84.000 CpG positions) including 
Dnmt KO`s, allowed us to compute maximum likelihood estimates for both methylation 
efficiencies on unmethylated and hemimethylated CpG dyads separately (Supplementary 
Table 3). In our model we also accounted for measurement errors based on exact bisulfite 
conversion rates and we approximated the variances of estimated methylation efficiencies 
in order to determine the quality of the estimation. As opposed to previous models, we 
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also did not assume that steady-states are reached in the KO ESC lines. Instead, we 
estimate the amount of cell divisions and infer parameters during the transient phase of the 
system, since at least Dnmt3a/3b DKO shows a processive loss of DNA methylation with 
increasing passage number (Chen et al. 2003).  
In our calculations we assumed that de novo methylation has the same probability 
to methylate unmethylated and hemi-mCpG dyads. We list the estimated efficiency values 
and standard deviations in Table 1, where the entries are the probabilities of Dnmt1, 
Dnmt3a and Dnmt3b mediated de novo or maintenance methylation in one DNA 
replication. The approximated standard deviations showed that for most elements and 
enzymes efficiencies were accurately estimated. For L1, a high standard deviation of the 
maintenance function for Dnmt3a showed that here the parameter is not identifiable. This 
is probably due to the small number of hemi- and fully methylated dyads in the KO’s of L1, 
which could be consulted for the model development.  
To substantiate the appropriateness of our model and the accuracy of our 
estimated methylation efficiencies, we then predicted the DNA methylation level for the 
parental wt ESC line (Table 2). Indeed we found excellent predictions for mSat, IAP and L1 
(maximum error rate of 1.8%, 2.1% and 3.3%, respectively) while the prediction for B1 had 
a maximal error rate of 12.1%.   
Based on the HMM calculations the de novo methylation efficiency of Dnmt1 at IAP 
and mSat is about four to five times lower than the maintenance methylation efficiency 
(IAP: 4.1, Sat: 4.7). At L1, Dnmt1 does not show a remarkable de novo methylation activity 
(for L1 <76 fold less compared to maintenance methylation). Interestingly, for the de novo 
methyltransferase Dnmt3a we observe a 1.8 (mSat) to 3 (IAP) fold higher contribution to 
methylation maintenance, which contrasts in vitro derived data (Okano et al. 1998). The 
contribution of Dnmt3b to methylation maintenance is even higher for IAP and mSat.  
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Discussion 
In our work we present the first high resolution DNA bisulfite methylation map of repetitive 
elements in double stranded DNA. Comparative analysis of wt and KO mouse ES lines 
revealed detailed insights in the relative contributions of Dnmts to CpG dyad and non-CpG 
methylation. In a HMM, we predicted the relative contribution of Dnmts to maintenance 
and de novo methylation.  
 
Distr ibution and specif icity of hemimethylat ion 
Our experimental approach allowed us to unambiguously assign DNA methylation at about 
140.000 CpG dyads on both DNA strands. Besides a general prevalence for symmetrical 
methylation we found a substantial portion of hemimethylated CpG dyads in all cell types 
analysed. The presence of such hemi-mCpGs can be explained by three different 
mechanisms: the improper recognition and maintenance activity of Dnmt1/NP95, the 
selective de novo methylation or active DNA demethylation. The different levels of 
hemimethylated CpGs in MEFs or embryonic liver cannot simply be explained by a variable 
expression of Dnmt1. At least on the transcriptional level Dnmt1, Dnmt3a and 3b appear 
to be equally expressed in both cell types (Supplementary Figure S3). This suggests that in 
liver the Dnmt1/NP95 maintenance fidelity is less pronounced or alternatively DNA 
demethylation is more pronounced at repetitive elements. The recently discovered 5hmC 
may play a major role for both processes. Since bisulfite modification does not 
discriminate between 5mC and 5hmC our sequencing data represent an unknown mixture 
of methylated and hydroxymethylated cytosines (32, 33). 5hmC was reported to be 
abundant in ESCs and some tissues, but less so in cultured cells ((34, 35). The relative 
abundance of 5hmC could therefore explain the observed effects on methylation 
maintenance, however the effect of 5hmC on 5mC maintenance is not yet clear. While 
5hmC was shown not to be bound by Dnmt1 in vitro (36), Np95 apparently recognizes 
and binds to 5hmC containing DNA (37). In ESCs, which posses a relative abundance of 
5hmC we observe variable frequencies of hemi-mCpGs at the different repetitive element 
classes. In L1 sequences an intermediate level of overall methylation is linked to a high 
level of hemimethylated sites (20%). Apparently the maintenance methylation is less 
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accurate at L1 in ESCs. From our data we see that a strong cooperativity of Dnmt1, 
Dnmt3a and Dnmt3b is needed to maintain methylation at L1 (a model of the contribution 
and interaction of enzymes is shown in Fig. 8). The increased presence of 5hmCs at L1 
sequences might contribute to an increased dynamic variation at L1 sequences in 
particular. Ficz et al. indeed observe an enrichment of 5hmC in L1 5’UTRs (38) while 
5hmC is not enriched at IAPLTR1 (Supplementary Fig. S3). Assuming that there is active 
DNA demethylation in ESCs, as shown e.g. for Nanog (39), it could be that certain L1 are 
prone to 5hmC induced demethylation resulting in hemimethylated sites and a lower 
methylation level. This scenario would be comparable the partial active DNA demethylation 
found at Line1 elements in mouse zygotes, while IAPs escape demethylation (40, 41). In 
addition, the increased de novo methylation activity of Dnmt1 at IAP, calculated with the 
HMM, and the increased “maintenance” functions of Dnmt3a and Dnmt3b might partially 
compensate for these “maintenance errors”. 
 
Control of CpA methylat ion 
DNA methylation outside of the CpG context was initially detected in mESCs using nearest 
neighbour analysis. This analysis revealed a strong prevalence for the CpA context (42). 
Recent genome wide single stranded bisulfite sequencing using Illumina short reads 
identified non-CpG methylation at various sequence contexts in human ESCs at rather 
high rates of 24.5% (human) of all methylated Cs (31) In the genome wide analysis no clear 
assignment of non-CpG methylation at repetitive elements has been performed. In our 
data set covering about 170.000 CpG positions and 106 bases we exclusively detect CpA 
methylation confined to only mSat sequences. This CpA methylation amounts to 5% of all 
methylated cytosines in mSat. It is possible that the primer based amplification of our 
analysis caused some selection against non-CpG methylation and we therefore 
underestimate the amount of non-CpG methylation. Still the CpA position dependent 
methylation remains outstanding. The CpA methylation is exclusively dependent on Dnmts 
3a and 3b in combination with Dnmt3L. Neither the absence of Dnmt1 nor Np95 altered 
the CpA methylation (see the model in Fig.9). Moreover the unchanged CpA methylation in 
Suv39hdn cells reveals that the proposed protective function of H3K9 trimethylation for 
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non-CpG methylation may not be true for mSat (43). The sequence analysis of Dnmt1 KOs 
unambiguously shows that CpA methylation is linked to Dnmt3a and Dnmt3b mediated 
CpG methylation. Along this line CpA positions are highly co-methylated with some 
neighbouring CpG positions (Supplementary S4 and S5). This indicates that the CpA 
methylation result as a position specific “side reaction” of Dnmt3a and Dnmt3b stimulated 
by Dnmt3L. In line with this Holz-Schietinger et al. show that Dnmt3L increases the 
processivity of Dnmt3a (11). Finally Dnmt3L is highly expressed in embryonic stem cells 
compared to somatic cells, where we do not find any evidence for CpA methylation (44).  
 
Model l ing of Dnmts maintenance and de novo methylat ion activit ies  
The HMM applied to estimate methylation efficiencies extends previous modelling 
approaches: i) by separating the effects of all three Dnmts based on KO data we could 
estimate de novo and maintenance methylation probabilities for each enzyme 
independently. ii) our experimental strategy allowed to precisely assign CpG dyads and 
account for experimental measurement errors (bisulfite conversion and mutation errors) as 
well as the number of cell divisions (passages). iii) we employed numerical techniques to 
infer optimal methylation efficiencies since analytic solutions of our more complex model 
are infeasible. By integrating all these parameters  we could functionally extend the 
previous models developed by Genereux et al. and Sontag et al. (17, 22). Morever byond 
prediction our validations (see  Table 2) demonstrate the appropriateness of the model at 
least for mSat and IAP, where experimental data is abundantly available. For L1, the 
prediction is very accurate even though maintenance activity of Dnmt3a is difficult to 
estimate. For B1, the prediction is rather weak, which indicates that further extensions of 
the model may be necessary to predict B1 methylation level. Since we presume based on 
the influence of Dnmt3a and 3b single and double KO that Dnmt3a can widely replace 
Dnmt3b activity, the model extension first should go in this direction. In the future the 
model should also account for maintenance and de novo methylation effect caused by 
hydroxymethylcytosine - which at least is enriched in Line 1 elements of ESCs. However 
given the fact that evidence for direct effects of 5hmC on local demethylation, 
maintenance and de novo methylation, respectively, and a clear distinction between 5mC 
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and 5hmC in sequences is still lacking the inclusion of 5hmC in the HMM is not yet 
feasible.    
For Dnmt1, HMM indicates a significant de novo methylation probability in ESCs (up 
to 15%), depending on the repetitive element/sequence. In vitro experiments analysing the 
methylation activity of Dnmt1 show 2 to 50 fold higher preference for hemimethylated CpG 
dyads, dependent on the substrate or conditions (45). Pre-existing methylated sites in vitro 
are shown to enhance the de novo methylation efficiency of Dnmt1 (46, 47). Our data 
corroborate these observations in vivo, linking an increased methylation to a higher de 
novo methylation activity of Dnmt1 (IAP, mSat > L1). Differential regulation of the CXXC 
domain binding capacities at the repetitive elements could osculate the de novo 
methylation activity of Dnmt1 (48). The fidelity for Dnmt1 to methylate hemi-mCpG dyads 
was shown to be 95% to 96% in vitro (47). Our HMM predicts fidelities of methylating 
hemi-mCpGs for IAP and mSat of 0.90 and 0.93, respectively, which fits quite well to the 
in vitro data. For a comparison with the in vitro derived data, we did not discriminate 
between de novo and maintenance methylation at hemimethylated CpG dyads (see values 
in Supplementary Table 3). At L1 elements, the fidelity decreases to 75%, according to our 
HMM mainly due to missing de novo methylation. Lower fidelity in comparison to in vitro 
derived data could arise from the presence of 5hmC at L1 elements (as discussed above).   
DNA methylation patterns of Np95 and Dnmt1 KO are very similar underpinning 
their  strong functional link in maintenance methylation. Nevertheless a few differences in 
the KO patterns of both enzymes point towards functional differences. E.g. hemi-mCpG 
sites on the upper and lower strand differ between both KOs. Np95 KO shows a 2 fold 
enriched proportion of mosaical hemimethylation compared to Dnmt1. This enrichment is 
seen at IAP and mSat sequences, where Dnmt1 show relatively high de novo methylation 
activity in HMM but is not so pronounced at B1 and L1 elements, where HMM only 
deduces a rather low Dnmt1 de novo methylation activity. This suggests that the 
distributive de novo methylation function of Dnmt1 is not influenced by Np95. Accordingly, 
compared to Dnmt1 KO, Np95 KO still allows the distributive de novo methylation by 
Dnmt1, leading to more hemimethylated sites distributed on both sites of the strand.  
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For Dnmt3a and Dnmt3b de novo and maintenance methylation contributions differ 
extensively across sequence elements. Such context dependent effects were not 
addressed in former in situ and in vitro modelling studies (7, 17) and may become only 
evident in the native chromatin context. HMM revealed a significant “maintenance” 
contribution for both enzymes at repetitive elements. The contribution of Dnmt3a and 3b 
to maintain full methylation at CpG dyads following replication might be attributed to 
targeted and enhanced de novo activity stimulated by the presence of CpG methylation 
density. Some studies show that Dnmt3a/3b can strongly bind to nucleosomes containing 
(hemi)methylated DNA (49, 50). By this Dnmt3a/3b could be triggered to “de novo” 
methylate hemimethylated sites following replication to maintain full methylation in the 
absence of Dnmt1. Indeed in Dnmt3a/3b fractions bound to nucleosomes SINEs and 
LINEs were found to be enriched and for these elements we observe high need for 
Dnmt3a/3b to maintain methylation. The activity of Dnmt3a and 3b is enhanced by 
Dnmt3L (11) apparently also for single stranded modification as apparent from the 
distribution of CpA sites which we almost exclusively detect only one of the two DNA 
strands in single reads. Finally, it is conceivable to speculate from our data that NP95 may 
also influence the methylation activity of Dnmt3a/b. Interactions of NP95 with both 
enzymes have been observed (16).     
 
Conclusion 
In summary our comparative deep sequencing analysis including Dnmt KO ESCs revealed 
a complex scenario of sequence, element and cell specific control of DNA methylation 
pattern control at CpG dyads. The data allowed to construct greatly improved HMMs to 
infer DNA methylation dynamics and efficiencies for the de novo and maintenance 
methylation function for all three Dnmts. Most strikingly we were able to allocate CpA 
methylation of major satellites in ESCs to distinct activities of Dnmt3a and 3b strongly 
stimulated by Dnmt3L.  
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Figures: 
 
 
Fig. 1 DNA methylat ion pattern of CpG dyads in WT ESCs, MEFs and 
embryonic l iver 
The bars sum up the DNA methylation status of all CpG dyads. The map next to the bar 
represents the distribution of methylated sites. Each column shows neighboured CpG 
dyads, and each line represents one sequence read. Red visualises fully methylated CpG 
dyads, light green and dark green hemi-mCpG dyads on the upper and lower strand, 
respectively, blue shows unmethylated CpG dyads and white strand for positions which 
are mutated or due sequence quality not analysable. The reads in the map are sorted first 
by fully methylated sites and then by hemi-m CpG dyads. *This picture shows the distance 
of the CpG dyads to each other. 
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Fig. 2: DNA Methylat ion of WT cel ls at major Satel l i tes (mSat), IAPLTR (IAP), 
L1Md_Tf (L1) and B1  
A: overal l  methylat ion level of WT cel ls Overall methylation level was calculated 
from all CpG dyads, hemimethylated sites assessed as 1 methylated site and fully 
methylated sites as 2 methylated sites. B: amount of hemimethylated sites spl itted 
by occurrence of the methylat ion on the upper or lower strand. C: relat ion 
of hemimethylated sites methylated on the upper or lower strand 
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Fig. 3 Methylat ion pattern map of ESCs depleted in Dnmts or factors of the 
methylat ion machinery 
The bars sum up the methylation status of all CpG dyads. The map next to the bar 
represents the distribution of methylated sites. Each column shows neighboured CpG 
dyads, and each line represents one sequence read. Red visualises fully methylated CpG 
dyads, light green and dark green hemi-mCpG dyads on the upper and lower strand, 
respectively, blue shows unmethylated CpG dyads and white strand for positions which 
are mutated or due sequence quality not analysable. The reads in the map are sorted first 
by fully methylated sites and then by hemi-m CpG dyads. *This picture shows the distance 
of the CpG dyads to each other. 
Results 
 
 109 
 
Fig. 4 Hemimethylated sites in ESCs depleted in DNMTs or factors of the 
methylat ion machinery 
A: Relat ive amount of hemimethylated sites The relative amount of 
hemimethylated sites was calculated by dividing the amount of hemimethylated sites with 
the overall methylation.  
B: Distr ibution of methylated/hemimethylated sites along reads Reads 
showing any methylation contributed to the fraction “reads with methylated sites”. The 
fraction of these sequences with any hemimethylated site is classified as fraction of “reads 
with hemimethylated sites”. Out of these reads which show hemimethylated sites on the 
upper and lower strand at the same time contribute to the fraction of “reads with 
hemimethylated sites on both strands”. 
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Fig. 5 non-CpG methylat ion of major Satel l i tes 
A major satel l i te genomic sequence of the hairpin bisulf i te PCR product. Non 
CpGs are marked grey with the corresponding number attached. CpGs are marked red. 
Purple shows the location of the lower primer.  
B-D non-CpG methylat ion of mESCs (B), dif ferentiated cel ls (C) and Dnmt 
and Np95 KOs (D) at major satel l i tes. Only CpA positions show methylation up to 
ten percent (position 4, 6, 11, 22 and 28). Knockouts of Dnmt3 family shows decrease of 
CpA methylation on different sites.  
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Fig. 6: Correlat ion of CpA and CpG methylat ion. A: The graph represents the 
relative amount of reads per CpG methylation level; in grey for reads showing no CpA 
methylation and in black for reads showing CpA methylation. Reads showing CpA 
methylation are depleted in the fraction of reads with low CpG methylation level and 
enriched in reads showing 50% or more CpG methylation. B: ratio between non CpA 
methylated reads and CpA methylated reads divided into three fraction by CpG 
methylation level (0-25%, 33-66,7%, 75-100%). C: Distribution of un-, hemi- and fully 
methylated CpG dyads in the reads showing CpA methylation or no CpA methylation. The 
fraction of reads showing CpA methylation is enriched in fully and hemimethylated CpG 
dyads. Hemimethylated CpG dyads, methylated on the upper strand, are mainly enriched. 
Interestingly, on the upper strand, we also observe the main part of CpA methylation. 
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Fig. 7 Inf luence of Suv39h double Knockout on methylat ion pattern 
A Methylat ion pattern map of CpG dyads The bars sum up the methylation status 
of all CpG dyads. The map next to the bar represents the distribution of methylated sites. 
Each column shows neighboured CpG dyads, and each line represents one sequence 
read.  
B non CpG methylat ion. We could not detect a changed non CpG methylation pattern 
in the Suv39KO cells. 
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Fig. 8 Model for CpG methylat ion at dif ferent repetit ive elements 
The arrows’ thickness shows the methylation efficiencies of the enzymes and enzyme 
complexes. 
Dnmt3a/b in one circle represents compensable function of both. The black circle 
represents cooperativity of the enzymes and enzyme complexes. The influence of 
enzymes without any linkage is analysed and not found. 
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Fig. 9 Model for CpA methylat ion at major satel l i tes  
The thickness of the arrows shows the methylation efficiencies of the enzymes and 
enzyme complexes. The influence of enzymes without any linkage is analysed and not 
found. Two arrows based on one enzyme represent different methylation activities 
depending on the CpA position.   
   Results 
 
 115 
 
 
 
Results 
 
 116 
 
 
   Results 
 
 117 
 
 
 
 
 
Cooperative DNA and histone binding by Uhrf2 links the 
two major repressive epigenetic pathways  
Results 
 
 118 
2.5 Cooperative DNA and histone binding by Uhrf2 links the two major repressive 
epigenetic pathways  
Cooperative DNA and Histone Binding by Uhrf2 Links the
Two Major Repressive Epigenetic Pathways
Garwin Pichler, Patricia Wolf, Christine S. Schmidt, Daniela Meilinger, Katrin Schneider,
Carina Frauer, Karin Fellinger, Andrea Rottach, and Heinrich Leonhardt*
Ludwig Maximilians University Munich, Department of Biology II and Center for Integrated Protein Science Munich
(CIPSM), Großhaderner Str. 2, 82152 Planegg-Martinsried, Germany
ABSTRACT
Gene expression is regulated by DNA as well as histone modifications but the crosstalk and mechanistic link between these epigenetic signals
are still poorly understood. Here we investigate the multi-domain protein Uhrf2 that is similar to Uhrf1, an essential cofactor of maintenance
DNA methylation. Binding assays demonstrate a cooperative interplay of Uhrf2 domains that induces preference for hemimethylated DNA,
the substrate of maintenance methylation, and enhances binding to H3K9me3 heterochromatin marks. FRAP analyses revealed that
localization and binding dynamics of Uhrf2 in vivo require an intact tandem Tudor domain and depend on H3K9 trimethylation but not on
DNA methylation. Besides the cooperative DNA and histone binding that is characteristic for Uhrf2, we also found an opposite expression
pattern of uhrf1 and uhrf2 during differentiation. While uhrf1 is mainly expressed in pluripotent stem cells, uhrf2 is upregulated during
differentiation and highly expressed in differentiated mouse tissues. Ectopic expression of Uhrf2 in uhrf1!/! embryonic stem cells did
not restore DNA methylation at major satellites indicating functional differences. We propose that the cooperative interplay of Uhrf2
domains may contribute to a tighter epigenetic control of gene expression in differentiated cells. J. Cell. Biochem. 112: 2585–2593,
2011. ! 2011 Wiley-Liss, Inc.
KEY WORDS: UHRF1; UHRF2; DNA METHYLATION; HISTONE MODIFICATIONS; EPIGENETICS
D NA methylation and histone modifications are majorepigenetic marks involved in the regulation of gene
expression, inheritance of chromatin states, genome stability, and
cellular differentiation [Bird, 2002; Kouzarides, 2007; Reik, 2007].
Misregulation of epigenetic pathways, like erroneous DNA
methylation, may lead to cancer and other diseases [Jones and
Baylin, 2007]. Open questions concern the crosstalk andmechanistic
link between different epigenetic signals.
Genome-scale DNA methylation studies revealed a connection
between DNA methylation and histone modifications. Specifically,
DNA methylation correlates with the absence of H3K4 methylation
and presence of H3K9 methylation [Meissner et al., 2008]. This
correlation may in part be caused by DNA methyltransferases
specifically recognizing histone modifications. For instance, the de
novo DNA methyltransferase Dnmt3a and its cofactor Dnmt3L
specifically recognize unmethylated H3K4 mediated by the ATRX-
Dnmt3-Dnmt3L (ADD) domain [Ooi et al., 2007; Otani et al., 2009].
Dnmt1, which is involved in maintenance methylation during DNA
replication and DNA repair [Leonhardt et al., 1992; Mortusewicz
et al., 2005], specifically methylates hemimethylated DNA [Bestor
and Ingram, 1983; Pradhan et al., 1997] and associates with
constitutive heterochromatin via its targeting sequence (TS) domain
[Easwaran et al., 2004].
Recently, Uhrf1 (also known as Np95 or ICBP90) has been shown
to link DNA and histone modifications and has emerged as an
essential cofactor for the maintenance of genomic DNA methyla-
tion. Genetic ablation of uhrf1 leads to remarkable genomic
hypomethylation, a phenotype similar to dnmt1!/! embryonic stem
cells (ESCs) [Bostick et al., 2007; Sharif et al., 2007]. Uhrf1 binds
hemimethylated DNA via a SET and RING associated domain (SRA)
domain and targets Dnmt1 to its substrate of maintenance DNA
methylation [Bostick et al., 2007; Sharif et al., 2007; Arita et al.,
2008; Avvakumov et al., 2008; Hashimoto et al., 2008; Qian et al.,
2008; Rottach et al., 2010]. This targeting activity of Uhrf1 is based
on specific binding to the heterochromatin mark H3K9me3 via a
tandem Tudor domain (TTD) [Karagianni et al., 2008; Rottach et al.,
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2010]. In addition, Uhrf1 interacts with Dnmt3a and Dnmt3b and
with histone modifying enzymes like HDAC1, G9a, and Tip60 [Unoki
et al., 2004; Achour et al., 2009; Kim et al., 2009; Meilinger et al.,
2009]. Finally, Uhrf1 displays E3 ubiquitin ligase activity for histone
H3 [Citterio et al., 2004] and is involved in large scale reorganization
of chromocenters [Papait et al., 2008].
Interestingly, a second member of the Uhrf family, Uhrf2, harbors
similar domains [Bronner et al., 2007]. Until now, the only
known function of Uhrf2 is a role in intranuclear degradation of
polyglutamine aggregates [Iwata et al., 2009]. In this study, we
systematically investigated the function and interplay of distinct
Uhrf2 domains in DNA and histone tail substrate recognition and
report first hints on cell-type specific functions of Uhrf1 and Uhrf2.
MATERIALS AND METHODS
EXPRESSION CONSTRUCTS
Expression constructs for GFP, RFP-PCNA, Uhrf1-GFP, and GFP
constructs of Dnmt1 were described previously [Sporbert et al.,
2005; Fellinger et al., 2009; Meilinger et al., 2009]. All Uhrf2
expression constructs were derived by PCR from mouse uhrf2-myc
cDNA (MR210744, ORIGENE). To obtain GFP fusion constructs, the
uhrf1 cDNA [Rottach et al., 2010] was replaced by uhrf2 encoding
PCR fragments in the pCAG-uhrf1-GFP vector. The deletion and
point mutant expression constructs were derived from the
corresponding wild-type constructs by overlap extension PCR
[Ho et al., 1989] and PCR-based mutagenesis. The following start
and end amino acids were chosen: Uhrf2 tandem Tudor domain,
amino acids 118–312; Uhrf2 PHD domain, amino acids 325–395;
Uhrf2 tandem Tudor–PHD domain, amino acids 118–395; Uhrf1
tandem Tudor–PHD domain, amino acids 121–370. The linker
exchange constructs were derived by PCR using overlapping primers
that contained the partial linker sequence. Amino acid sequences of
the linkers: Uhrf1: KERRPLIASPSQPPA; Uhrf2: GAHPISFADGKF.
All constructs were verified by DNA sequencing. Throughout this
study enhanced GFP constructs were used and for simplicity referred
to as GFP fusions.
CELL CULTURE, TRANSFECTION, CELL SORTING, AND
DIFFERENTIATION
HEK293T cells, MEFs, and ESCs were cultured and transfected as
described [Schermelleh et al., 2007; Rottach et al., 2010] with the
exception that Lipofectamin (Invitrogen) was used for transfection
of MEFs. E14 uhrf1!/! ESCs were transfected with Uhrf1-GFP and
Uhrf2-GFP expression constructs using FuGENE HD (Roche)
according to the manufacturer’s instructions. ESCs were sorted
for GFP positive cells 48 h after transfection with a FACS Aria II
instrument (Becton Dikinson). ESC strains wt E14, wt J1, and E14
uhrf1!/! were cultured and differentiated to embryoid bodies as
described [Szwagierczak et al., 2010]. The ESC strain wt JM8A3.N1
(EUCOMM, Germany) was cultured in Knockout D-MEM (Gibco-
BRL, Grand-Island, NY) medium containing 10% fetal bovine serum
(PAA Laboratories GmbH, Austria), 0.1mM b-mercaptoethanol
(Gibco-BRL), 2mM L-glutamine, 100U/ml penicillin, 100mg/ml
streptomycin (PAA Laboratories GmbH). The medium was supple-
mented with 1,000U/ml recombinant mouse LIF (Millipore,
Temecula, CA).
RNA ISOLATION, CDNA SYNTHESIS, AND QUANTITATIVE
REAL-TIME PCR
RNA isolation and cDNA synthesis were performed as described
[Szwagierczak et al., 2010]. Equal amounts of cDNA were used for
Real-time PCR with TaqMan Gene Expression Master Mix (Applied
Biosystems) on the 7500 Fast Real-time PCR System (Applied
Biosystems) according to the manufacturer’s instructions. The
following TaqMan Gene expression assays were used: Gapdh (Assay
ID: Mm99999915_g1), uhrf1 (Assay ID: Mm00477865_m1) and
uhrf2 (Assay ID: Mm00520043_m1). Gene expression levels were
normalized to Gapdh and calculated using the comparative CT
Method (DDCT Method).
IN VITRO DNA BINDING AND HISTONE-TAIL PEPTIDE
BINDING ASSAY
The in vitro binding assays were performed as described previously
[Frauer and Leonhardt, 2009; Rottach et al., 2010]. NoCpG DNA
substrates were produced in a primer extension reaction [Frauer and
Leonhardt, 2009] others by hybridization of two DNA oligos
(Supplementary Fig. S7B–D). Histone-tail peptides were purchased
as TAMRA conjugates (PSL, Germany; Supplementary Fig. S7A).
Peptides were added in a molar ratio 1.5:1 (peptide/GFP fusion) and
the binding reaction was performed at RT for 15min with constant
mixing. For combined assays, samples were additionally incubated
with either H3K9me3 or H3K9ac histone-tail peptides in a molar
ratio 1.5:1 (peptide/GFP fusion) or increasing amount of DNA
substrate as indicated. The binding reaction was performed at RT for
60min with constant mixing.
IMMUNOFLOURESCENCE STAINING AND ANTIBODIES
For immunostaining, MEF cells and ESCs were grown on cover slips
and transiently transfected with Uhrf2-GFP (MEF cells), or co-
transfected with Uhrf2-GFP and RFP-PCNA (ESCs). Cells were fixed
with 2.0% or 3.7% formaldehyde in PBS and permeabilized in PBS
containing 0.2% Triton X-100. The post-translational histone
modification H3K9me3 was detected via a rabbit primary antibody
(Active Motif) and a secondary anti-rabbit antibody conjugated to
Alexa Fluor 594 (Molecular Probes, Eugene, OR). The antibodies
were diluted 1:1,000 or 1:500, respectively, in PBS containing
0.02% Tween-20 and 2% BSA. GFP-Binder (ChromoTek, Germany)
was used to boost GFP signals and was labeled with Alexa Fluor 488.
Cells were counterstained with DAPI and mounted in Vectashield
(Vector Laboratories, Burlingame, CA). Images of the cells were
obtained using a TCS SP5 AOBS confocal laser scanning microscope
(Leica, Wetzlar, Germany) with a 63x/1.4 NA Plan-Apochromat oil
immersion objective. GFP, Alexa Fluor 488, RFP, and Alexa Fluor
594 were excited with a 488-nm argon laser and a 561-nm diode
laser, respectively. Image series were recorded with a frame size of
512# 512 pixels, a pixel size of 100 nm and with a detection pinhole
size of 1 Airy Unit.
2586 COOPERATIVE DNA- AND HISTONE BINDING BY UHRF2 JOURNAL OF CELLULAR BIOCHEMISTRY
LIVE CELL MICROSCOPY AND FLUORESCENCE RECOVERY AFTER
PHOTOBLEACHING (FRAP) ANALYSIS
Live cell imaging and FRAP analyses were performed as described
[Schermelleh et al., 2007] with the exception that imported images
were intensity normalized, converted to 8-bit and Gauss-filtered
(2 pixel radius). Data sets showing lateral movement were corrected
by image registration using the StackReg plug-in of ImageJ
[Abramoff et al., 2004] starting with a frame when approximately
half recovery was reached. Within the first 30 s after bleaching,
images were taken every 150ms and then in intervals of 1 s.
DNA METHYLATION ANALYSIS
Genomic DNA was isolated with the QIAmp DNA Mini Kit (Qiagen)
and 1.5mg were bisulfite converted using the EZ DNA Methylation-
Gold Kit (Zymo research) according to the manufacturer’s
instructions. Primer sequences for major satellites were AAAAT-
GAGAAACATCCACTTG (forward primer) and CCATGATTTT-
CAGTTTTCTT (reverse primer). For amplification we used Qiagen
Hot Start Polymerase in 1# Qiagen Hot Start Polymerase buffer
supplemented with 0.2mM dNTPs, 0.2mM forward primer, 0.2mM
reverse primer, 1.3mM betaine (Sigma) and 60mM tetramethy-
lammonium-chloride (TMAC, Sigma). Major satellites were ampli-
fied in a single amplification and pyrosequencing reactions were
carried out by Varionostic GmbH (Ulm, Germany).
STATISTICAL ANALYSIS
Results were expressed as means$ SD or means$ SEM. The
difference between two mean values was analyzed by Student’s
t-test and was considered as statistically significant in case of
P< 0.05 (%) and highly significant for P< 0.001 (%%).
RESULTS
OPPOSITE EXPRESSION PATTERN OF UHRF1 AND UHRF2 DURING
DIFFERENTIATION
Recently, Uhrf1 has emerged as an essential factor for the
maintenance of DNA methylation. Sequence analyses revealed
that Uhrf2 harbors five recognizable domains similar to Uhrf1
(Fig. 1A), but its role in the regulation of DNA methylation is still
unclear. We compared the expression pattern of uhrf1 and uhrf2 in
ESCs and somatic cells, during differentiation and in differentiated
mouse tissues (Fig. 1B–D and Supplementary Fig. S1). Interestingly,
both genes show opposite expression patterns; while uhrf1 is
expressed in ESCs and down regulated during differentiation, which
is consistent with previous reports [Muto et al., 1995; Fujimori et al.,
1998; Hopfner et al., 2000], uhrf2 is upregulated and highly
expressed in differentiated mouse tissues. The switch in the
expression pattern argues against a functional redundancy of
both genes and is consistent with the drastic loss of DNA
methylation in uhrf1!/! ESCs despite the presence of intact
uhrf2 alleles. Therefore, the opposite expression pattern of both
genes suggests different functional roles of uhrf1 and uhrf2 in
development.
Fig. 1. Opposite expression pattern of uhrf1 and uhrf2 during differentia-
tion. A: Schematic outline of the multi-domain architecture of Uhrf1 in
comparison to Uhrf2. An N-terminal ubiquitin-like domain (Ubl) is followed
by a tandem Tudor domain (TTD), a plant homeodomain (PHD), a SET and RING
associated (SRA) domain and a C-terminal really interesting new gene (RING)
domain. Numbers indicate primary sequence similarities of single domains
determined by BlastP search [Altschul, 1991]. Expression analysis of uhrf1 and
uhrf2 by Real-time PCR in ESCs and somatic cells (B), during differentiation of
wt J1 ESCs (C) and in various adult mouse tissues in comparison to the
expression data in ESCs (D). Expression levels are relative to uhrf1 in wtJM8A
(B), day 0 of differentiation (C) and to kidney (D) (uhrf1 set to 1). Shown are
means$ SD of at least two independent experiments.
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COOPERATIVE BINDING OF REPRESSIVE EPIGENETIC MARKS
BY UHRF2
To investigate DNA and histone-tail binding preferences of Uhrf2 in
vitro, we used a versatile binding assay developed for GFP fusion
proteins [Rothbauer et al., 2008; Frauer and Leonhardt, 2009;
Rottach et al., 2010]. Similar to Uhrf1, histone-tail peptide binding
assays revealed that Uhrf2 preferentially binds to H3(1–20) and
H3K9me3 peptides (Fig. 2A). This binding activity of Uhrf2 is
mediated by the TTD but not the PHD domain (Fig. 2B). Consistently,
acetylation of H3K9, underrepresented in heterochromatin,
Fig. 2. Cooperative binding of repressive epigenetic marks by Uhrf2. In vitro binding ratios of fluorescently labeled substrate over bound GFP fusion proteins were determined.
A: Histone H3- and H4-tail binding specificities of Uhrf2. Shown are means$ SD of biological duplicates. B: Histone H3 tail binding specificity of Uhrf2, its tandem Tudor
domain (TTD), its PHD domain and its TTD mutant (Y214A Y217A). Shown are means$ SEM of at least three independent experiments. C: DNA binding properties of Uhrf1,
Uhrf2 and of single (SRA, TTD) and combined Uhrf2 domains (TTD–PHD–SRA). Shown are means$ SEM of three independent experiments. D: DNA binding properties of Uhrf1,
Uhrf2 and Uhrf2 Y214A Y217A in combination with histone-tail peptide binding. Shown are means$ SD of three independent experiments (Uhrf1, Uhrf2) and of two
independent experiments (Uhrf2 Y214A Y217A). Values were normalized to the binding ratio of each GFP fusion for unmethylated DNA without histone-tail peptide. Statistical
significance of differences between the binding ratios with un- and hemimethylated DNA is indicated; %P< 0.05. E& F: H3K9me3 peptide binding by Uhrf1, Uhrf2, and
Uhrf1DSRA with increasing concentrations of DNA substrate containing either one central hemimethylated (E) or noCpG site (F). Shown are means$ SD of biological
duplicates. Values were normalized to the binding ratio of Uhrf1DSRA without DNA.
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prevented the binding of Uhrf2 and its TTD. The binding of Uhrf1 to
H3K9me3 is mediated by an aromatic cage in the TTD [Rottach et al.,
2010]. Site-directed mutagenesis of Uhrf2 changing the two
conserved tyrosine residues to alanine (Y214A Y217A) (Supple-
mentary Fig. S2) abolished specific peptide binding (Fig. 2B) and
supports a function of the aromatic cage in H3K9me3 recognition.
Whereas Uhrf1 preferentially binds to hemimethylated DNA,
Uhrf2 failed to show a preference for hemi-over unmethylated DNA
(Fig. 2C). These differences in DNA binding preferences between
Uhrf1 and Uhrf2 were confirmed by electrophoretic mobility shifts
(Supplementary Fig. S3). To further investigate the functional
interplay between DNA and histone binding we performed
combined binding assays (Fig. 2D). Interestingly, binding to
heterochromatin-specific H3K9me3 peptides induced a significant
preference of Uhrf2 for hemi-over unmethylated DNA. Uhrf1
already on its own showed preference for hemimethylated DNA that
was further enhanced by binding to H3K9me3 peptides. To test the
specificity of this cooperativity we mutated the aromatic cage in
Uhrf2 that is necessary for H3K9me3 histone-tail peptide binding.
The mutated Uhrf2 (Y214A Y217A) showed comparable DNA
binding activity as the wild-type Uhrf2 but addition of heterochro-
matin-specific H3K9me3 peptides did not induce preference for
hemi-over unmethylated DNA (Fig. 2D).
In the reverse experiment, addition of DNA enhanced binding of
Uhrf1 and Uhrf2 to the H3K9me3 peptide (Fig. 2E,F). This was not
observed for the DNA binding mutant of Uhrf1 (Uhrf1DSRA) which
showed constant peptide binding with increasing DNA concentra-
tions. These findings suggest that single binding events of distinct
Uhrf2 domains lead to multivalent engagement of different
repressive epigenetic marks. In fact, multivalent engagement of
DNA and histone tail peptides via the SRA domain and the TTD,
respectively, results in affinity enhancement and additional
specificity for hemimethylated DNA, the substrate of maintenance
methylation.
CELLULAR LOCALIZATION AND DYNAMICS OF UHRF2 DEPEND ON
HISTONE H3K9 METHYLATION
To monitor the subcellular localization of Uhrf2, we expressed
Uhrf2-GFP constructs in cells with different genetic backgrounds. In
wild type (wt) ESCs, Uhrf2 is localized in the nucleus and is enriched
at pericentric heterochromatin (PH) (Fig. 3A,B and Supplementary
Fig. S4A–C). To investigate which epigenetic marks at PH are
recognized by Uhrf2 we determined the localization of Uhrf2 in
genetically modified ESCs either lacking all three major DNA
methyltransferases Dnmt1, Dnmt3a, and Dnmt3b (TKO) [Tsumura
et al., 2006] or ESCs lacking the two major H3K9 methyltransferases
Suv39H1/H2 (Suv39h dn) [Lehnertz et al., 2003]. TKO cells are
practically devoid of genomic DNA methylation and Suv39h dn
ESCs show substantially reduced H3K9me3 levels. We found Uhrf2
localized at PH in TKO but not in Suv39h dn ESCs, indicating that
localization of Uhrf2 is dependent on H3K9 but not on DNA
methylation (Fig. 3A). Consistently, immunostaining of wt mouse
embryonic fibroblasts (MEFs) showed co-localization of Uhrf2 and
H3K9me3 marks at PH, which was not observed in Suv39h dnMEFs
[Peters et al., 2001] (Fig. 3B). Also, mutations in the TTD (Uhrf2
Y214A Y217A) that abolished binding to H3K9me3 peptides in vitro
disrupted enrichment at PH in wt MEFs (Fig. 3B). The dependence of
Uhrf2 localization on H3K9me3 was also confirmed by quantitative
correlation analysis (Supplementary Fig. S4D,E).
To investigate the effect of H3K9me3 on the dynamics of Uhrf2 in
living cells we performed quantitative fluorescence recovery after
photobleaching (FRAP) analyses in wt and Suv39h dn MEFs. We
chose to bleach half nuclei to include a representative number of
Fig. 3. Cellular localization and dynamics of Uhrf2 depend on histone H3K9
methylation. A: Confocal mid sections of fixed wt J1, TKO and Suv39h dn ESCs
transiently expressing Uhrf2-GFP and RFP-PCNA and counterstained with
DAPI, which preferentially highlights PH. Merged images are displayed on the
right side (GFP: green; DAPI: red). Scale bar 5mm. B: Confocal mid sections of
fixed wt MEFs and Suv39h dn MEFs transiently expressing Uhrf2-GFP or Uhrf2
Y214A Y217A-GFP were immunostained for H3K9me3 and counterstained
with DAPI. Merged images are displayed on the right side (GFP: green; DAPI:
red). Scale bar 5mm. C: Dynamics of Uhrf2-GFP and Uhrf2 Y214A Y217A-GFP
in living MEFs determined by half nucleus FRAP analysis. GFP is shown as
reference. Curves represent means$ SEM from at least 8 nuclei.
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interactions from different nuclear domains and structures in
the bleached area [Rottach et al., 2010]. Recovery of Uhrf2-
GFP fluorescence in Suv39h dn MEFs (half-time t1/2' 5.9$ 0.6 s)
and of the TTD mutant in wt MEFs (t1/2' 3.2$ 0.4 s) was
considerably faster than the recovery of Uhrf2-GFP in wt MEFs
(t1/2' 11.8$ 0.6 s) pointing to a crucial role of H3K9me3 in Uhrf2
dynamics in living cells (Fig. 3C). Taken together, these results
clearly demonstrate that the interaction of Uhrf2 with the
heterochromatin mark H3K9me3 is required for the localization
at PH and affects binding dynamics in living cells.
COOPERATIVE BINDING OF THE COMBINED UHRF2 TTD–PHD
DOMAIN
Recently, several studies showed multivalent binding to histone-tail
peptides [Ruthenburg et al., 2007]. In case of Uhrf1 and Uhrf2, the
TTD is followed by a second histone-tail binding domain, a PHD
domain (Fig. 1A). As the isolated PHD domains of Uhrf1 and Uhrf2
did not show binding to H3 histone-tail peptides (Fig. 2B) [Rottach
et al., 2010], we tested whether the combination of the PHD and the
TTD results in cooperative histone-tail binding. Surprisingly, the
combined TTD–PHD domain of Uhrf2 displayed a fourfold increased
binding to H3K9me2/me3 in comparison to the single TTD, which
was not observed for the corresponding construct of Uhrf1
(Figs. 2B and 4A).
Sequence alignments of the combined domains revealed two
striking differences between Uhrf1 and Uhrf2. Firstly, Uhrf2 harbors
an additional stretch of 33 highly conserved amino acids present in
the TTD (Supplementary Fig. S5A). Secondly, the linker region
between the TTD and PHD domain of Uhrf2 is highly conserved,
whereas this region is highly diverse in Uhrf1 (Supplementary
Fig. S5A). To test which sequence is responsible for the observed
cooperative interplay between PHD and TTD, we generated
and tested different hybrid and deletion constructs (Supplementary
Fig. S5B). Notably, replacement of the native linker in the Uhrf2
TTD–PHD construct by the Uhrf1 linker caused decreased relative
binding ratios to H3K9me2/3 comparable to the single Uhrf2 TTD
(Fig. 4B). Transferring the Uhrf2 linker to the Uhrf1 TTD–PHD
construct as well as deletion of the Uhrf2 stretch region did not affect
the binding to H3K9me3 peptides (Fig. 4B).
These results suggest that the cooperative interplay of different
Uhrf2 domains, which is responsible for the increased binding to
heterochromatin marks, is dependent on the highly conserved linker
region connecting the TTD and PHD domains. A similar functional
importance of linker sequences has been described for BPTF and
histone lysine demethylases [Li et al., 2006; Horton et al., 2010].
UHRF1 AND UHRF2 ARE NOT FUNCTIONALLY REDUNDANT IN ESCS
To investigate whether Uhrf1 and Uhrf2 are functionally redundant
we performed interaction and rescue assays. Like Uhrf1, also Uhrf2
interacts with Dnmts (Supplementary Fig. S6) suggesting a similar
function in DNA methylation. To test for such a functional role, we
ectopically expressed Uhrf2-GFP or Uhrf1-GFP in uhrf1!/! ESCs
and determined DNA methylation levels at major satellites by
pyrosequencing. While ectopic expression of Uhrf1-GFP led to
significant increase of DNA methylation levels at CpG sites of major
satellite DNA in uhrf1!/! ESCs, Uhrf2-GFP did not restore DNA
methylation at these sites (Fig. 5). These results point to functional
differences between Uhrf1 and Uhrf2 in vivo.
DISCUSSION
Over the past decades many different histone modifications were
discovered that are involved in epigenetic gene regulation. A key
question is how these histone marks are linked to DNA methylation
pattern and how this complex epigenetic information is integrated
and translated into defined chromatin structures and gene
expression levels. Epigenetic regulators that bind DNA and histone
marks are ideally suited to link these pathways and intramolecular
interactions between different binding domains may contribute to
Fig. 4. Cooperative binding of the combined tandem Tudor–PHD domain of
Uhrf2. A: Histone H3 N-terminal tail binding specificity of the TTD of Uhrf2
and of the combined TTD and PHD domain (TTD–PHD) of Uhrf1 and Uhrf2.
Shown are means$ SEM from at least six independent experiments. B: Histone
H3K9me3 binding of the combined TTD–PHD domains of Uhrf1 and Uhrf2,
hybrid proteins (L1 and L2 specify inserted linker sequences derived from Uhrf1
and Uhrf2, respectively) and a stretch deletion Uhrf2 construct. Shown are
means$ SEM from at least three independent experiments.
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substrate specificity and epigenetic regulation [Hashimoto et al.,
2009].
Recently, Uhrf1, an essential factor for the maintenance of DNA
methylation, has been shown to bind to repressive DNA and histone
modifications via an SRA and a tandem Tudor domain, respectively.
Here we provide the first systematic characterization of the second
member of the Uhrf family, Uhrf2, and demonstrate that Uhrf2 binds
to the H3K9me3 heterochromatin mark via an aromatic cage of a
tandem Tudor domain (TTD). Mutations in the aromatic cage
abolished binding to H3K9me3 histone-tail peptides in vitro and
prevented enrichment of Uhrf2 at pericentric heterochromatin in
vivo. Interestingly, similar mutations in the aromatic cage of Uhrf1
prevented repression of p16INK4A [Nady et al., 2011] suggesting a
link between H3K9me3 binding and a function of Uhrf proteins in
gene repression.
Our results point to a complex regulation of substrate recognition
by Uhrf2 involving cooperative binding domains and critical linker
sequences. In contrast to Uhrf1, preferential binding of Uhrf2 to
hemimethylated DNA, the substrate of DNA maintenance methyla-
tion, was only induced upon simultaneous binding to H3K9me3
histone-tail peptides. Binding of Uhrf1 and Uhrf2 to DNA in turn
enhanced binding to H3K9me3 histone-tail peptides. Consistently,
SILAC-based proteomic analysis identified enrichment of UHRF1 at
nucleosomes containing repressive DNA and H3K9 methylation
marks [Bartke et al., 2010]. Together, these data demonstrate a
cooperative interplay between DNA and histone tail binding
domains of Uhrf1 and Uhrf2. A similar effect was reported for
MSL3 that specifically binds to H4K20me1 via a chromodomain
only in the presence of DNA [Kim et al., 2010].
An additional level of complexity was added by recent studies
showing multivalent binding of histone-tail peptides by mixed two-
effector modules [Ruthenburg et al., 2007]. Notably, the combined
TTD–PHD domain of Uhrf2, but not of Uhrf1, showed enhanced
binding to H3K9me3 histone-tail peptides. This cooperativity was
dependent on the highly conserved linker region connecting the TTD
and PHD domains. Similarly, an important role was attributed to
the linker sequence between the histone binding domain (PHD) and
the histone modifying domain of jumanji histone lysine demethy-
lases [Horton et al., 2010].
The dramatic loss of DNA methylation in uhrf1!/! ESCs [Bostick
et al., 2007; Sharif et al., 2007] is remarkable, especially considering
the presence of the uhrf2 gene, which encodes a highly similar
protein as demonstrated in this study. As one possible explanation
for this lack of functional redundancy we found, in contrast to
uhrf1, relatively low uhrf2 mRNA levels in ESCs, which were not
affected by genetic uhrf1 ablation. Moreover, both genes also show
opposite expression patterns during differentiation. The failure of
ectopically expressed Uhrf2 to restore DNA methylation in uhrf1
deficient cells clearly points to functional differences between both
proteins in vivo. However, more definitive insights into the specific
function(s) of Uhrf2 will require targeted mutations and subsequent
analyses of pluripotent as well as differentiated cells. Based on the
cooperative binding of Uhrf2 domains to repressive DNA and
histone marks we propose that Uhrf2 might contribute to a tighter
control of gene repression in differentiated cells as compared to a
less stringent control by Uhrf1 in pluripotent ESCs.
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Supplementary Figure S1. Opposite expression pattern of uhrf1 and uhrf2. Expression 
analyses of uhrf1 and uhrf2 by Real-time PCR during differentiation of ESCs with two 
different genetic backgrounds (wt E14 (A) and wt JM8A (B)). Transcript levels of uhrf1 at day 
0 of EB formation are used as reference point (set to 1). Shown are means ± SD from three 
technical replicates of one biological experiment. 
 
 
Supplementary Figure S2. Model of the tandem Tudor domain (TTD) of Uhrf2. (A) A model of 
the TTD of Uhrf2 was generated using SWISS Model [Arnold et al., 2006; Guex and Peitsch, 
1997] with the solved structure of the TTD of Uhrf1 (PDB: 3DB3) as template. Both 
structures, the Uhrf2 model in red and the Uhrf1 template in cyan, are superimposed in 
PyMOL [Schrodinger, 2010]. (B) H3K9me3 is embedded in an aromatic cage formed by 
three aromatic residues of Uhrf2. 
  
 
 
Supplementary Figure S3. Electrophoretic mobility shift of Uhrf1 and Uhrf2. (A) Un- and 
hemimethylated DNA substrates (1 pmol each in direct competition) were incubated with 
0.63 pmol purified Uhrf1-GFP or Uhrf2-GFP. Samples were subjected to 3.5% non-
denaturing PAGE and analyzed with a fluorescence scanner (Typhoon TRIO scanner, GE 
Healthcare) to detect ATTO550 (unmethylated substrate), ATTO647N (hemimethylated 
substrate) and GFP. (B) Band intensities were quantified with ImageJ [Abramoff, 2004]. To 
quantify bound DNA/protein ratios, grey values of unbound DNA bands were subtracted from 
the corresponding DNA input bands and subsequently normalized by the grey values of the 
GFP bands. All values were normalized to the relative binding ratio of Uhrf1 to unmethylated 
substrate. Shown are means ± SD from three independent experiments. Statistical 
significance between the binding ratios of un- and hemimethylated DNA is indicated; 
*P < 0.05. 
  
 
 
Supplementary Figure S4. Cell-cycle dependent localization of Uhrf2 in cells with different 
genetic backgrounds. Confocal mid sections of fixed wt J1 (A), TKO (B) and Suv39h dn 
ESCs (C), transiently expressing Uhrf2-GFP. Cells were co-transfected with a RFP-PCNA 
expression vector to distinguish S phase stages [Sporbert et al., 2005] and counterstained 
with DAPI. Merged images are displayed on the right. Scale bar 5 µm. In wt J1 and TKO 
ESCs the Uhrf2 fusion protein accumulates at pericentric heterochromatin independent of the 
cell-cycle stage and methylation levels (A) (B). In contrast, Uhrf2-GFP shows a fully 
dispersed nuclear distribution in Suv39h dn cells indicating the dependency on H3K9me3 
methylation for localization at PH in vivo (C). (D) and (E) Scatter blot of GFP-Uhrf2 and DAPI 
signals in wt MEFs and Suv39h dn MEFs. The corresponding Pearson correlation 
coefficients R ± SEM are calculated from ten analysed cells. The software Volocity (Perkin 
Elmer) was used for analysis, selecting the cell nucleus as region of interest. Note that 
Pearson correlation coefficients range from +1 to -1 for perfect to no co-localization. 
  
 
 
Supplementary Figure S5. Alignment and recombination of Uhrf1 and Uhrf2 domains. (A) 
Alignment of the tandem Tudor domain (TTD) and PHD domains from vertebrate Uhrf2 and 
Uhrf1 orthologs. Accession numbers for Uhrf2: Homo sapiens CAH74119.1; Bos taurus 
AAI48950.1; Mus musculus Q7TMI3; Rattus norvegicus NP_001101055.1; Pan troglodytes 
XP_528534.2; Xenopus laevis AAI28674.1. Accession numbers for Uhrf1: Homo sapiens 
Q96T88.1; Bos taurus AAI51672.1; Mus musculus Q8VDF2.2; Rattus norvegicus Q7TPK1.2; 
Dario rerio NP_998242.1; Xenopus laevis AAI28674.1, Gallus gallus XP_418269.2. Arrows 
show the start and end positions of the TTD and PHD domains. Absolutely conserved 
residues are black shaded, while positions showing conservative substitutions are boxed with 
residues in bold face. The additional stretch region found in the TTD of Uhrf2 and the linker 
region between TTD and PHD finger are boxed with dotted black lines. (B) Schematic outline 
of engineered constructs including the deletion of the stretch region and the swapping of 
linker sequences. 
  
 
 
Supplementary Figure S6. Uhrf2 interacts with Uhrf1, Dnmt1 and Dnmt3a/b. (A) Co- 
immunoprecipation of Uhrf2-myc and GFP-Uhrf1, GFP-Dnmt3a, GFP-Dnmt3b, GFP-HP1, 
GFP-HP1, GFP-HP1 or GFP transiently co-expressed in HEK293T cells. Note that Uhrf2 
interacts with Uhrf1, Dnmt3a and Dnmt3b. (B) Co-immunoprecipation of Uhrf2-myc and 
GFP-Dnmt1 constructs transiently co-expressed in HEK293T cells: GFP-Dnmt1 (G-Dnmt1), 
GFP-fusions of the N-terminal and C-terminal part of Dnmt1 (G-D1-Nterm, G-D1-Cterm) and 
truncated Dnmt1 constructs (G-Dnmt1 1-309, G-TS 310-629, G-Dnmt1 630-1111). Note that 
Uhrf2 interacts with full-length Dnmt1, the N-terminal part and the targeting sequence (G-TS 
310-629). One percent of input (I) relative to bound fractions (B) was loaded. Co-
immunoprecipitation was performed using the GFP trap [Rothbauer et al., 2008]. Co-
precipitated myc-tagged proteins were detected using a mouse monoclonal primary anti-myc 
antibody (Invitrogen, Germany) and an HRP- or Cy5-conjugated secondary anti-mouse 
antibody (Sigma, Germany, or Jackson ImmunoResearch Laboratories, USA, respectively). 
 
  
 
 
Supplementary Figure S7. Histone-tail peptide and DNA sequences and quality control of 
DNA substrates. (A) Amino acid sequence of TAMRA-labelled peptides for in vitro histone-
tail peptide binding assays. Histone-tail peptides were purchased as TAMRA conjugates 
(PSL, Germany). (B) DNA oligos used for preparation of double-stranded probes for in vitro 
DNA binding assays. M: 5-methyl-cytosine. For hybridization, DNA oligos were mixed in 
equimolar amounts, heated to 92°C and cooled down to room temperature. DNA substrates 
for Figure 2F were completed in a primer extension reaction. By using a control set of DNA 
probes with identical sequence but different fluorescent labels we observed effects due to 
probe preparation and/or unspecific binding of ATTO dyes (data not shown). The values 
obtained from the control set were used to normalize every probe/protein pair. (C) Quality 
control of DNA substrates. Un- and hemimethylated DNA substrates (2 pmol; Atto647N 
labelled) were digested with 1 unit MspI or HpaII and analyzed by 15% non-denaturing 
PAGE for CpG methylation. Note that unmethylated DNA substrate is digested by both 
enzymes, whereas hemimethylated substrate is only cut by MspI. Enzyme recognition motifs 
are boxed and asterisks represent ATTO labels.  
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Recent studies have indicated that nuclear protein of 95 kDa
(Np95) is essential for maintaining genomic methylation by
recruiting DNA methyltransferase (Dnmt) 1 to hemi-methylated
sites. Here, we show that Np95 interacts more strongly with
regulatory domains of the de novo methyltransferases Dnmt3a
and Dnmt3b. To investigate possible functions, we developed an
epigenetic silencing assay using fluorescent reporters in embryo-
nic stem cells (ESCs). Interestingly, silencing of the cytomegalo-
virus promoter in ESCs preceded DNA methylation and was
strictly dependent on the presence of either Np95, histone H3
methyltransferase G9a or Dnmt3a and Dnmt3b. Our results
indicate a regulatory role for Np95, Dnmt3a and Dnmt3b in
mediating epigenetic silencing through histone modification
followed by DNA methylation.
Keywords: DNA methylation; histone modification; epigenetics;
silencing; Uhrf1
EMBO reports (2009) 10, 1259–1264. doi:10.1038/embor.2009.201
INTRODUCTION
In mammals, DNA methylation contributes to the establishment and
maintenance of cell-type-specific gene expression programmes,
imprinting, X-chromosome inactivation and genome stability (Bird,
2002). The majority of genomic methylation occurs at cytosine
residues within CpG dinucleotides and is catalysed by the DNA
methyltransferases (Dnmt) 1, 3a and 3b. Dnmt1 is responsible for
maintaining genomic methylation, whereas Dnmt3a and Dnmt3b
are mainly involved in de novo establishment of methylation
patterns during cellular differentiation (Leonhardt et al, 1992; Li et al,
1992; Lei et al, 1996; Okano et al, 1999; Spada et al, 2007).
Nuclear protein of 95 kDa (Np95; also known as Uhrf1) has
recently been identified as an essential co-factor for maintaining
genomic methylation (Bostick et al, 2007; Sharif et al, 2007;
Achour et al, 2008). dnmt1/ and np95/ embryonic stem cells
(ESCs) and embryos have similar reduced levels of DNA methylation.
In addition, Np95 interacts with Dnmt1, binds hemi-methylated CpG
sites through its Set and Ring associated (SRA) domain and both Np95
and Dnmt1 accumulate at replication sites (Uemura et al, 2000;
Bostick et al, 2007; Papait et al, 2007; Arita et al, 2008; Avvakumov
et al, 2008; Hashimoto et al, 2008). Thus, it has been proposed that
Np95 mediates maintenance of genomic methylation by recruiting
Dnmt1 to hemi-methylated CpG sites generated during replication.
Here, we investigated a possible involvement of Np95 in
epigenetic regulation beyond its role in Dnmt1-mediated main-
tenance of DNA methylation. We found that Np95 interacts with
the de novo methyltransferases, Dnmt3a and Dnmt3b, and
mediates promoter silencing before DNA methylation is detected.
RESULTS AND DISCUSSION
Np95 interacts with Dnmt3a and Dnmt3b
Immunoprecipitation experiments showed that different isoforms
of both de novo methyltransferases Dnmt3a and Dnmt3b interact
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with Np95 in wild-type (wt) ESCs, including the more abundant
Dnmt3a2 and Dnmt3b1 (Fig 1A). Furthermore, using a green
fluorescent protein (GFP) trap (Rothbauer et al, 2008), we
co-immunoprecipitated endogenous Dnmt1 and isoforms of
Dnmt3a and Dnmt3b with a GFP–Np95 fusion construct
transiently expressed in np95/ ESCs and, vice versa, endo-
genous Np95 co-immunoprecipitated with GFP–Dnmt3a or
GFP–Dnmt3b1 fusions in dnmt3a and 3b double knockout
(DKO) ESCs (supplementary Fig S1A,B online). In addition, we
observed co-immunoprecipitation of endogenous DNMT3b and
inverted CCAAT box binding protein of 90 kDa—the human
homologue of Np95—from human embryonic kidney 293T
(HEK293T) cell extracts (supplementary Fig S1C online). We
confirmed the interaction of Np95 with Dnmt3a/b by using a
recently developed fluorescent two hybrid assay (F2H; Zolghadr
et al, 2008). GFP–Dnmt3 fusion constructs were used as bait by
tethering them to a lac operator array present in baby hamster
kidney (BHK) cells, so that the array was visible as a distinct
nuclear spot of enriched GFP fluorescence (Fig 1B). A Cherry–
Np95 fusion (prey) accumulated at this spot only when GFP
fusions of full-length Dnmt3a and Dnmt3b1 or their amino-
terminal regions were used as bait and not when their isolated
Carboxy-terminal catalytic domains were used. We further
mapped the interaction of Np95 with Dnmt3a/b through co-
immunoprecipitation of deletion constructs and isolated domains
transiently expressed in HEK293T cells (supplementary Fig S2
online). The results were consistent with those produced by F2H:
the N-terminal regions of Dnmt3a and Dnmt3b1, but not their
C-terminal catalytic domains, interacted with Np95. Deletion of
the PHD or PWWP domains of Dnmt3a and Dnmt3b did not
eliminate the interaction with Np95. We then determined the
domains of Np95 involved in this interaction. We found that the
SRA domain and the N-terminal 298 amino acids of Np95, which
include the ubiquitin-like domain, interacted with Dnmt3a and
Dnmt3b1, whereas the PHD domain and the C-terminal 132
amino acids, including the Ring domain, did not. Furthermore,
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Fig 1 | Np95 interacts with de novo methyltransferases Dnmt3a and Dnmt3b. (A) Co-immunoprecipitation of Dnmt3a and Dnmt3b with Np95 in wt and
np95/ E14 ESCs. The Dnmt3a2 isoform is shown in the lower panel. (B) F2H shows recruitment of Cherry–Np95 (prey) at the lac operator array
(indicated by arrowheads) when GFP fusions of full-length Dnmt3a and Dnmt3b1 (G-Dnmt3a/b fl) or their amino-terminal regions (G-Dnmt3a/b N)
are used as bait and not with their isolated C-terminal catalytic domains (G-Dnmt3a/b C). Scale bars, 5mm. (C) Co-immunoprecipitation of
Np95-His with GFP-tagged Dnmt1, Dnmt3a and Dnmt3b1 (G-Dnmt) transiently co-expressed in HEK293T cells. Co-expression of GFP was used as the
control. In the upper row, immunoprecipitations carried out in the presence of 150 mM NaCl throughout the procedure are shown, whereas in the
lower row, immunoprecipitation and wash buffers were carried out using 300 and 500 mM NaCl, respectively. Two per cent of input and supernatant
relative to bound fractions were loaded in (A) and (C). B, bound; Dnmt, DNA methyltransferase; ESCs, embryonic stem cells; F2H, fluorescent
two-hybrid assay; GFP, green fluorescent protein; HEK293T, human embryonic kidney 293T; I, input; Np95, nuclear protein of 95 kDa;
S, supernatant; wt, wild type.
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Fig 2 | Promoter silencing activity in wild-type and mutant ESCs. ESCs with the indicated phenotypes were transiently co-transfected with CMV
promoter-driven mRFP and CAG promoter-driven GFP reporter constructs. Between 90 and 150 images per sample were acquired either (A) every
second day after transfection from a single experiment or (B) only at days 2 and 7–10 after transfection from 3–5 independent experiments. Relative
levels of red over green fluorescence are shown with values for day 2 (first day of imaging) set to 1 (A). Wild-type J1 and E14 cells
gave similar results (data not shown). suv39/ stands for Suv39h1/2 double null ESCs. (C) Representative images of wt and np95/ E14 ESCs
co-transfected as in (A) and (B) (upper panels) and respective heat map intensity plots (lower panels). Scale bar, 15 mm. CAG, CMV early enhancer/
chicken b actin promoter; CMV, cytomegalovirus promoter; DKO, double knockout; Dnmt, DNA methyltransferase; ESCs, embryonic stem cells; GFP,
green fluorescent protein; mRFP, monomeric red fluorescent protein; Np95, nuclear protein of 95 kDa; TKO, triple knockout; wt, wild type.
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we observed co-immunoprecipitation of endogenous Np95 with
GFP–Dnmt3a and GFP–Dnmt3b transiently expressed in dnmt1/
ESCs, indicating that Dnmt3a and Dnmt3b interact with Np95
independently of Dnmt1 (supplementary Fig S1D online). To
compare the relative association between endogenous Np95 and
Dnmts, we re-probed the blot in Fig 1A with a Dnmt1 antibody and
observed a substantially weaker signal for the co-immunoprecipitated
Dnmt1 relative to the input than in the case of Dnmt3a2 and
Dnmt3b1 (supplementary Fig S3A online). To compare further
the stability of Np95 interactions with the Dnmts, we transiently
co-expressed Np95-His with GFP–Dnmt1, GFP–Dnmt3a or
GFP–Dnmt3b1 in HEK293T cells and immunoprecipitated with
the GFP trap in the presence of different salt concentrations (Fig 1C;
supplementary Fig S3B online). Interestingly, under high salt
conditions, the interaction between Np95-His and GFP–Dnmt1
was lost, whereas co-immunoprecipitation of GFP–Dnmt3a and
GFP–Dnmt3b1 remained relatively unaffected. These data clearly
indicate that Np95 interacts more strongly with the de novo
methyltransferases, Dnmt3a and Dnmt3b, than with Dnmt1.
Np95, Dnmt3a/3b and G9a mediate epigenetic silencing
As DNA methylation has a central role in epigenetic silencing, we
investigated the requirement of DNA methyltransferases and
Np95 for promoter silencing in ESCs. We found that, on transient
transfection of wt ESCs, constructs driven by the cytomegalovirus
(CMV) promoter were rapidly silenced, as opposed to longer-
lasting expression of constructs driven by the chimeric CMV early
enhancer/chicken b actin (CAG) promoter (Fig 2), which is
consistent with the popularity of the CAG promoter for stable
transgene expression in ESCs and mice. We then established an
epigenetic silencing assay based on this observation. ESCs were
co-transfected with two distinct plasmids, one expressing mono-
meric red fluorescent protein (mRFP) under the CMV promoter,
the other expressing GFP driven by the CAG promoter. mRFP and
GFP expression was monitored after transfection for up to ten days
by using automated image acquisition and quantification
of fluorescent signals (supplementary Fig S4A online). The ratio
between mRFP and GFP expression declined steadily in wt ESCs,
reflecting preferential silencing of the CMV promoter (Fig 2).
By contrast, DKO ESCs and ESCs lacking all three major DNA
methyltransferases (dnmt1, 3a and 3b triple knockout) showed no
preferential silencing of the CMV promoter. Surprisingly, np95/
ESCs were also unable to silence the CMV promoter, whereas
dnmt1/ ESCs showed only partly reduced silencing under these
conditions. Similar results were obtained on swapping GFP and
mRFP reporter sequences, ruling out potential artefacts due to
differences in their coding sequences or stability of the reporter
proteins (supplementary Fig S4B online). Thus, despite expressing
a full complement of DNA methyltransferases, ESCs lacking Np95
are as deficient in promoter silencing activity as ESCs lacking all
three major Dnmts. We next investigated whether silencing of the
CMV promoter correlates with CpG methylation. Interestingly,
promoter methylation was detected only ten days after transfec-
tion and was lower in np95/ than in wt ESCs, whereas none of
the dnmt mutant ESCs showed appreciable DNA methylation
(Fig 3; supplementary Fig S5A online). At the same time no
obvious methylation was detected in any of the ESC lines within
the CpG island of the CAG promoter construct (supplementary
Fig S5B online). Thus, CMV promoter silencing depends on the
presence of both Np95 and de novo Dnmts, but ensues well
before de novo methylation of the promoter is detected. This
prompted us to investigate the involvement of repressive histone
methylation as a possible mechanism for the observed silencing.
We found that in the absence of histone H3 lysine 9 methyl-
transferases (H3K9MTs), G9a or Suv39h1/2, silencing of the CMV
promoter was completely abolished or reduced, respectively,
indicating that G9a and, in part, Suv39h1/2 are also required for
silencing (Fig 2B).
The results shown here indicate that Np95 interacts with
Dnmt3a and Dnmt3b and mediates silencing of the CMV
promoter by mechanisms that are, at least initially, independent
of de novo DNA methylation. Importantly, our data also show the
involvement of H3K9MTs, G9a and Suv39h1/2 in CMV promoter
silencing. H3K9MTs were reported to associate with de novo
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Fig 3 | Methylation of the CMV promoter 2, 6 and 10 days after
transfection. Wild-type and np95/ ESCs were transfected as in Fig 2
and GFP-positive cells were sequentially sorted at the indicated days after
transfection. Total DNA was isolated from sorted cells and bisulphite-
treated. A proximal part of the CMV promoter was amplified and
subjected to pyrosequencing. (A) Schematic drawing of the 14 proximal
CpG sites analysed (shown as open circles). The numbers above
correspond to the CpG sites shown in (B) and (C) and numbers in
brackets refer to the position of CpG sites with respect to the
transcription start site. (B,C) Methylation percentage at individual CpG
sites for (B) wt and (C) np95/ ESCs as measured by pyrosequencing.
CMV, cytomegalovirus; ESCs, embryonic stem cells; GFP, green
fluorescent protein; wt, wild type.
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Dnmts, and major satellite repeats were found to be hypomethy-
lated in ESCs lacking either Suv39h1/2 or Dnmt3 enzymes.
However, major satellite transcript levels were altered only in
Suv39h1/2-deficient cells and not in Dnmt3-deficient cells (Fuks
et al, 2003; Lehnertz et al, 2003; Martens et al, 2005). A recent
study showed that G9a, Dnmt1, Dnmt3a and Dnmt3b are
required for normal methylation at long terminal repeats of
endogenous retrotransposable elements, although transcription of
these elements was increased in Dnmt-deficient ESCs, but not
G9a-deficient ESCs (Dong et al, 2008). Furthermore, recent studies
have shown that G9a interacts with Dnmt3a and Dnmt3b and
mediates de novo methylation of the oct4, nanog and dnmt3l
promoters on retinoic-acid-induced differentiation of ESCs (Feld-
man et al, 2006; Li et al, 2007; Epsztejn-Litman et al, 2008).
However, two of these studies showed that neither G9a nor de
novo Dnmts are required to silence the oct4 promoter, and G9a
was also found to be dispensable for silencing the nanog and
dnmt3l promoters (Feldman et al, 2006; Epsztejn-Litman et al,
2008). In the third study, nanog, but not oct4, was shown to be
silenced in differentiating ESCs lacking both Dnmt3a and Dnmt3b
(Li et al, 2007). We found that silencing of oct4 during embryoid
body differentiation is largely independent from the presence of
Np95 as well as all three major Dnmts, and occurs in the absence
of DNA methylation (D.M., F.S., S.B., and H.L., unpublished
data). These data, together with our findings on silencing of the
CMV promoter in ESCs, indicate that Dnmts, Np95 and H3K9MTs
mediate silencing through many mechanisms that do not
necessarily involve DNA methylation and might depend on the
presence of different cis elements and an intricate interplay with
other epigenetic and transcription factors. Interestingly, Np95 was
recently shown to interact with G9a (Kim et al, 2009) and here we
show that silencing of the CMV promoter in ESCs strictly depends
on Np95 and on de novo Dnmts as well as G9a. Taken together
these observations suggest that Np95, de novo Dnmts and G9a
might be involved in a common silencing pathway.
In summary, our data clearly support a crucial role of Np95 in
epigenetic silencing mediated by de novo DNA and histone
methyltransferases, and make Np95 an attractive target for
epigenetic reprogramming strategies.
METHODS
Cell culture and transfection. HEK293T cells, BHK cells and ESCs
were cultured and transfected as described by Schermelleh et al
(2007), except FuGENE HD (Roche, Mannheim, Germany) was
used for transfection of ESCs. The dnmt1/ J1 ESCs used in this
study were homozygous for the c allele (Lei et al, 1996). BHK cells
were co-transfected on glass coverslips with GFP–Dnmt3 and
Cherry–Np95 constructs using Transfectin (Bio-Rad, Munich,
Germany) according to the manufacturer’s instructions. Cell
fixation and microscopy were carried out as described by
Zolghadr et al (2008).
Co-immunoprecipitation. ESCs and HEK293T cell extracts were
prepared in lysis buffer (20 mM Tris–HCl (pH 7.5), 0.5 mM EDTA,
2 mM phenylmethyl sulphonyl fluoride and 0.5% NP40) contain-
ing 150 or 300 mM NaCl (high-salt condition) and diluted with
lysis buffer without NP40. GFP trap (Rothbauer et al, 2008) and a
specific rabbit antiserum (Citterio et al, 2004) were used for
immunoprecipitation of GFP fusions and endogenous Np95,
respectively. GFP trap and protein G beads (Sigma, Taufkirchen,
Germany) were washed with dilution buffer containing increasing
salt concentrations (150 and 300 mM, or 300 and 500 mM NaCl
for the high-salt condition) and re-suspended in SDS–PAGE
sample buffer. The following mouse monoclonal antibodies
were used for immunoblotting: anti-His (C-terminal, Invitrogen,
Karlsruhe, Germany), anti-Dnmt3a (clone 64B1446, Imgenex, San
Diego, CA, USA) and anti-Dnmt3b (clone 52A1018, Abcam,
Cambridge, UK). Np95 was detected with the same antiserum
used for immunoprecipitation and a rabbit antiserum was used for
detection of Dnmt1 (Grohmann et al, 2005). Horseradish
peroxidase-conjugated rabbit anti-mouse or goat anti-rabbit
secondary antibodies (Sigma) and ECL Plus reagent (GE Health-
care, Munich, Germany) were used for detection.
Silencing assay. ESCs were co-transfected with pCAG-eGFP-IB
and pCMV-mRFP as described above and images from live cells
were acquired at the indicated time points with an InCell Analyser
1000 (GE Healthcare) using a  20 air objective (NA¼ 0.45) and
standard filter settings for GFP and RFP. A total of 90–150 images
were acquired for each channel, using the same exposure time
throughout the time course. Cells were passaged every second day
and images were taken 4–5 h after seeding. Images were analysed
using ImageJ v1.42a software. To calculate fluorescent reporter
expression, pictures were processed using a Gaussian blur
algorithm (radius (sigma)¼ 2), and a threshold for maximal signal
and minimal background coverage was adjusted and applied to
each channel (supplementary Fig S4A online). The threshold was
converted into area selection and the total size of the selected area
was measured.
DNA methylation analysis. ESCs were transfected as in the
silencing assay with pCAG-eGFP-IB and pCMV-mRFP, and GFP-
positive cells were sequentially sorted with a FACSVantage or
FACSAria II (Becton Dickinson, Heidelberg, Germany) at days 2, 6
and 10 after transfection. After each sorting, total DNA was
isolated using the QIAmp DNA Mini kit (Qiagen, Hilden,
Germany) and bisulphite treated with the EZ DNA Methylation-
Gold kit (Zymo research, Orange, CA, USA). The following
primers were used for PCR amplification: CMV-forward TGGGAT
TTTTTTATTTGGTAGT; CMV-reverse ATGGGAGTTTGTTTTGG
TATTA; CAG-forward GGAGAGGTGAGGAGGTAGTTAATTAGA
and CAG-reverse CCCCAAACCCCTCAAAACTT. Pyrosequencing
was carried out by Varionostic GmbH (Ulm, Germany).
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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Supplementary Figure S1. Np95 interacts with de novo methyltransferases Dnmt3a and 3b. 
(A) Co-immunoprecipitation of endogenous Dnmt3a2 (left and right), Dnmt3b isoforms (left) 
and Dnmt1 (right) with GFP-Np95 transiently expressed in np95-/- ESCs. Left and right panels 
are from independent experiments where 2 and 4% of input (I) relative to bound (B) fractions 
was loaded, respectively. (B) Co-immunoprecipitation of endogenous Np95 with either 
GFP-Dnmt3a (left panel) or GFP-Dnmt3b1 (central panel) transiently expressed in DKO 
ESCs. Transient expression of GFP was used as control (right panel). GFP and GFP fusions 
were immunoprecipitated with GFP-trap as in experiments shown in Fig. 1B. 2% of input (I) 
relative to bound (B) fractions was loaded. (C) Co-immunoprecipitation of endogenous 
ICBP90/UHRF1 and DNMT3b in HEK293T cells. Antibodies to mouse proteins cross-react 
with the respective human homologues. 4% of input (I) relative to bound (B) fractions was 
loaded. (D) Co-immunoprecipitation of endogenous Np95 with either GFP-Dnmt3a or 
GFP-Dnmt3b1 (lower panel) transiently expressed in dnmt1-/- ESCs. 
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Supplementary Figure S2. Mapping the interaction domains of Dnmt3a/b and Np95. (A) 
Schematic representation of GFP-Dnmt3a/b fusion constructs used for mapping the 
interaction site with Np95 (N-terminal GFP tag is not shown). (B) Co-immunoprecipitation of 
Np95-His with GFP-Dnmt3 constructs (G-3a/b) from extracts of transiently transfected 
HEK293T cells. (C) Schematic representation of Np95-His constructs used for mapping the 
interaction site with Dnmt3a/b. (D) Co-immunoprecipitation of Np95-His domains shown in c 
with GFP-Dnmt3a/b constructs from extracts of transiently transfected HEK293T cells. G 
indicates the GFP fusion. The GFP-trap was used for all the immunoprecipitations in panels B 
and D. 0.5% of input (I) and 40% of bound (B) fractions were loaded. PWWP, domain with 
conserved pro-trp-trp-pro motif; NLS, nuclear localization signal; PHD, plant homeodomain; 
Ubl, ubiquitin-like domain; SRA, set and ring associated domain; RING, really interesting 
new gene domain. Results of mapping are scored by + or -. 
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Supplementary Figure S3. Relative stability of Np95 interactions with Dnmt1, 3a and 3b. 
(A) The Dnmt3a/3b blot in Fig. 1A (shown here as middle and lower panels) was reprobed 
with an anti-Dnmt1 antibody (upper panel) to compare the relative amounts of endogenous 
Dnmts associated with Np95. The lower panel shows the Dnmt3a2 isoform. (B) The blots in 
Fig. 1C (shown here in the two upper panels) were reprobed with an anti-GFP antibody (two 
lower panels) to reveal that similar amounts of each GFP construct were immunoprecipitated 
in low and high salt conditions. Both results point to a tighter association of Np95 with 
Dnmt3a and 3b as compared to Dnmt1. 
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Supplementary Figure S4. (A) Automated procedure for quantification of fluorescent signals 
from digital micrographs for the promoter silencing assay. A macro was written for the 
ImageJ software that applies a Gaussian blur filter (left panel) and signal thresholding (right 
panel) to raw images (data not shown) and then calculates the total signal area. (B) Silencing 
assay results are not affected by the choice of fluorescent reporter. wt and np95-/- ESC were 
cotransfected with either CMV-driven mRFP and  CAG-driven GFP (red) or CAG-driven 
mRFP and CMV-driven GFP (blue) expression constructs and the ratio of CMV- over CAG-
driven fluorescence was quantified at the indicated time points after transfection as for Figure 
2A.
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Supplementary Figure S5. Methylation analysis of CMV and CAG promoters 2, 6 and 10 
days after transfection. ESCs with the indicated genotypes were transfected, sorted, total DNA 
was isolated and bisulfite treated as for Fig. 3. (A) The same proximal region of the CMV 
promoter was amplified and pyrosequenced as in Fig. 3. (B) A fragment of the CAG construct 
containing 13 CpG sites was amplified and subjected to pyrosequencing. The analyzed 
fragment spans across the 3’ part of the promoter, the first exon and the 5’ part of the first 
intron of the chicken ß-actin gene and is part of a CpG island. Methylation percentages at 
individual CpG sites within the respective promoter sequences are averaged. The plot on the 
left of A was derived from the same data presented in Fig. 3C. 
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Supplementary methods 
Plasmid construction. The CMV-driven enhanced GFP construct was from Clontech 
(pEGFP-C1). To generate the CMV-driven mRFP construct (pCMV-mRFP) the coding 
sequence for eGFP in pEGFP-C1 was replaced with that for mRFP from pRSETB-mRFP 
(Campbell et al, 2002; provided by Roger Tsien). To create CAG-driven eGFP, mRFP and 
mCherry expression constructs (pCAG-eGFP-IB, pCAG-mRFP-IB and pCAG-mCherry-IB, 
respectively) sequences coding for the respective fluorescent proteins from pEGFP, 
pRSETB-mRFP and pRSETB-mCherry (Shaner et al, 2004; also provided by R. Tsien) were 
inserted downstream to the CAG promoter in the pCAG-IRESblast vector(Chen et al, 2003). 
The expression construct for Np95-His was described previously (Citterio et al, 2004). To 
generate expression constructs for GFP-Np95, Ch-Np95, GFP-Dnmt3a and GFP-Dnmt3b1 the 
sequences coding for Np95, Dnmt3a or Dnmt3b1 were then transferred from the respective 
CMV promoter-driven constructs (Chen et al, 2003; Citterio et al, 2004) to either 
pCAG-eGFP-IB or pCAG-mCherry-IB downstream to sequences coding for the fluorescent 
protein. GFP-Dnmt3a and GFP-Dnmt3b1 deletion constructs were generated by overlap 
extension mutagenesis(Ho et al, 1989) to remove the following amino acids from Dnmt3a and 
3b1, respectively: 278-343 and 223-287 (ΔPWWP); 485-582 and 435-532 (ΔPHD). GFP 
fusion constructs of N-terminal regions (aa 1-629 and 1-580) and C-terminal domains (aa 
630-908 and 581-859) of Dnmt3a and 3b, respectively, were generated by PCR cloning using 
full length constructs as templates. All constructs were characterised by sequencing and 
immunoblotting. 
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2.7 Role of DNA methylation in silencing of pluripotency genes during embryonic stem 
cell differentiation 
We have recently shown that Np95 is involved in a common silencing process of 
ectopically expressed promoter constructs with Dnmt3a, Dnm3b and the histone 
methyltransferase G9a ((Meilinger et al, 2009) see chapter 2.6). Moreover, we showed that 
Np95 interacts with the de novo methyltransferases Dnmt3a and Dnmt3b. These findings 
pointed us towards the investigation of a possible Np95 role in silencing of endogenous 
promoter regions. We addressed this question by differentiating various knockout cell lines 
and compared expression and methylation level changes of the pluripotency factors oct4 
and nanog during differentiation.  
Mater ia l  and Methods 
Cell lines: Wild type (J1 and E14), dnmt1-/-, DKO (dnmt3a-/-dnmt3b-/-), TKO (dnmt1-/-, 
dnmt3a-/-dnmt3b-/-), and np95-/- cell lines described previously (Meilinger et al, 2009). 
Cell culture, transfection and stable cell line generation: Mouse ES cells were cultured 
without feeder cells in gelatinized flasks and in DMEM supplemented with 16% fetal calf 
serum, 1000U/ml LIF, ß-mercaptoethanol and L-Glutamin as described previously (Frauer 
et al., 2011). Cell were transfected immediately after splitting with FuGENE HD (Roche, 
Mannheim) according to manufactures protocol.  
GFP-positive cells were sorted 48 hours after transfection with a FACS Aria II (Becton –
Dickinson). Sorted cells were plated under low density for stable cell line generation. The 
remaining GFP-positive cells were subsequently sorted and cultured until a stable pool of 
GFP-expressing cells was obtained.   
Differentiation into embryoid bodies: a single cell suspension was obtained after 
resuspending in ESC medium without LIF. Cells were counted and adjusted to 3x104 
cells/ml and 20 µl drops were spotted on the lid of a bacterial dish. The lid was turned and 
put back on the dish filled with PBS to prevent desiccation. After 2 or 4 days of incubation, 
EBs were collected and propagated in ESC medium without LIF. To prevent adhesion, 
EBs were transferred into a bacterial dish for further cultivation. Samples were collected 
every second or fourth day and genomic DNA as well as RNA was extracted and purified.  
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Genomic DNA and RNA Isolation from embryoid bodies: Genomic DNA was isolated using 
QIAmp DNA Maxi kit following the protocol for tissue lysis and isolation. Lysis was carried 
out 1-4 hours in lysis buffer to guarantee complete lysis. For simultaneous purification of 
DNA and RNA samples were collected in 1ml TRIzol reagent (Invitrogen) and either lysed 
by repetitive pipetting or by using a Dounce Homogenisator at later time points. Genomic 
DNA was further purified using a QIAmp Mini column and bisulfite treated using DNA 
Methylation Gold kit (Zymo Research). 
Methylation Analysis based on Pyrosequencing: Bisulfite treated DNA was amplified in a 
PCR reaction with specific primer sets and nested PCR conditions for oct4 and nanog 
promoter regions (see Table 3). The amplified PCR product was subjected to 
pyrosequencing carried out by varionostic GmbH, Ulm.  
Table 3: Bisulfite primer sequences for oct4 and nanog promoter 
promoter forward pr imer sequence reverse pr imer sequence length CpG  
oct4 
 
GTTGTTTTGTTTTGGTTTTG
GATAT 
GTTAGAGGTTAAGGTTAGAGGGTGG   
ATGGGTTGAAATATTGGGTT
TATTTA 
GTTAGAGGTTAAGGTTAGAGGGTGG-
bio 
454bp 12 
nanog 
 
GAGGATGTTTTTTAAGTTTTT
TTT 
TTATTATATTGATATGAGTGTGGG   
AATGTTTATGGTGGATTTTG
TAGGT 
TTATTATATTGATATGAGTGTGGG-bio 369bp 6 
 
DNA methylat ion and expression of oct4 and nanog dur ing EB di f ferent iat ion 
We investigate a possible function of Np95 in silencing of endogenous promoter regions 
by differentiating np95-/-, dnmt1-/- ES cells and their respective wild types into EBs and 
compared expression and methylation level changes of the pluripotency factors oct4 and 
nanog. Various differentiation protocols are available, but EB formation by the hanging-
drop method provides the most homogenous population. The differentiation process in 
EBs is similar to the one observed in early embryonal development. During EB formation 
cells are not forced into specific cell lineages and thus this method allows differentiation 
into cells from all three germ layers.  We controlled the size of the EBs by using a defined 
number of cells. EBs were harvested after 2-4 days and transferred into bacterial dishes to 
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avoid adhesion and further cultivation. To compare methylation of oct4 and nanog 
promoter with transcript levels, we harvested EBs every 2-4 days and analyzed 
methylation level changes of oct4 and nanog promoter regions as well as transcript levels. 
For methylation analysis, we isolated and bisulfite treated genomic DNA before subjecting 
it to pyrosequencing.  
The pyrosequencing analysis of the oct4 promoter in wild type ES cells shows that 
methylation steadily increases after 4 days of initiation of differentiation and reaches a 
plateau after 16 days (see Figure 2-5). The results are strikingly similar in both analyzed 
wild type cell lines: E14 and J1, which are the respective wild type backgrounds for np95-/- 
ES cells and the dnmt knockout ES cells (TKO and dnmt1-/-). Notably, expression of oct4 
declines fast after initiation of differentiation and already at day 4 lowest transcript levels 
were detected indicating a complete down regulation (provided by Christine Schmidt).  
Similar effects can be observed in the analysis of the nanog promoter, yet methylation 
levels are significantly lower and reach only 40% methylation compared to approximately 
70% that were found in the oct4 promoter sequence (see Figure 2-6). Interestingly, we 
found down regulation of oct4 and nanog in np95-/- and dnmt1-/- knock out cells to be 
surprisingly similar compared to the respective wild type cell lines and with a similar 
kinetics. Moreover, methylation levels were established at day 4 of differentiation, which is 
comparable to data obtained in wild type cell lines.  However, methylation levels by far do 
not reach those observed in the respective wild type cells and stagnate at day 8 with 
around 20% and 10% in the oct4 promoter and the nanog promoter, respectively. 
Furthermore, methylation levels decrease slightly after day 8 in dnmt1-/- ES cells but not in 
np95-/- ES cells. This observed difference was unexpected considering that np95-/- and 
dnmt1-/- ES cells have such strikingly similar methylation levels on both single copy 
promoter sequences and repetitive elements (see figure Figure 2-4) and given the fact that 
enzymatic activity of Dnmt1 is directly depended on the interaction with Np95 (Bostick et 
al, 2007; Sharif et al, 2007).  
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Figure 2-4: Comparison of methylation in wild type, dnmt1-/- and np95-/- ES cells. CpG methylation of major 
satellite repeats was analyzed by bisulfite treatment, PCR amplification and pyrosequencing for quantitative 
analysis. Both wild type cell lines J1 and E14 have methylation levels of around 80% at each CpG site. 
Strikingly, similar recused methylation levels were found in dnmt1-/- and np95-/- ES cells.  
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Figure 2-5: Methylation and expression of pluripotency factor oct4 during EB differentiation in wild type and 
knockout ES cells. Two wild type cell lines (J1, E14) were differentiated into EB up to 24 days and oct4 
promoter methylation was analyzed every 2-4 days. Methylation levels from 5 CpG sites were averaged at 
each time point for each cell lines. (B) Simultaneously to genomic DNA extraction, mRNA was prepared for 
relative oct4 mRNA expression at each time point (provided Christine Schmidt). 
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Figure 2-6 Methylation and expression of pluripotency factor nanog during EB differentiation in wild type and 
knockout ES cells: Two wild type cell lines (J1, E14) were differentiated into EB up to 24 days and nanog 
promoter methylation was analyzed every 2-4 days. Methylation levels from 5 CpG sites were averaged at 
each time point for each cell lines. (B) Simultaneously to genomic DNA extraction, mRNA was prepared for 
relative nanog mRNA expression at each time point (provided by Christine Schmidt). 
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Taken together, the comparison of the methylation level profiles in np95-/- and dnmt1-/- 
knockout cell lines revealed that de novo methylation carried out by Dnmt3a and Dnmt3b 
is not impaired in np95-/-ES cells, as we expected from the CMV promoter silencing data. 
Moreover, our data suggest that interaction of Np95 with the de novo methyltransferases 
Dnmt3a and Dnmt3b ((Meilinger et al, 2009) see chapter 2.7) is not involved in silencing of 
endogenous promoters. However, consistent with our previous findings that silencing of 
the CMV promoter precedes DNA methylation, our data on silencing of the pluripotency 
factors oct4 and nanog clearly shows that initial down regulation is independent of DNA 
methylation and DNA methyltransferases. 
Down regulat ion of oct4 in TKO cel ls  
In addition to the analysis of wild type and np95-/- and dnmt1-/- ES cells we differentiated 
TKO cells and TKO cells stably expressing GFP-Dnmt1 (see chapter 2.3) into EBs and 
determined methylation of oct4 and nanog promoter as well as their transcript levels 
during differentiation. We found that both; oct4 and nanog mRNA levels decrease steadily 
during the first 4 days and stagnate at about 20%, indicating an initial down regulation but 
incomplete silencing of oct4. These findings strongly support further that the initial down 
regulation process of pluripotency genes is independent of DNA methylation and DNA 
methyltransferases. 
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Figure 2-7 Methylation and expression of oct4 in TKO cells rescued with Dnmt1. TKO cells stably expressing 
GFP-Dnmt1 were differentiated over 24 days into EBs. Methylation of oct4 promoter was analyzed in those 
cells and no methylation was detectable at any time point. In comparison, mRNA levels of oct4 were 
determined at the same time points during differentiation and down regulation was detectable reaching a 
stable relative level of around 20% (provided by Christine Schmidt). 
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Identification of differentiation area  
(manuscript in preparation) 
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2.8 Identification of differentiating area 
 
 
                                                   
                                                                    
                    
      
 
 
 
Identification of differentiating area  
 
Background 
Embryoid bodies (EB) are spherical	   three-­‐dimensional	   cell	   aggregates	   derived from 
embryonic stem cells which serve as model system for embryonic development. The 
formation of EBs allows studying cellular and molecular interactions in a three-
dimensional manner in the early stages of embryogenesis. The differentiation process 
finally leads to a large variety of differentiated cell types that can be studied and 
characterized in vitro [Desbaillets	   et	   al.,	   2000;	   Itskovitz-­‐Eldor	   et	   al.,	   2000;	   Son	   et	   al.,	  
2011].	  	  
 
High content imaging enables quantitative analysis of fluorescent marker intensities 
combined with cellular morphology and textures, and has proven to be a precise and 
rapid tool for characterizing cells. Here, we present an imaging approach for cell 
identification and stem cell marker quantification in a three-dimensional object using the 
Operetta® High Content Imaging System and the Harmony® High Content Imaging 
and Analysis Software. Classification of stem cell marker positive and negative cells 
allowed the discrimination of differentiated and undifferentiated areas of the EBs.   
APPLICATION NOTE 
Key Features  
• 3D confocal imaging  
• Cell identification in maximum 
intensity projection image 
• Quantification of marker positive 
cells 
Quantitat ive Analysis of Embryoid 
Bodies using Operetta 
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Application  
ES cells (ESCs) were used that express GFP under control of the Oct4 promotor a well 
known stem cell marker [Rodriguez et al., 2007]. To study differentiation process ESCs 
were differentiated into EB using the hanging drop method. ESCs were counted and 
adjusted to 3x104 cells/ml in ESC medium without LIF and 20µl drops were spotted on the 
lid of a bacterial dish. The lid was turned and put back on the dish filled with PBS to 
prevent desiccating. After 4 days of incubation in hanging drops, EBs were collected and 
propagated in ESC medium without LIF. EBs were collected at day 4 and day 8 washed 
with PBS and fixed with 3,7% formaldehyde for 30 minutes.  
Fixed 4-day and 8-day old EBs were permeabilized with 0.5% Triton X-100 (15 min). The 
nuclei and actin cytoskeleton were stained by incubating them with Hoechst 33342 (20 
µM) and Rhodamine Phalloidin (Invitrogen®, final conc. 1 unit/ml), respectively. Finally the 
EBs were transferred to a 384-well CellCarrier™ microtiter plate (PerkinElmer, 6007550) 
for imaging. 
The images were acquired on the Operetta using the confocal mode and a 20X high NA 
objective. A z-stack of 80 planes with a total distance of 160 µm was measured. For 
image analysis the stack processing method “maximum intensity projection” was used. 
With this procedure all planes of the stack measurement are reduced to a single image. 
The maximum intensity value was applied to each pixel of the generated projection image 
gets across the stack planes. The projection images (Figure 1) were used to further 
calculate the morphology and intensity properties of the 4-day and 8-day old EBs. 
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Figure 1 
  
Figure 1: Maximum intensity projection images of 4-day old EB (left) and 8-day old EB (right). The maximum intensity 
projection was generated using all 80 planes of the acquired z-stack. Images show a false color overlay of nuclei (blue), 
actin (red) and Oct4 (green). Compared to the 4-day old EB, the 8-day old EB is larger, more complex and expresses 
less stem cell marker Oct4, indicating advanced differentiation.  
 
For image analysis, the EB region could be clearly discriminated from background by 
texture-based segmentation using the actin image. By calculating the morphology 
properties of the EB region, there was already a significant readout comparing area and 
roundness of the bodies. While the total area of the 8-day old EB is clearly increased, the 
roundness decreases due to an uneven and complex structured surface of the body 
(Figure 3). The Hoechst channel enabled further segmentation of the EB into single nuclei. 
By calculating the Oct4 intensity properties of each nucleus, cells were subdivided into 
Oct4 intensity classes allowing the generation of a histogram (Figure 3).  The histogram 
clearly shows that the main proportion of cells from the 4-day old EB show a high Oct4 
intensity, while the 8-day old body contains mainly cells with lower intensities. This 
provides further evidence of the advanced differentiation of the growing EB. Setting an 
Oct4 intensity threshold allows the separation of the cells into marker positive and marker 
negative cell populations, enabling the identification of differentiated and undifferentiated 
regions inside the body (Figure 2).  
  
 
4-day old EB 8-day old EB 50 µm 
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Figure2                                                                                                  Figure3 
 
 
 
 
 
Figure 2: Image segmentation and identification of Oct4 positive/negative area in the maximum intensity projection 
image. Texture-based segmentation enables the EB region (upper panel, green border) to be found. The generated 
nuclei mask in the EB region is used to calculate the intensity properties of each nucleus in the Oct4-channel (middle 
panel). Setting an intensity threshold allows a marker positive and a marker negative cell population (lower panel) to be 
selected, and an undifferentiated area (shown in green) and differentiating area (shown in red) can be located.  
Figure 3: Quantification of several readouts indicating differentiation of EB. The Oct4 mean intensities of all detected 
nuclei were subdivided into intensity classes. The histogram (A) shows the number of nuclei in each of the intensity 
classes for both EBs. The 4-day old EB (light blue bars) mainly contains cells with high Oct4 intensity whereas the 8-day 
old body (dark blue bars) essentially contains cells with low Oct4 intensity. The table (B) summarizes a selection of the 
most important quantitative readouts evaluating the progress of EB differentiation. As the increased area of the 8-day old 
body indicates growth, the decreased values for roundness and Oct4 positive area simultaneously imply differentiation of 
the body. 
 
  
  
  
 
 
A 
B 
4 days EB 8 days EB 
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Conclusion 
In this study, we analyzed three-dimensional embryoid bodies (EBs) using the Operetta 
High Content Imaging System. The applied method of confocal stack measurement 
combined with analysis of the maximum intensity projection image is a robust approach 
for characterizing 3D bodies. The maximum intensity projection comprises the extracted 
information from all planes rather than each plane individually so that image analysis can 
be achieved much more quickly.  
 
Alongside the quantification of area, roundness and Oct4 intensity the Harmony High 
Content Imaging and Analysis Software enables the discrimination of differentiated and 
undifferentiated regions of the body by classifying cells according to their Oct4 expression 
level. For the EBs studied here we observed a differentiation in the rim and outer regions 
while the center remained undifferentiated after 8 days of incubation. It would be quite 
straightforward to further characterize the differentiation process by including additional 
differentiation markers into the high content imaging approach.             
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3. [Discussion] 
3.1 Analyzing DNA methylation in living cells  
The main focus of this study was the analysis of DNA methylation changes as a result of 
the regulation and activity of DNA methyltransferases in living cells. DNA methyltransferase 
activity is commonly measured in vitro using DNA substrates in either radioactive or 
fluorescent assays.  Within this context, it is important to stress that results of 
methyltransferase assays might differ drastically, dependent on whether they are 
performed in vitro or in vivo. DNA substrates used in in vitro assays are usually naked DNA 
oligonucleotides, where physiological compaction into nucleosomes is missing. Hence, 
analysis of DNA methyltransferase activity in its physiological environment in living cells is 
ultimately the most important experimental assay to determine methyltransferase activity. 
To this aim, complementation or rescue assays in the respective knockout cell lines are 
used to determine the activity of DNA methyltransferases and their “mutants” in vivo. 
Knock out cells are transfected with the respective DNA methyltransferase expression 
vector followed by a methylation analysis to determine the ability of the protein to re-
methylate in vivo. A rescue assay can either be performed transiently or by generating 
stably expressing cell lines, which allows studying long-term effects concerning status and 
levels of DNA methylation in addition to various other applications like biochemical 
approaches and/or microscopy. We aimed to investigate DNA methyltransferase activity in 
living cells and therefore improved the generation of stable ES cell lines by a new FACS 
based approach (see chapter 2.3). This new protocol enabled us to establish stable cell 
lines faster than conventional methods. Furthermore, we improved classic DNA 
methylation protocols, to obtain reliable, reproducible and quantitative data.  
3.1.1 Improved Stable ES Cell Line Generation  
To generate a cell line stably expressing a fluorescent fusion protein, cells are transfected 
with respective expression constructs of a protein-of-interest and subsequent rounds of 
FACS sorting for positive fluorescent cells and expansion are followed including intervals of 
propagation in tissue culture. This results in the creation of a cell population that stably 
expresses the fluorescent fusion protein. This new FACS based approach can also be 
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adapted for other stable cell line production like somatic cell lines and has several crucial 
advantages.  
(i) This approach allows the generation of a pool of stably expressing cells in a shorter 
amount of time compared to classic methods based on solely antibiotic selection. Only 2-
3 weeks of subsequent sorting is necessary to obtain a pool of stably expressing cells and 
adjacent single cell sorting can be used to generate single clones. In addition, it is possible 
to generate several different cell lines in parallel when using this approach. Furthermore it 
is possible to combine this approach with antibiotic selection, which makes it even easier 
to generate multiple stable cell lines in parallel. (ii) By using fluorescent fusion proteins, a 
high throughput microscopy system can be used to screen single clones in a 96 well 
format to compare expression levels and choose clones with different expression levels for 
further analysis. (iii) Those stable cell lines can be used for protein-protein interaction 
studies using the GFP-trap technique without the limitations of low transient transfection 
efficiencies (Rothbauer et al, 2008). (iv) Our approach allows generating double stable cell 
lines by using two different fluorescent markers in only one transfection round.  
Having in hand these cell lines with fluorescent marker proteins opens the whole field of 
combining in vitro and in vivo studies with only one cell line, without the need to repeatedly 
perform transient transfections. Moreover, it offers the possibility to study protein-protein 
interactions in vitro and in vivo, cell cycle depended localization, protein kinetics and 
methyltransferase activity in living cells (see figure Figure 3-1).  
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Figure 3-1 Overview FACS bases approach to generate stable cell lines for methylation analysis. ES cells are 
sorted repeatedly for GFP positive cells, indicated by the green nucleus in the cartoon. After the first round of 
sorting, cells are cultivated and sorted again for the remaining GFP positive cells. After a third round of 
sorting, a stably expressing pool of GFP positive cells is generated. Possible following applications are 
methylation analysis, microscopy including localization studies as well as protein kinetics analysis with FRAP 
and biochemical analyses including the study of protein-protein interactions. 
 
3.1.2 Improved DNA methylation analysis protocol  
Due to the importance of detailed methylation analysis in studying DNA methyltransferase 
activity, gene specific regulation, as well as cancer diagnostics, various protocols to 
determine DNA methylation levels have been established. Bisulfite treatment of DNA is 
often considered as the gold standard in DNA methylation analysis and many methods are 
based on the selective deamination of cytosine but not methylated cytosine bases and 
subsequent PCR amplification of a defined region (Frommer et al, 1992). Based on this 
reaction principle, two protocols, Combined Bisulfite Restriction Analysis (COBRA) and 
classical bisulfite sequencing are established and commonly used. However, both 
protocols (COBRA and bisulfite sequencing) have clear disadvantages and limitations. 
More specifically, bisulfite treatment and PCR amplification can result in a methylation 
dependent creation of new restriction sites, which is used to determine the methylation 
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level at the respective site in an COBRA assay (Xiong & Laird, 1997). However, methylation 
analysis in COBRA is limited to the created restriction site. In classical bisulfite sequencing 
protocols, the PCR product is cloned into a target vector and individual clones are 
selected and sequenced, resulting in detailed information of each CpG sites within the 
amplified sequence. Despite the fact that this method grants an analysis of the methylation 
status of each CpG site within single molecules, obtaining quantitative data requires 
sequencing of a large number of clones, which is very laborious and cost intensive.  
To overcome these limitations and to detect even subtle changes in the methylation 
profile, we established a pyrosequencing methylation analysis protocol. Pyrosequencing is 
based on bisulfite treatment, followed by amplification of a specific DNA sequence with 
one biotinylated primer to allow a sequencing by synthesis application (Colella et al, 2003; 
Ronaghi, 2001). Pyrosequencing is on the one hand a mid- to high throughput approach 
but enables on the other hand the simultaneous quantification and analysis at single CpG 
site resolution. Moreover, the method has a detection limit of only 1-5% methylation (Tost 
et al, 2003). Although the generation of quantitative methylation data with only one-step 
PCR amplification is beneficial, pyrosequencing can only measure amplicons up to a 
length of 120 base pairs (bp), which makes it necessary to use several sequencing 
reactions when analyzing whole CpG islands and large promoters. 
Since the method is based on PCR amplification a possible bias must be considered. 
Differences in secondary structure formation between methylated versus unmethylated 
DNA after bisulfite treatment may result in different amplification efficiencies during PCR. 
Indeed, such observations have already been documented during the methylation analysis 
of the human p16 promoter, where unmethylated DNA was amplified with a greater 
efficiency than the methylated sequences (Warnecke et al, 1997). To minimize such bias 
we systematically tested PCR conditions for the sequences subjected to pyrosequencing. 
The addition of TMAC (tetramethylammonium chloride) to a PCR reaction has been 
reported to reduce bias in normal PCR amplifications, while the addition of betaine 
(N,N,N,-trimethylglycine) has been shown to drastically reduce a PCR induced bias in 
bisulfite treated PCR amplifications (Chevet et al, 1995; Voss et al, 1998). Methylation 
analysis of control DNA titrations (0%, 10%, 25%, 50%, 75%, 90% and 100% methylated) 
by pyrosequencing showed expected methylation values at each site and in each analyzed 
Discussion  
 
 173 
sequence. These results confirm that our bisulfite PCR protocols have nearly no 
detectable bias and that both, methylated and unmethylated sequences are amplified with 
a similar efficiency.  
Recently, a new modified base, 5-hydroxymethylcytosine (5-hmC) was discovered, that 
shows chemically similar properties to 5mC and thus might be indistinguishable in 
standard bisulfite based methods (Kriaucionis & Heintz, 2009; Tahiliani et al, 2009).  
Indeed, a study showed that 5-hmC, like 5-mC is resistant to deamination, indicating that 
standard bisulfite methods, including pyrosequencing are not able to distinguish 5-hmC 
from 5-mC (Huang et al, 2010). Thus, it is important to take this finding into consideration 
when analyzing methylation data that is obtained from bisulfite-based methods, in 
particular in cells with a high amount of 5-hmC such as ES cells.  
3.2 Role and dynamics of the regulatory subunits of Dnmt1  
Faithful maintenance of DNA methylation is coupled with replication of DNA during S-
Phase (Chuang et al, 1997; Easwaran et al, 2004; Leonhardt et al, 1992). Dnmt1 is the 
main maintenance methyltransferase in mammalian cells and interacts with the replication 
machinery via its PCNA binding domain (PBD). It has been previously proposed that this 
interaction is crucial for proper maintenance of DNA methylation especially in early S-
Phase (Easwaran et al, 2004). In this study we further investigated the role of the Dnmt1 
interaction with the replication machinery by a detailed analysis of the PBD-PCNA 
interaction using different experimental approaches ((Schermelleh et al, 2007) see chapter 
2.1). By comparing PBD domains of different species, a highly conserved region termed 
PCNA-interacting peptide (PIP)-Box was detected and specific point mutations were 
introduced. These PBD point mutants abolish interaction with PCNA in vitro and in vivo 
and one point mutant Dnmt1Q162E was further used to determine the ability to restore 
methylation in mouse dnmt1-/- ES cells. Interestingly, we found that Dnmt1Q162E was able to 
restore methylation of single copy genes as well as of repetitive sequences in a similar 
fashion compared to wild type Dnmt1 suggesting that the catalytic activity is not impaired 
in Dnmt1Q162E. 
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Our data clearly imply that the PBD-PCNA interaction is highly transient, but not strictly 
required for the restoration of global methylation levels in vivo ((Schermelleh et al) see 
chapter 2.1). However, this interaction enhances the methylation efficiency by a factor of 
two and may thus function as an additional safety mechanism. This enhanced efficiency 
might be important in cell types that contain low Dnmt1 expression levels (Ratnam et al, 
2002; Robertson et al, 1999). In addition, Dnmt1 has also been found at sites of DNA 
repair mediated by a similar targeting mechanism via the PBD-PCNA interaction 
(Mortusewicz et al, 2005), thus contributing to genomic integrity by coupling epigenetic 
and genetic repair pathways. Furthermore, also other domains of the regulatory N-
terminus of Dnmt1 e.g. the TS domain are known to be responsible for targeting Dnmt1 to 
heterochromatic sites (Leonhardt et al, 1992; Easwaran et al, 2004).  
The TS domain is the largest regulatory subdomain within the N-terminal domain of Dnmt1 
and is a crucial structure involved in targeting Dnmt1 to heterochromatin, N-C terminal 
interaction, protein-protein interaction and catalytic activity (Easwaran et al, 2004; Fellinger 
et al, 2009; Leonhardt et al, 1992; Margot et al, 2000). Furthermore, the TS domain 
interacts with Np95 (Uhrf-1), a multi domain protein that is crucial and essential for DNA 
methylation (Bostick et al, 2007; Sharif et al, 2007; Fellinger, 2009). Strikingly, Np95 
knockout ES cells have a similar loss of genomic methylation compared to Dnmt1 
knockout ES cells underlining the crucial role of the TS-Np95 interaction in maintenance of 
DNA methylation (Feldman et al, 2006; Bostick et al, 2007; Sharif et al, 2007)see also 
figure Figure 2-4). Interestingly, the catalytic activity of a Dnmt1 mutant protein, lacking the 
complete TS domain, is not impaired as measured in vitro assays, while the catalytic 
activity is abolished in living cells (unpublished data Weihua Qin). Given the fact that in vitro 
assays were performed on naked DNA, which is not the physiological substrate of Dnmt1, 
a discrepancy between in vivo and in vitro studies might occur and underlines the 
importance to analyze the regulation and function of Dnmt1 in living cells.  
Several recent studies, resolving crystal structures of Dnmt1 fragments provided new hints 
to understand function and regulation of Dnmt1 (Song et al, 2011; Syeda et al, 2011; 
Takeshita et al, 2011). According to the crystal structure, the TS domain binds to the 
catalytic domain of Dnmt1 and thereby inhibits the catalytic activity of Dnmt1, the TS 
domain has to be released from the catalytic pocket in order to allow substrate binding by 
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the catalytic domain (Takeshita et al, 2011). Thus, the crystal structure of the TS domain 
suggests an inhibitory role of the TS for the catalytic activity of Dnmt1. Furthermore it was 
proposed that interaction of the TS domain with Np95 would then allow Dnmt1 to bind to 
its DNA target site (Syeda et al, 2011). This autoinhibitory role for the TS domain together 
with our own data showing that deletion of the TS leads to an abolishment of the catalytic 
activity of Dnmt1 sheds new light onto the functions of the TS domain and underlines its 
crucial role in Dnmt1. Further assays performed in living cells would be necessary to 
confirm the autoinhibitory role of the TS domain. For this purpose, mutagenesis based on 
the crystal structure followed by a rescue assay in ES cells would be necessary to 
determine the effect of Dnmt1 subdomains on catalytic activity in living cells.  
Given the critical role of the TS domain in catalytic activity and targeting of Dnmt1 to 
heterochromatin, this domain has been intensively studied in our own lab and is subject of 
ongoing work. We aim to determine potential interaction partners and characterize the 
respective binding properties in different cellular states. FRAP experiments using the 
isolated TS domain as well as several N-terminal deletion constructs demonstrated a 
surprisingly strong association to chromatin in the nucleus (unpublished data, Daniela 
Meilinger diploma thesis). This interaction seems to be independent of DNA methylation 
levels and Np95 interaction (unpublished data, Andrea Rottach). Preliminary data show 
that the isolated TS domain binds to H3K9me3 peptides in vitro (unpublished data, 
Patricia Wolf), a finding that is consistent with the clear enrichment of the TS domain within 
heterochromatin in vivo. 
The CXXC zinc finger motif of Dnmt1 has been proposed to be essential for substrate 
binding, allosteric activation and catalytic activity of Dnmt1, and was suggested to be 
involved in N-and C-terminal interaction (Margot et al, 2000; Fatemi et al, 2001; Pradhan 
et al, 2008). The available data regarding the binding specifies of the CXXC zinc finger of 
Dnmt1 are controversial, since they have used different construct length, places and size 
of deletion of Dnmt1 CXXC zinc finger and also used constructs from different species. To 
address the binding specificity and the function of the CXXC zinc finger of Dnmt1 we 
generated several deletion constructs and performed a detailed in vitro and in vivo analysis 
of those constructs (Frauer et al, 2011) see chapter2.1). In this study we used a precise 
deletion of the mouse zinc finger motif (aa 652-697), trying to prevent disruption of the 
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surrounding protein structure, as well as the isolated domain for in vitro analysis. To 
resolve the function of the CXXC finger domain and to clarify the role in DNA binding we 
performed an in vitro binding assay developed in our laboratory (Frauer & Leonhardt, 
2009). Our data showed that the CXXC zinc finger preferentially binds to unmethylated 
DNA in vitro. However, deletion of the zinc finger within the context of the full-length 
protein (Dnmt1ΔZn) did not impair the capability to restore DNA methylation in living cells.  
Taken together, our results suggest that the CXXC zinc finger domain of Dnmt1 is 
negligible for faithful DNA methylation maintenance in ES cells since deletion of the CXXC 
Zn finger within the context of the full-length protein (Dnmt1ΔZn) is able to restore 
methylation patterns similar to the wild type Dnmt1 enzyme. However, since only few 
sequences were analyzed, possible sequence specific effects cannot be excluded. 
Genome wide mapping of methylation would be a possible approach to study effects of 
Dnmt1ΔZn on specific sequences within the genome. In addition, long-term effects on a 
possible impaired DNA methylation maintenance cannot be excluded due to the fact that 
these results were done in a transient rescue experiment. Therefore, a cell line stably 
expressing Dnmt1ΔZn or even a mouse model would be necessary to address eventual 
long-term effects on DNA methylation maintenance. Furthermore, a mouse model would 
allow studying potential effects during differentiation, development and different cell types 
by following methylation level changes during differentiation and detailed analysis of 
different cell types.  
One possible function for the CXXC zinc finger domain of Dnmt1 could be an auto-
inhibitory effect due to the binding specifies of the zinc finger to unmethylated DNA 
sequences and therefore prevent aberrant de novo methylation of Dnmt1. Indeed, recent 
structural studies further support this hypothesis by showing co-crystal structures of 
Dnmt1 with unmethylated DNA where the CXXC zinc finger is proposed to bind to 
unmethylated DNA (Song et al, 2011). By binding to unmethylated DNA the CXXC zinc 
finger prevents the catalytic pocket of Dnmt1 to bind to its substrate. In addition, an in vitro 
DNA methylation activity assays could furthermore show an increased methylation activity 
of Dnmt1 on unmethylated substrates when the zinc finger is missing thus proposing a de 
novo methylation activity (Song et al, 2011). Notably, rescue experiments in ES cells using 
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wild type Dnmt1 and Dnmt1ΔZn showed that methylation at the imprinted promoter region 
of H19a remains unmethylated in both rescue experiments arguing against a possible de 
novo activity of Dnmt1 lacking the CXXC zinc finger. To fully investigate whether deletion of 
the CXXC zinc finger in Dnmt1 would lead to an increased de novo activity of Dnmt1 in 
living cells, rescue assays in unmethylated TKO cells should be performed and genome 
wide methylation levels analyzed.  
 
Figure 3-2 Domain overview of Dnmt1 with essential interaction partners and their influence on catalytic 
activity. The PBD domain of Dnmt1 interacts with PCNA enhances catalytic activity by two fold but deletion 
of this domain does not affect catalytic activity. The TS domain interacts with the UBL domain of Np95, 
H3K9me3 and is essential for catalytic activity. Np95 binds via the SRA domain to methylated DNA and 
recruits Dnmt1. The Zn finger binds unmethylated DNA (in vitro). Both, TS and Zn are involved in 
intramolecular N-C terminal interaction and thereby influence catalytic activity of Dnmt1 (autoinhibitory effect). 
The Zn finger seems dispensable for catalytic active in vivo.  
3.3 Dnmt1 and its role beyond DNA methylation maintenance  
Dnmt1 maintains DNA methylation patterns after replication and shows a clear preference 
for hemimethylated CpG sites, which occurs in post-replicative DNA sequences (Bestor & 
Ingram, 1983; Hermann et al, 2004b; Pradhan et al, 1999; Leonhardt et al, 1992). 
Whether Dnmt1 also features an additional de novo activity in vivo is yet unclear and still 
remains to be addressed. Dnmt1 has low, but detectable activity on unmethylated 
substrates in vitro (Frauer & Leonhardt, 2009). Moreover, overexpression of an Dnmt1 
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transgene in cancer cells lead to hypermethylation of imprinted promoter regions which 
might also hint to a possible de novo activity of Dnmt1 (Biniszkiewicz et al, 2002). The de 
novo activity of Dnmt1 was shown to be enhanced by proximal methylated CpG sites 
(Goyal et al, 2006; Tollefsbol & Hutchison, 1997). Notably, those studies were performed 
using in vitro assays and clear evidence for a de novo activity of Dnmt1 has yet to be 
shown in living cells. Up until now, determination of Dnmt1 methylation activity in vivo has 
been performed by rescuing dnmt1-/- ES cells and by a subsequent analysis of methylation 
level changes after re-introducing Dnmt1. However, since the de novo methyltransferases 
Dnmt3a and Dnmt3b are still expressed in those cells, a clear distinction between 
maintenance and de novo activity of Dnmt1 has not been possible so far.  Therefore, the 
generation of a methylation devoid triple knockout ES cell line (TKO) that lacks all three 
major methyltransferases, Dnmt1, Dnmt3a and Dnmt3b offered a new possibility to study 
methyltransferase activity in vivo (Tsumura et al, 2006). These TKO made it possible to 
distinguish de novo methylation activity from maintenance methylation activity by re-
expressing Dnmts and a careful subsequent methylation analysis.  
First, we transiently transfected TKO cells with a GFP-Dnmt1 expression construct and 
sorted for GFP-positive cells after 48 hours (see chapter 2.3). Notably, in none of the 
analyzed sequences was methylation above background detectable, which lead us to the 
establishment of stable expressing cell lines to investigate long-term effects and to be able 
to detect even rare de novo methylation events. With our new FACS based approach to 
generate stable cell lines (see chapter 3.1.1), we were able to generate TKO cell lines that 
stably express GFP-Dnmt1 and analyze the ability to restore methylation of unmethylated 
DNA. We established three different stable pools of TKO cells expressing GFP-Dnmt1 and 
generated single clones that express GFP-Dnmt1 comparable to endogenous dnmt1 
expression in wild type cells.  We analyzed samples from different time points, 3 and 6 
weeks after initial transfection, to monitor a possible accumulation of methylation over 
time. The methylation analysis of different stably expressing GFP-Dnmt1 cell lines and the 
analysis at different time points clearly shows that methylation levels in those rescued TKO 
cell lines are below the detection limit and indicate no measurable de novo activity of 
Dnmt1 in those cells. Clearly, our data provide strong evidence that Dnmt1 alone is not 
able to de novo methylate unmethylated substrate in vivo. However, we only analyzed 
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selected sequences, thus cannot exclude that methylation occurs at sites, which have 
been not accessed in our experimental approach. Within this context, it would be 
important to perform global as well as genome wide methylation analysis.   
As mentioned above, it has been shown in vitro that Dnmt1 does have a de novo activity 
particularly if proximal CpG sites were already methylated (Goyal et al, 2006; Tollefsbol & 
Hutchison, 1997). Recent work supports the hypothesis that Dnmt1 is involved in 
spreading of CpG methylation ((Arand et al) see chapter 2.4). A detailed bisulfite 
sequencing analysis based on a hairpin linker approach was used to determine 
methylation levels in dnmt1-/-, dnmt3a-/- dnmt3b-/- (DKO), and np95-/- ES cell lines. Using 
this approach it was possible to discriminate hemimethylated, fully methylated and 
unmethylated sites. Interestingly, based on this data set de novo activity of Dnmt1 at major 
satellite and IAP sequences was predicted via a mathematical model (see chapter 2.4). It 
should be noted that these data were obtained by comparing cell lines that are 
hypomethylated but not completely devoid of methylation as it is the case in TKO cells, 
thus are not contradicting with the inability of Dnmt1 to de novo methylate unmethylated 
substrate as we have observed in our rescue experiments outline above. Taken together, 
our data imply that Dnmt1 de novo activity in vivo seems to require the presence of pre-
existing methylated CpG sites. To address whether pre-existing proximal methylated sites 
in the TKO cell system initiates de novo methylation of Dnmt1, introduction of methylation 
in specific and clearly determined regions would be necessary to investigate this question 
in vivo.  
Finally, it should be noted that Dnmt1 is part of part of a complex epigenetic network 
where interacting factors exert an important accessory function and therefore in most 
cases not assessed in in vitro assays. However, those interacting factors are essential 
when determine and analyzing DNA methylation activity. To further investigate whether the 
interaction of Dnmt1 with Dnmt3a and Dnmt3b might influence or even activate a potential 
de novo activity of Dnmt1, it would be interesting to perform double rescue experiments in 
TKO cells with catalytic inactive Dnmt3a and Dnmt3b, respectively.  
Clearly, our data contradict in vitro data predicting de novo methylation activity of Dnmt1 
on unmethylated DNA. It should be noted that in vitro assays normally use naked DNA 
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oligonucleotides, where nucleosomes and thus chromatin compacting is missing. 
Additionally, the lack of interacting partner might influence Dnmt1 activity, leading to 
differences between in vitro and in vivo data. In TKO cells we were able to analyze the 
activity of Dnmt1 on DNA substrates within its physiological environment.  
3.4 Role of Np95 in methylation-dependent promoter silencing 
Np95 is an essential cofactor of DNA methylation maintenance. It is postulated that Np95 
binds to hemimethylated sites and recruits Dnmt1 by its interaction with the TS domain of 
Dnmt1 (Achour et al, 2008; Bostick et al, 2007; Sharif et al, 2007). Dnmt1 and Np95 
knockout cell lines show a strikingly similar hypomethylation and developmental arrest 
(Bostick et al, 2007; Muto et al, 2002) indicating that the lack of Np95 results in a loss of 
DNA methylation maintenance comparable to a Dnmt1 loss of function. Given the 
fundamental importance of Np95 in DNA methylation we raised the questions whether 
Np95 is involved in de novo methylation processes. To this aim, we investigated the role of 
Np95 as well as the methyltransferases Dnmt1, Dnmt3a and Dnmt3b in exogenous and 
endogenous promoters silencing processes ((Meilinger et al, 2009) see chapters 2.6 and 
2.7).   
3.4.1 Role of Np95 and DNA methyltransferases in exogenous promoter silencing 
processes 
By co-immunoprecitation experiments we found strong evidence that Np95 interacts with 
both de novo methyltransferases Dnmt3a and Dnmt3b in vitro and in vivo (Meilinger et al, 
2009) see chapter 2.6). Dnmt3a and Dnmt3b play crucial roles in gene silencing by setting 
new methylation marks in regulatory gene regions and we raised the question whether the 
interaction with Np95 plays a role in this process.   
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Figure 3-3: Domain overview of Np95 and interacting partners. The Ubl domain of Np95 interacts with the 
TS domain of Dnmt1, which is an essential interaction for DNA methylation maintenance. The Tudor domain 
binds H3K9me3 and SRA domain binds to hemimethylated DNA. Ubl, Tudor and SRA domain are involved 
in the interaction with the de novo methyltransferases Dnmt3a/3b. Np95 is involved in ectopic promoter 
silencing in vivo.  
In order to further investigate the functional significance of this interaction we developed a 
fluorescent reporter-silencing assay in ES cells ((Meilinger et al, 2009); see chapter 2.6). 
For this approach we utilized the observation that the commonly used cytomegalovirus 
(CMV) promoter for expression in mammalian cells is rapidly silenced in transient 
transfections of mouse ES cells. In contrast, the chimeric CMV early enhancer/chicken b-
actin (CAG) promoter remains stably active in wild type ES cells and thus is often used to 
generate stable cell lines. Accordingly, ES cells were simultaneously transfected with a red 
fluorescent protein (RFP) construct driven by the CMV promoter and a GFP construct 
driven by the CAG promoter. The fluorescent signal of both fluorescent markers was 
monitored up to 10 days and acquisition was performed using an automated imaging 
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system allowing a medium-throughput approach. With this assay we analyzed the 
decrease of the CMV driven fluorescence in comparison to the CAG driven GFP decrease 
in various cell lines lacking proteins that are involved in DNA methylation, as well as histone 
modifications. The fluorescence of the CMV promoter steadily decreased in wild type cells 
whereas dnmt1-/- ES cells showed a partly decreased silencing effect. Surprisingly, there 
was no decrease detectable in np95-/-, dnmt3a-/-/dnmt3b-/- (DKO) and TKO cells, arguing 
for an impaired silencing ability in those cell lines. Interesting was the impaired silencing 
effect observed in np95-/- ES cells, especially considering that those cells express all three 
active methyltransferases. We argue that the selective decrease of the CMV promoter 
driven fluorescence reflects a promoter silencing effect and we further explored the role of 
DNA methylation in this process by pyrosequencing both CAG and CMV promoter 
regions. Interestingly, we found that methylation was only detectable at the end point of 
our analysis in the CMV promoter region in wild type cells, suggesting that methylation 
plays no distinct role in the initiation of the observed silencing effect. Our data imply that 
the de novo methyltransferases Dnmt3a/3b and Np95 are involved in silencing of the CMV 
promoter. 
The dispensability/independence of DNA methylation in the initial silencing mechanism 
leads us to investigate the involvement of repressive histone marks and histone modifying 
proteins. For this purpose we analyzed knockout cell lines that are devoid of the H3K9 
methyltransferases G9a or Suv39h1/2, respectively. Notably, these histone 
methyltransferases are known to interact with Np95 as well as Dnmt1, Dnmt3a and 
Dnmt3b (Epsztejn-Litman et al, 2008; Kim et al, 2009). Furthermore, interaction of G9a 
with the de novo methyltransferase mediates de novo methylation of oct4 and nanog 
promoters during differentiation (Epsztejn-Litman et al, 2008; Feldman et al, 2006).  Data 
derived from our silencing assay indicated that G9a is required for silencing of the CMV 
promoter similar to a similar extent as Np95, Dnmt3a and Dnmt3b. Suv39h1/2 seems to 
be only partially involved. With regard to previous findings that plasmids are chromatinized 
upon transfection in mammalian cells (Mehta et al, 2009; Riu et al, 2007), it was expected 
to find histone modifying enzymes involved in silencing of the CMV promoter Whether a 
silenced CMV promoter exhibits heterochromatin marks such as H3K9me similar to native 
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marks observed in mammalian cells should be addressed by performing a Chromatin 
Immuno-precipitation (ChIP) assay.  
Our data clearly show that Np95 not only interacts with Dnmt1, but also with Dnm3a and 
Dnmt3b. Furthermore, we were able to demonstrate an involvement of Np95, Dnmt3a 
Dnmt3b and G9a in a silencing process that is initially independent of DNA methylation. 
Surprisingly, Dnmt1 is only partially involved in this process. With these observations we 
provide an additional co-regulatory role of Np95 with the de novo methyltransferases 
Dnmt3a and Dnmt3b and therefore provide deeper insight in the complex network of 
epigenetic silencing processes. 
3.4.2 Role of Np95 and DNA methyltransferases in endogenous promoter silencing  
Although our silencing assay provides a powerful tool to screen factors involved in 
silencing of ectopically expressed promoters, it is imperative to investigate the role of those 
factors on endogenous promoter silencing. It is of profound interest whether exogenous 
and endogenous promoter silencing share a common pathway. To this aim, we wanted to 
investigate the role of DNA methyltransferases as well as Np95 in silencing of pluripotency 
genes oct4 and nanog and the involvement of DNA methylation during differentiation (see 
chapter 2.7). Oct4 and nanog are pluripotency genes that undergo silencing and 
methylation upon differentiation (Li et al, 2007). We differentiated np95-/-,dnmt1-/- as well as 
their respective wild type cells into embryoid bodies (EBs) and analyzed changes of the 
methylation levels of oct4 and nanog promoters. These results were further compared to 
the transcript levels of oct4 and nanog during differentiation. 
Consistent with our previous findings on CMV promoter silencing, down regulation of oct4 
and nanog transcripts precedes promoter methylation.  Interestingly, methylation levels of 
oct4 and nanog promoters were similar in np95-/- and dnmt1-/- knockout cell lines and 
reached a plateau around 6 days after initiation of differentiation. This methylation is most 
likely carried out by the de novo methyltransferases Dnmt3a and Dnmt3b since they are 
both present in the analyzed cells and a synergistic function of Dnmt3a and Dnmt3b in 
methylation of oct4 and nanog promoters has been reported previously (Li et al., 2007). 
However, the similar observed initial methylation increase in np95-/- and dnmt1-/- knockout 
cell lines argues that de novo methylation catalyzed by Dnmt3a and Dnmt3b is not 
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impaired in np95-/-ES cells. These findings do not support our hypothesis that interaction 
of Np95 with the de novo methyltransferases Dnmt3a/3b is involved in silencing of 
endogenous promoters. To test whether de novo activity of Dnmt3a and Dnmt3b is not or 
only slightly impaired in the absence of Np95, one could establish a stable cell line 
expressing a Np95 construct where interaction with Dnmt3a and Dnmt3b is disrupted, 
followed by an analysis of methylation levels during differentiation.  
Furthermore, methylation levels by far do not reach those observed in wild type cells and 
more importantly a slight but notable decrease in methylation levels was observed in 
dnmt1-/- ES cells most likely due to the lack of DNA methylation maintenance. Surprisingly, 
no such decrease was observed in np95-/- ES cells, even though the catalytic activity of 
Dnmt1 is highly controlled by its interaction with Np95. These findings could argue for a 
residual methylation activity of Dnmt1 independent of Np95, or for the concerted action of 
the de novo methyltransferases Dnmt3a and Dnmt3b in maintaining DNA methylation 
maintenance. Another possibility explaining this residual methylation would be a functional 
redundancy of Np97 to Np95 in maintaining DNA methylation. Np97 is a recently 
discovered protein that comprises similar domain structures as Np95. In addition we have 
shown recently that Np97 is upregulated during differentiation (Pichler et.al. 2011; see 
chapter 2.5), which could hint to a compensating role Np97.  
Taken together, our data show that initial silencing of the pluripotency genes oct4 and 
nanog does not depend on the involvement of Np95, Dnmt1 and Dnmt3a/b and argue for 
a different silencing pathway than we have observed in CMV promoter silencing. Similar to 
the involvement of histone methyltransferases in silencing of the CMV promoter, histone 
modification and histone modifying enzymes are also involved in silencing of endogenous 
promoters (Myant et al, 2011; Feldman et al, 2006). It was shown that G9a mediated 
methylation of H3K9 and silencing of the oct4 promoter during retinoic acid treatment 
precedes methylation of the promoter region (Feldman et al, 2006). These data imply a 
model where histone modifications like H3K9me3 are involved in an initial silencing 
processes and histone modifications as well as interaction between histone modifying 
enzymes and DNA methyltransferases are essential for long term silencing processes.  
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3.5 Differentiation of ES cells lacking all three major methyltransferases and silencing of 
pluripotency genes 
With the CMV promoter silencing assay we showed that silencing of the retroviral CMV 
promoter was impaired in TKO cells (see chapter 2.6). When differentiating TKO cells into 
embryoid bodies (EBs), we observed that the EBs were smaller when compared to wild 
type EBs. Interestingly, we did not observe a change in apoptosis rate, which has been 
suggested to increase during differentiation of hypomethylated cells (Lei et al, 1996; 
Panning & Jaenisch, 1996; Jackson et al, 2004). To test whether the differentiation 
potential of TKO is impaired in comparison to wild type ES cells, we analyzed the 
expression of pluripotency genes oct4 and nanog, which should decrease with the level of 
differentiation. During differentiation of TKO cells into EBs oct4 and nanog mRNA levels 
decline during the first 4 days of differentiation in a similar timely manner as during wild 
type differentiation. This was a remarkable observation considering that TKO cells have no 
active methyltransferases, but are still able to down regulate pluripotency genes in vivo, 
indicating that no active DNA methyltransferases are involved in this initial silencing 
process. Our findings suggest that TKO cells have differentiation potential, yet it has to be 
determined to which extent. In accordance to our findings, recent studies showed that 
TKO cells are able to develop into embryonic and extraembryonic cell types (Sakaue et al, 
2010). It would be of profound interest to characterize TKO EB’s and determine their 
differentiation potential by analyzing genome wide expression profiles as well as cell type 
and lineage specific marker proteins, which is in work progress.  
However, mRNA levels were not completely down regulated as observed in wild type cells 
and stagnate at a residual level of around 20%, arguing for an important role of 
methylation at a later stage in the silencing process and suggest the requirement of DNA 
methylation for complete silencing.   
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Figure 3-4: Schematic representation of relative expression level changes and quantitative methylation level 
changes during EB differentiation. ES cells and subsequent EB formation is shown with representative 
images in the upper panel at day 0, day 4 and day 20 of differentiation. ES cells and EBs are stained with 
DAPI and kindly provided by Irina Solovei. The expression levels of pluripotency genes decline fast after 
onset of differentiation (blue line). In contrast, methylation levels begin to increase with a delay at day 4 of 
differentiation (red line).   
Our data provide strong evidence that methylation and DNA methyltransferases are not 
involved in the initial process of differentiation and that down regulation of the pluripotency 
genes oct4 and nanog do not primarily depend on the contribution of any known active 
methyltransferases. In fact, DNA methylation is a process that occurs later in the 
differentiation process and might be involved in long term silencing. We are currently 
working on the question whether cells that are impaired in DNA methyltransferase activity 
are able to reverse the differentiation process. To address this question, we generated 
stable wild type and TKO cell lines that express a fluorescent marker (GFP) under the 
endogenous oct4 promoter (see chapter 2.8). Having in hand a fluorescent read out, we 
are able to follow the differentiation and de-differentiation process by FACS as well as by 
fluorescence microscopy. Preliminary data show that a recovery of the GFP signal by the 
addition of LIF and therefore subsequent initiation of a de-differentiation process is evident 
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only in TKO but not wild type cells. These results would support the hypothesis that 
methylation is involved in a long-term silencing pathway.  
 
In conclusion we investigated the role of the Dnmt1 subdomains PBD and the CXXC zinc 
finger motif in faithful methylation maintenance and our data suggest that both domains 
seem dispensable for enzymatic activity of Dnmt1 and maintenance of DNA methylation in 
living cells. However, the PBD domain enhances DNA methylation efficiency by two-fold. 
Moreover, we provide data regarding the involvement of Dnmt1 in de novo methylation, 
which was controversially discussed previously and we clearly showed that Dnmt1 is not 
able to de novo methylate unmethylated DNA sequences in living cells. Given the fact the 
Np95 is such a crucial factor in DNA methylation maintenance and links DNA methylation 
with histone modifications, we investigated its role in de novo methylation and silencing of 
promoter sequences. We found strong evidence that Np95, together with the de novo 
methyltransferases Dnm3a/Dnmt3b and the histone methyltransferase G9a is involved in 
this silencing pathway. The above findings initiated a detailed methylation and expression 
analysis of pluripotency factors during differentiation. We obtained clear data supporting 
the hypothesis that methylation is dispensable for initiation of differentiation but suggests 
that methylation is required for stable and long term gene silencing.  
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4.2 Abbreviations  
5-aza-dC 5-aza-2'-deoxycytidine 
5hmC 5 hydroxymethyl-cytosine 
5mC 5 methyl-cytosine 
aa amino acids 
amp ampicilline 
BAH bromo adjacent homology domain 
CAG chicken beta actin 
CMV cytomegalie virus 
COBRA combined bisulfite restriction analysis 
CpG cytosine-phosphatidyl-guanine 
DAPI 4’,6-diamidino-2’-phenylindole dihydrochloride 
DKO  dnmt3a-/-3b-/- double knockout ESCs 
DNA desoxyribonucleid acid 
Dnmt DNA methyltransferase 
EB embryoid body 
ES embryonic stemcells  
ESCs ES cells 
F2H fluorescence two-hybrid 
FACS fluorescence activated cell sorting 
FRAP fluorescence recovery after photo bleaching 
GFP green fluorescent protein 
H3K4me histone 3 lysine 4 methylation 
H3K9me3 histone 3 lysine 8 trimethylation 
HDACs histone deacetylases 
HP1 heterochromatin protein 1 
IAP intracisternal A-type particle 
ICF immunodeficiency, centromere instability and facial anomalies 
ICM  inner cell mass 
IPS induced pluripotent stem cell 
LIF leukemia inhibitory factor 
LSD1 lysine specific demethylase 
Lsh lymphoid specific helicase 
MBD methyl CpG binding domain 
MeCP2 Methyl CpG binding protein 2 
mRFP monomeric red fluorescent protein 
NLS nuclear localization signal 
Np nuclear protein 
Np95 nuclear protein 95kDa 
Np97 nuclear protein 97kDa 
PBD PCNA binding domain 
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PCNA proliferating cell nuclear antigen 
PCR polymerase chain reaction 
PGC primordial germ cell 
PH pericentic heterochromatin 
PHD plant homeo domain 
PWWP proline-tryptophane-tryptophane-proline motif 
RF replication foci 
RING really interesting new gene 
S-phase  synthesis phase 
SRA SET and RING associated domain 
SUV39H1 suppressor of variegation 3-9 homolog 1 
TKO dnmt1-/-3a-/-3b-/- triple knockout ESCs 
TMAC tetramethylammonium chloride 
TS targeting sequence 
UBL ubiquitin-like domain 
UHRF ubiquitin-like, containing PHD and RING finger domains  
wt wildtype 
ZnF zinc finger 
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4.3 Contributions 
Declarat ion of contr ibut ions to “Dynamics of Dnmt1 interact ion with the 
repl icat ion machinery and i ts ro le in postrepl icat ive maintenance of DNA 
methylat ion” (see chapter 2.1) 
This study was conceived by Heinrich Leonhardt and Lothar Schermelleh. I performed the 
bisulfite sequencing methylation analysis of the skeletal α-actin promoter and prepared 
supplementary figure 5. I established and performed a COBRA assay for IAP-LTRs and 
prepared figure 4 (A). The manuscript was written with Lothar Shermelleh and Heinrich 
Leonhardt. 
Declarat ion of contr ibut ions to “Di f ferent binding propert ies and funct ional 
re levance of CXXC z inc f inger domains in Dnmt1 and Tet1” (see chapter 2.2) 	  
This study was conceived by Heinrich Leonhardt, Carina Frauer, Andrea Rottach and 
Fabio Spada. I performed the rescue assay in ES cells and analyzed methylation by 
pyrosequencing. I contributed and prepared figure 5, wrote the figure legend and the 
corresponding material and methods section. Heinrich Leonhardt, Carina Frauer and 
Andrea Rottach wrote the manuscript.  
Declarat ion of contr ibut ions to “De novo Act iv i ty of DNA Methyl t ransferase 1 in 
Tr ip le Knock-out mouse ES cel ls” (see chapter 2.3) 
I conceived and laid out the project aims together with Heinrich Leonhardt and Fabio 
Spada. I generated the stably expressing Dnmt1 TKO cell lines and performed the 
transient rescue assays in TKO cells. I designed and established the protocols for the 
bisulfite pyrosequencing methylation analysis for all analyzed sequences. I developed a 
FACS based assay to establish stable TKO cells and performed the FACS sorting myself. I 
wrote the preliminary manuscript with the help of Heinrich Leonhardt.  
Declarat ion of contr ibut ions to “DNA-methylat ion of CpG dyads and markov 
model ing of DNA-methylat ion contro l  in mammals”(see chapter 2.4) 
This study was conceived by Jörn Walter and Julia Arand. I isolated the genomic DNA of 
the knock out ES cells. Jörn Walter and Julia Arand wrote the manuscript.  
Declarat ion of contr ibut ions to “Cooperat ive DNA and histone binding by Uhrf2 
l inks the two major repressive epigenet ic pathways” (see chapter 2.5) 
This study was conceived by Garwin Pichler and Heinrich Leonhardt. I performed the 
rescue assay in ES cells and analyzed the methylation analysis by pyrosequencing.  I 
contributed and prepared figure 5 and wrote the corresponding material and methods 
section. Garwin Pichler wrote the manuscript with the help of Heinrich Leonhardt.  
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Declarat ion of contr ibut ions to “Np95 interacts with de novo DNA 
methyl t ransferases Dnmt3a and 3b and mediates epigenet ic s i lencing.” (see 
chapter 2.6) 
This study was conceived by me, Heinrich Leonhardt and Fabio Spada. I developed the 
CMV promoter silencing assay in ES cells and performed the silencing assay experiments 
with the help of Sebastian Bultmann. I performed the cell sorting myself on a FACS ARIA II. 
I designed and performed the methylation analysis of CAG and CMV promoter. I prepared 
figures 2, 3 and supplementary figures 4, 5 wrote the corresponding figure legends and 
materials and methods sections. Karin Fellinger designed and performed all biochemical 
experiments and identified and mapped the interactions described. I helped writing the 
manuscript together with Karin Fellinger, Fabio Spada and Heinrich Leonhardt. 
Declarat ion of contr ibut ions to “Role of DNA methylat ion in s i lencing of 
p lur ipotency genes dur ing embryonic stem cel l  d i f ferent iat ion” (see chapter 2.7) 
I conceived and laid out the project aims together with Sebastian Bultmann, Heinrich 
Leonhardt and Fabio Spada. I differentiate ES cells into EBs with the help of Sebastian 
Bultmann. I designed and established the protocols for the bisulfite pyrosequencing 
methylation analysis for the pluripotency genes oct and nanog. I performed the methylation 
analysis of the promoter regions during differentiation. I established the stable cell lines 
expressing GFP under the oct4 promoter together with Sebastian Bultmann. Christine 
Schmidt established and performed the expression analysis of the pluripotency genes oct 
and nanog. I wrote the preliminary manuscript with the help of Heinrich Leonhardt.  
Declarat ion of contr ibut ions to “ Ident i f icat ion of d i f ferent iat ing area” (see chapter 
2.8) 
This application note was conceived by Stefan Letzsch (PerkinElmer). I established the 
stable cell lines expressing GFP under the oct4 promoter, differentiated them into EBs and 
fixed samples at day 4 and 8 with the help of Sebastian Bultmann. I wrote the material and 
methods section. The application note was written Stefan Letzsch. 
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Declaration According to the “Promotionsordnung der LMU München für die 
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